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A significant proportion of people with depression do not experience expected 
improvement following treatment and are considered to have treatment resistant depression. 
Despite this, there is relatively little research exploring the experiences of this group, who 
represent a significant minority of those who experience depression. The current study 
explored how people with treatment resistant depression make sense of depression that has 
not resolved following adherence to professional advice and treatment. The accounts of nine 
people with treatment resistant depression recruited from a private psychiatry practice in 
Auckland, New Zealand were analysed using narrative analysis. The participants told stories 
about what it was like to experience depression that persisted over many years using two 
narratives: that of order and of disorder. The narrative of order was used to organise and make 
predictable their experiences. The narrative of disorder was used to describe the ways their 
depression defied predictability and management. The participants also told stories to account 
for why they had remained depressed long-term despite receiving treatment. At times, 
participants attributed their persistent distress to having a treatment resistant brain or 
personality. There were also two alternative accountings - a narrative of bad patient behaviour 
and a narrative of it just taking some time to find a suitable medication. These accounts were 
strongly shaped by narratives of mental distress and recovery that suggest that depression 
follows predictable patterns and that treatment results in resolution of symptoms. Today, 
these narratives are increasingly encompassed by powerful and pervasive narratives of 
neoliberalism. The participants in this research emphasised personal accountability and self-
management, and self-blame when they did not achieve the desired and expected outcome of 
resolution of symptoms. The implications of these findings for those experiencing persistent 
distress, such as TRD, as well as for health professionals working in mental health domains 
are discussed.  
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CHAPTER ONE: INTRODUCTION 
Depression 
Major depressive disorder (hereafter referred to as depression) is traditionally conceptualised 
as a condition that involves sad, empty, or irritable mood, and physical and cognitive changes that 
impair a person’s functioning (American Psychiatric Association, 2013). From a mainstream 
perspective, it is a clinical condition objectively defined by symptom-based diagnostic classification 
systems, such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the 
International Classification of Diseases (ICD). According to the most recent edition of the DSM, 
depression is characterised by the presence of at least five of the following symptoms: depressed 
mood, marked loss of interest or pleasure in usual activities, weight gain or loss, insomnia or 
hypersomnia, psychomotor retardation or agitation, fatigue, difficulties with concentration, feelings 
of guilt or worthlessness, and recurrent thoughts of suicide or death (American Psychiatric 
Association, 2013). For a diagnosis to be made, at least one of the symptoms must be depressed 
mood or marked loss of interest or pleasure in usual activities. These symptoms, which are broadly 
arranged in cognitive, physical, and emotional clusters, must be present most of the day, nearly every 
day, for a period of at least two weeks and lead to significant impairment or distress for the affected 
person.  
Depression has been named the leading cause of disability worldwide by the World Health 
Organisation (World Health Organisation, 2019). It has been associated with significant impairment, 
physical and mental comorbidity, and mortality. Depression is also highly prevalent in New Zealand. 
According to the most recent New Zealand Health Survey, the lifetime prevalence of depression 
among New Zealanders is approximately 16% (Ministry of Health, 2019). This means that 
approximately 620,000 New Zealanders have been affected by depression, although this is likely an 
underestimation as the Health Survey definition requires people to have been diagnosed by a medical 




in areas of high economic deprivation (Ministry of Health, 2019). This is likely due to the 
association between mental distress and social and economic inequality (Health Promotion Agency, 
2018).  
Treatment resistant depression (TRD) 
Despite the emergence of new depression treatments over recent years, a significant 
proportion of people experiencing depression do not experience recovery as expected following 
treatment. In the 1970s, the term ‘treatment resistant depression’ (TRD) emerged in the literature to 
describe this group (Murphy, Sarris, & Byrne, 2017). TRD is not a diagnosis present in diagnostic 
classification systems, such as the DSM or the ICD. Instead, it is a broad label applied to people with 
depression who experience non-response to treatment. Whilst TRD has been the focus of increasing 
study, there is a lack of consensus around some basic issues, such as the way it is defined and 
conceptualised as well as its aetiology (Wijeratne & Perminder, 2008).  
Definitions of TRD. There is general consensus in both academic literature and clinical 
settings that TRD is characterised by the presence of diagnosable depression as well as non-response 
to treatment (Wijeratne & Perminder, 2008). Beyond this, however, systematic reviews of TRD 
studies have highlighted considerable heterogeneity in the way TRD is understood and defined 
(Brown et al., 2019). Additionally, definitions have not been provided or suggested by health 
guidance bodies, such as the National Institute for Health and Care Excellence. Broadly, there are 
two predominant approaches to conceptualising TRD: a definitional approach, in which a person is 
categorised as having TRD if they fit a simple definition, and a staging model approach, in which a 
person’s treatment resistance is assessed based on progression through a model outlining treatment 
steps.  
Within the definitional approach, a person is said to have TRD when they are experiencing 
depression and have not responded to a number of treatments. This approach appears to offer a 




people with depression that does not. However, there is little consensus on the details, with 
employed definitions varying in a number of ways. One recent study found that across the 150 
studies included in their systematic review, there were 155 slightly varying TRD definitions used 
(Brown et al., 2019). The definitions differed in terms of level of detail provided, forms of treatments 
considered, details of what constituted an adequate dose and duration of treatment, as well as the 
number of failed treatment rounds required. For example, some merely stated that participants had 
failed to respond to one antidepressant medication (with no reference to dose or duration), whereas 
others provided specific details about dose, duration, type, and class of pharmacological treatments. 
In terms of treatments considered, the majority of studies only considered pharmacological 
treatments – usually only antidepressants, but sometimes also mood stabilisers or electroconvulsive 
therapy. Additionally, the number of treatments required to meet treatment resistant criteria ranged 
from one to six (Brown et al., 2019). This variation in TRD definitions means that studies are not 
exploring a homogenous group, and that there are significant variations in study findings.  
Whilst there is significant heterogeneity in definitions employed, there appear to be some 
areas where there is more consensus. There is general agreement that ‘response’ to treatment 
constitutes a 50% reduction in depression severity, based on the scores of a standardised depression 
rating scale (Wijeratne & Perminder, 2008). Additionally, Brown et al. (2019) concluded that the 
mostly commonly adopted definition of TRD was an episode of depression that had not responded to 
two or more rounds of antidepressant medication at an adequate dose and duration. This appears to 
be supported by the findings of The Sequenced Treatment Alternatives to Relieve Depression 
(STAR*D) study, the largest study to date to evaluate the effectiveness of pharmacological 
depression treatments, which found that the chances of a person responding to and achieving 
remission following antidepressant treatment reduced dramatically after the second antidepressant 




50.3% of studies employing this definition, its position as the most commonly employed definition is 
marginal (Brown et al., 2019).  
Definitional approaches to conceptualising TRD have been criticised for oversimplifying the 
construct of TRD and for treating response to treatment as categorical (e.g., people either do or do 
not respond to treatment) rather than dimensional (Ruhé, van Rooijen, Spijker, Peeters, & Schene, 
2012). As a result, several arguably more nuanced staging models for capturing treatment resistance 
have been proposed (Murphy et al., 2017). Staging models go beyond the presence or absence of 
TRD to evaluate people in terms of the extent of treatment they have received. They place people 
with depression on a scale of treatment resistance according to the number of ineffective trials they 
have experienced, the duration of their depressive episodes, and the types of treatments they have 
tried (Mazo, Neznanov, & Krizhanovskii, 2016). 
In their systematic review, Ruhé et al. (2012) identified a total of five staging models. The 
Antidepressant Treatment History Form, the first staging model to be developed, was originally 
created with the purpose of evaluating vigorousness of any antidepressant treatments a person had 
received prior to commencing electroconvulsive therapy (Sackeim et al., 1990). When using the 
Antidepressant Treatment History Form, each treatment round in the current episode of depression is 
assigned an adequacy score on a 0 to 5 scale based on treatment type and duration, and an overall 
score is calculated. Several years later, the Thase and Rush Staging Model was developed as a tool 
for guiding psychiatrists in clinical practice (Thase & Rush, 1997). Within this tool, people with 
depression are assigned to categories, ranging from stage I to stage V, based on the number and types 
of failed treatment rounds they have experienced. The European Staging Model (Souery et al., 1999) 
was developed at a similar time as an alternative to the Thase and Rush Staging Model, and also 
assigns people to graded categories ranging from ‘non-responder’ to ‘TRD’ to ‘chronic resistant 




In response to criticisms of these various models, Fava (2003) adapted the Thase and Rush 
Staging Model to develop the Massachusetts General Hospital Staging Model. These adaptations 
included the addition of more treatment types, removal of the hierarchy system of antidepressant 
classes and strategies, and a switch to dimensional scoring rather than a categorical system. The most 
recent staging model to be developed is the Maudsley Staging Model (Fekadu, Wooderson, 
Donaldson, Markopoulou, & Masterson, 2009). This version calculates an overall treatment 
resistance score based on duration and severity of depression, number of antidepressant treatment 
failures experienced, and whether or not other treatment strategies such as augmentation of 
electroconvulsive therapy have been employed. Despite their similarities, staging models have 
gradually evolved from assigning a person to a treatment resistance category based purely on 
perceived adequacy of each treatment trial (e.g., Sackeim et al., 1990) to models that are based on 
multiple relevant factors and are less categorical in nature (e.g., Fekadu, Wooderson, Donaldson, et 
al., 2009).  
However, as with the definitional approach, there have been criticisms of the use of staging 
models in conceptualising TRD as these approaches predominantly focus on progression through 
pharmacological treatment options. Some argue that many factors influence treatment response, 
including a range of biopsychosocial factors, and that these should be factored into any model aimed 
at evaluating treatment resistance (Mazo et al., 2016). Additionally, despite growing evidence for the 
effectiveness of psychotherapeutic treatments for TRD (e.g., Ijaz et al., 2018), none of the staging 
models take psychological treatments into consideration and only one includes non-pharmacological 
treatment (in the form of electroconvulsive therapy) (Ruhé et al., 2012). Additionally, none have 
been thoroughly evaluated. Consistent with the definitional approach, there is not one staging model 
that has been accepted for widespread use, so different models are employed across research and 




Not only is there a lack of consensus on TRD definitions within the academic domain, but 
there also appears to be little overlap between academic understandings and usage in clinical 
settings. Brown et al. (2019) interviewed health professionals about TRD definitions employed in 
clinical practice and found significant disconnects between research and practice. Rather than 
judging non-response based on number of failed treatments, health professionals described 
considering multiple characteristics of the individual and their context (Brown et al., 2019). Labels 
such as ‘treatment resistant’ were not commonly employed in clinical realms, either in interactions 
with patients or between health professionals. Instead, health professionals described using terms 
such as ‘complex needs’ and ‘struggled throughout their life’. Additionally, whilst most definitions 
and staging models only take pharmacological treatment into consideration, this was not reported to 
be the case in clinical practice. When asked how they would define TRD, even if not used in 
practice, participants reported that patients would need to have received an adequate trial of 
psychotherapy as well as two to three rounds of antidepressant medications to be considered 
treatment resistant. This incongruence between academic and clinical understandings likely impedes 
the application of research findings to clinical practice.  
Although the construct of TRD first appeared in the medical literature close to 50 years ago, 
there remains little consensus on how it should be defined or conceptualised and major incongruence 
between academic ideas and clinical practice. These conceptual issues have consequences for 
research focused on TRD, in terms of estimating prevalence, identifying risk factors, and evaluating 
which treatments are the most effective. These conceptual issues also have significant implications 
for both people with depression and their families, as well as health professionals working in the 
field. Despite the apparent issues relating to the manner in which TRD is defined and conceptualised, 
the term TRD is used throughout this thesis. In the context of this research, it is referred to, not as a 




used to describe people with depression who have not experienced the expected improvement 
following treatment. 
Comparisons to other forms of depression. Several other categories of persistent 
depression have been proposed and employed. These categories tend to be confused with the 
construct of TRD. For example, in the previous version of the DSM, the DSM-IV, there were three 
potential diagnoses for people experiencing persistent forms of depression: dysthymic disorder, 
major depressive disorder with chronic specifier, and major depressive disorder with recurrent 
specifier (American Psychiatric Association, 2000). These diagnoses are commonly referred to in the 
literature as ‘dysthymia’, ‘chronic depression’, and ‘recurrent depression’ respectively and will be 
referred to as such hereafter. These terms and diagnostic categories are sometimes used 
interchangeably with TRD and, whilst there can be overlap (Spijker, van Straten, Bockting, 
Meeuwissen, & van Balkom, 2013), there are some important differences that should be noted. 
Approximately 75% of people who experience a single episode of depression will go on to 
experience multiple episodes later in life (Hollon & Beck, 1994). The experience of multiple distinct 
episodes of depression with full inter-episode remission was previously diagnosed in the DSM-IV as 
recurrent depression (American Psychiatric Association, 2000). In comparison to people with TRD, 
who may experience some response to treatment but not full remission, people with recurrent 
depression experience full remission between episodes. Additionally, there is no evidence to suggest 
that people with recurrent depression experience problems with treatment response (Gelenberg, 
Kocsis, McCullough Jr, Ninan, & Thase, 2006).  
Some people describe experiences of symptoms of low mood that persist, and the DSM-IV 
classified such experiences as either dysthymia or chronic depression. Whilst an acute episode of 
depression has an average duration of two to five months (Kessler et al., 2003), to be diagnosed with 
dysthymia or chronic depression, a person must continually meet diagnostic criteria for a period of at 




depression diagnosis, full depression criteria of five or more symptoms must be met, whereas for a 
dysthymia diagnosis, only two depression symptoms need be present. It is also this lesser severity 
that differentiates dysthymia from TRD, as to be deemed ‘treatment resistant’ a person must meet 
full criteria for depression.  
The diagnosis most commonly conflated with TRD appears to be chronic depression, which 
is thought to affect approximately 15-25% of people with depression (Bschor, Bauer, & Adli, 2014; 
Hollon & Beck, 1994). However, the widespread belief that chronic depression persists because it is 
treatment resistant has been increasingly challenged (Michalak & Lam, 2002). The two forms of 
depression are said to have different aetiologies and prognoses (Moore & Garland, 2003). Rather 
than persisting due to treatment resistance, chronic depression appears to persist, in part, due to 
inadequate treatment. One study found that only approximately 25% of people with chronic 
depression had experienced failure to respond to antidepressant medication (Gelenberg et al., 2006). 
However, as many as 66% of participants with chronic depression had not yet received an adequate 
trial of antidepressant medication despite experiencing depression for two years or more (Kocsis et 
al., 2008). When issues of treatment inadequacy are addressed, such as low doses of antidepressants, 
short durations of treatment, or lack of exposure to evidence-based psychotherapy, it appears that 
chronic depression often responds favourably to treatment (Gelenberg et al., 2006; Michalak & Lam, 
2002). This differentiates it from TRD, which is defined by lack of improvement despite adequate 
healthcare input.  
With the latest revision of the DSM, the DSM-5, an overarching diagnostic category for all 
persistent forms of depression, labelled persistent depression disorder (PDD), has been created 
(American Psychiatric Association, 2013). This occurred in light of findings of few demographic, 
clinical, or psychosocial differences between people with dysthymia, chronic depression, and 
recurrent depression (Bschor et al., 2014; McCullough et al., 2003; Moore & Garland, 2003). To 




for a minimum of two years (American Psychiatric Association, 2013). PDD differs from TRD in 
that fewer symptoms are required for diagnosis. PDD requires presence of only two depression 
symptoms, whereas TRD requires a full diagnosis of depression, where five or more depression 
symptoms are present. Additionally, there is no evidence to suggest that people with PDD encounter 
difficulties with treatment response. As this change occurred relatively recently in 2013, a significant 
proportion of the existing literature on persisting forms of depression uses the terms chronic 
depression and recurrent depression. 
Whilst there may be overlap between the various forms of persistent depression (Spijker et 
al., 2013), TRD appears to differ from dysthymia, chronic depression, recurrent depression, and PDD 
in the way that individuals with TRD must meet full criteria for depression, be seeking help from 
health professionals, have failed to respond to at least two rounds of antidepressant medication at an 
adequate dose and duration, and not have experienced periods of remission. These factors suggest 
that the experiences and understandings of people with TRD may be unique.  
Prevalence of TRD. The previously described heterogeneity in TRD definitions has led to 
significant difficulty in estimating prevalence (Nemeroff, 2007). Reported rates of TRD among 
people experiencing depression vary according to the TRD definition employed in study inclusion 
criteria (Murphy et al., 2017). Studies exploring the efficacy of treatments for depression give some 
insight into just how common it may be to continue to experience depressive symptoms even after 
receiving treatment. The STAR*D study is considered the largest, most comprehensive, and most 
community representative study to date to evaluate the efficacy of pharmacological depression 
treatments (Rush et al., 2008). Of the sample of over 4000 outpatients with depression, only 
approximately 50% responded (defined as 50% reduction on a depression measure) and 37% 
achieved remission (defined as a score of 5 on a depression measure) following the first round of 
antidepressant medication. Response rates to subsequent trials are unavailable, however, 50% of the 




remission after four rounds of treatment (Rush et al., 2008). New Zealand prevalence rates of TRD 
are unavailable, as data are only collected for major mental disorders, such as major depressive 
disorder. However, these international findings suggest that TRD is a substantive issue - representing 
a significant minority of those experiencing depression.  
Causes of TRD – patient characteristics. Many studies have explored potential predictors 
of TRD in the hope of prospectively identifying people with depression who are less likely to 
respond to treatment. In recent years, a plethora of predictors found to be associated with TRD have 
been reported. Several factors linked to the clinical presentation of the individual have been 
associated with TRD. These include experiences of depressive episodes that are more severe (e.g., 
Gronemann, Jorgensen, Nordentoft, Andersen, & Osler, 2020), have an earlier age of onset (e.g., 
Dudek et al., 2010), and have melancholic features (e.g., Souery et al., 2007). Other clinical factors 
include presence of comorbid anxiety disorders, moderate to high suicide risk, experience of 
previous hospitalisations for depression, and non-response to the first antidepressant ever taken (e.g., 
Gronemann et al., 2020; Souery et al., 2007). A number of psychosocial factors have also been 
linked to TRD. Firstly, personality has been implicated in poor response to depression treatments, 
with some studies reporting associations between TRD and personality disorders (e.g., Papakostas et 
al., 2003) or personality traits, such as high neuroticism or low extraversion (e.g., Takahashi et al., 
2013). Additionally, factors such as experience of stressful life events, trauma, financial difficulties, 
and relationship problems have been described as common among people with TRD (e.g., Amital, 
Fostick, Silberman, Beckman, & Spivak, 2008; Tunnard et al., 2014). Older age is the only 
demographic factors that has been associated with non-response to treatment, with one study 
reporting increased risk among those aged 65-84 years (Gronemann et al., 2020).  
A growing body of literature has also focused on biological and genetic predictors of non-
response to treatment among people with depression. In terms of biological factors, several authors 




TRD. For example, TRD has been linked to decreased concentrations of inhibitory amino acid 
neurotransmitter γ-amino-butyric acid (GABA) in the occipital cortex and anterior cingulate cortex 
(Price et al., 2009), as well as disturbances in the hypothalamic-pituitary-adrenal (HPA) axis, which 
is central to a person’s stress response (Carvalho, Torre, & Papadopoulos, 2013). More recently, 
there has been increasing interest in the association between activation of the body’s inflammatory 
system and non-response to treatment (Carvalho et al., 2013; Kubera, Basta-Kaim, Wrobel, Maes, & 
Dudek, 2004). Genetically, poor response to treatment has been associated with a range of gene 
polymorphisms. For example, Anttila et al. (2007) reported that people with depression carrying the 
combination of polymorphisms in both BDNF and serotonin type1A (5-HT1A) had a three times 
higher likelihood of experiencing TRD.  
Two systematic reviews have attempted to make sense of the array of findings regarding 
predictors of non-response to treatment in depression (Bennabi et al., 2015; De Carlo, Calati, & 
Serretti, 2016). Recognising the conceptual issues relating to TRD, the systematic reviews employed 
strict inclusion criteria – only reviewing studies that used standardised definitions of TRD, and 
concluded that findings are largely mixed and often contradictory so no conclusions regarding 
correlates of TRD could be made. They did, however, point to some potential risk factors. Across the 
two reviews, the predictors that most consistently emerged were comorbid anxiety disorders, 
comorbid personality disorders and factors associated with depression severity, such as early onset of 
depression, higher risk of suicide, hospitalisation, and longer episodes of depressive episodes 
(Bennabi et al., 2015; De Carlo et al., 2016). Despite much work on the topic, there remains no clear 
consensus on factors associated with non-response to treatment in depression. Many authors attribute 
this, in part, to the previously outlined conceptual issues, such as heterogeneity of definitions 
employed in studies (Murphy et al., 2017). Clinically, this leaves researchers and health 
professionals no closer to being able to identify people with depression who may experience poor 




Causes of TRD – treatment characteristics. The majority of approaches to defining and 
conceptualising TRD frame non-response to treatment as a phenomenon that occurs as a result of the 
idiosyncrasies of the individual and their depression. The ineffectiveness of an antidepressant 
medication is interpreted as indicative of a resistant depression or patient (Dyck, 1994), so efforts 
have focused on exploring what it is about the person that may be causing this. Dyck (1994) argued 
that the conflating of antidepressant treatment effectiveness with condition or person description is 
one of several fundamental flaws in the way that TRD is conceptualised. He refuted the positioning 
of TRD as a homogenous diagnosis, condition, or syndrome, arguing that the construct says more 
about health professionals’ assumptions about response to treatment than the individual in question. 
Fava and colleagues (2020) agree, highlighting the taken-for-granted idea that antidepressant 
treatment is effective, and the tendency to link lack of expected recovery to the characteristics of the 
patient. Rather than prompting consideration of whether it may be the treatment approach that is 
flawed, non-response triggers a shift in focus to the individual and any characteristics that may be 
getting in the way of the ‘effective’ antidepressant from doing its job. Through this process, people 
with depression are “implicitly blamed” for non-response to treatment (Fava et al., 2020, p. p. 268).  
In light of these arguments, several authors have explored the possibility that non-response 
occurs as a result of factors relating to the treatment approach or service delivery. For example, some 
argue that much of the apparent non-response to antidepressant medication can be explained by so-
called pseudo-resistance (Murphy et al., 2017). The  concept of pseudo-resistance was first termed 
by Nierenberg and Amsterdam (1990) to describe apparent resistance to antidepressant medication 
caused by diagnostic and treatment factors. These factors include misdiagnosis, unrecognised 
comorbidity, delivery of inadequate treatment, strained therapeutic relationship, or poor patient 
adherence to treatment (Murphy et al., 2017). Once these issues are corrected, it is argued that people 
with depression that was previously categorised as treatment resistant may experience improvement 




Recent studies exploring antidepressant efficacy may also support the hypothesis that a 
person’s apparent non-response to treatment may be related, at least in part, to the treatment 
approach. The STAR*D study shed light on the fact that antidepressants may not be as effective as 
previous randomised controlled trials (RCTs) have suggested. A recent systematic review of over 
400 antidepressant trials highlighted an average response rate that was significantly higher than the 
rate reported in STAR*D (Salanti et al., 2018). These studies had similar treatment conditions to the 
first treatment round of STAR*D and only differed in the way that the treatment conditions were 
double blinded. After one round of antidepressant treatment, the studies had an average response rate 
of 59%, compared to 47% in STAR*D. As response is the most common primary outcome measure 
in RCTs, data on remission rates is less available. However, in the studies that do report remission 
rates, the same pattern seems to hold. A review of 90 antidepressant trials reported an average 
remission rate of 44% (Sinyor, Levitt, et al., 2010), again significantly higher than the 28% reported 
in STAR*D. The STAR*D authors concur, noting that rates of response and remission were 
significantly lower than expected and the majority of people experiencing depression needed 
sequential treatments before their symptoms improved (Rush et al., 2008). These discrepancies have 
been attributed to several factors. As STAR*D was a pragmatic trial, it more closely approximated 
the real world, so included participants who were less likely to respond or remit, compared to RCTs 
that employed strict inclusion criteria (Sinyor, Schaffer, & Levitt, 2010). Publication biases (Murphy 
et al., 2017) and design features (Sinyor, Schaffer, et al., 2010) of RCTs may also make 
antidepressants appear more efficacious than they really are. In any case, these findings support the 
hypothesis that antidepressants may not be as effective as once contended.  
In addition to being less effective than suggested by previous RCTs, some authors suggest 
that antidepressant medications have adverse effects that directly contribute to continuation of 
symptoms. Fava and colleagues (2020) argue that antidepressant medications exert iatrogenic effects 




effects are adverse effects caused by a treatment. Fava and colleagues suggest that several clinical 
presentations that appear to be resistance may actually be due to these effects. For example, people 
may experience an antidepressant not working in a current episode when it worked in the past, an 
antidepressant losing its clinical effect within an episode, or the worsening of symptoms or 
appearance of new symptoms when an antidepressant is commenced. These experiences may all 
result from development of tolerance to antidepressant medication, either from taking it previously 
or from taking it for a long period of time (Fava et al., 2020). The authors suggest that repeated 
prescription of antidepressants with iatrogenic effects may cause long-term problems. Combined, 
these authors suggest that rather than the issue of treatment resistance lying in the individual, the 
issue may lie in the medications – which are either ineffective or exert iatrogenic effects, such as the 
development of tolerance.    
Treatment of TRD. Whilst guidelines exist for the treatment of depression in general, there 
is no standard approach to treatment when a person does not respond as expected to initial 
interventions (Davies et al., 2019). In light of this, many studies have focused on exploring the 
efficacy of conventional and novel treatments for people with TRD. These have included 
pharmacological, somatic, and psychological therapies.  
Pharmacological treatments for TRD. The pharmacological leaning of definitions and 
conceptualisations of TRD has led to a largely pharmacological focus in terms of treatment (Jenkins 
& Goldner, 2012). Initial steps with TRD generally involve altering the existing antidepressant 
treatment regime. For example, the National Institute of Health and Clinical Excellence suggests the 
health professional consider increasing the antidepressant dose, switching to a new antidepressant 
from the same or a different class, or augmenting the original antidepressant with another medication 
(2009). However, evidence for the effectiveness of these strategies is limited. A recent Cochrane 
review of RCTs exploring these treatment approaches reported that, whilst some of these strategies 




the authors described moderate to high quality evidence for the effectiveness of augmenting an 
existing antidepressant with an antipsychotic medication, and some evidence for the effectiveness of 
augmenting an existing antidepressant with another antidepressant. This is in keeping with 
systematic reviews that have specifically explored augmentation strategies (e.g., Zhou, Qin, & Del 
Giovane, 2014). However, Davies et al. (2019) note that there is limited evidence for the 
effectiveness of other antidepressant treatment strategies for TRD, such as increasing the dose on an 
existing antidepressant or switching to a new antidepressant medication. The findings of the 
STAR*D study also suggest that there are ceiling effects with strategies that involve switching, 
augmenting, and combining antidepressants, with a relatively low likelihood of achieving remission 
after two treatment rounds regardless of the strategies subsequently employed (Papadimitropoulou, 
Vossen, Karabis, Donatti, & Kubitz, 2017; Rush et al., 2008). Concerningly, this suggests that some 
next step treatment approaches for TRD suggested by health guidance bodies and routinely 
employed in clinical practice are not entirely empirically supported.  
The limitations of antidepressant medication strategies for TRD have led to the development 
of novel pharmacological interventions. Rather than targeting the monoamine system as do SSRIs, 
these medications often exert effects on the glutamatergic and opioid systems (Papakostas et al., 
2003). Due to their recreational use and abuse potential, they have received significant attention in 
both the scientific community and the media. Ketamine, a commonly used anaesthetic that targets 
the glutamatergic system, is one such pharmacological treatment (Green & Li, 2000). It has been 
described as having superior efficacy when compared to other pharmacological treatments, as it 
exerts antidepressant effects almost immediately and leads to higher response rates 
(Papadimitropoulou et al., 2017; Ruberto, Jha, & Murrough, 2020). However, its effects are short-
lived, lasting only days to weeks, so current efforts are focused on extending these effects (Thase, 
2017). Other medications at the forefront of antidepressant research include buprenorphine (Stanciu, 




psilocybin (commonly known as magic mushrooms) (Griffiths et al., 2016), all of which exert effects 
on the opioid system. Additionally, with increasing interest in the association between inflammation, 
depression, and non-response to treatment, research groups have begun to explore the effectiveness 
of anti-inflammatory medications in treating TRD (Köhler et al., 2014; Uher et al., 2014). Whilst 
these treatment approaches show promise, further research is needed to ensure that they deliver safe 
and effective outcomes long term.  
Somatic treatments for TRD. Several forms of somatic therapies have also been investigated 
among people with TRD (Voineskos, Daskalakis, & Blumberger, 2020). Rather than altering brain 
chemistry, these treatments alter neural activity through the delivery of electrical currents or 
magnetic forces. In general, somatic therapies are not delivered as first-line treatments, but are 
offered if pharmacological or psychological interventions have not led to expected reductions in 
depressive symptoms (Voineskos et al., 2020). Electroconvulsive therapy (ECT), the delivery of 
electrical currents to the brain to induce seizure, is the most established of these treatments (Cusin & 
Dougherty, 2012). Whilst the mechanisms of action of ECT are still largely unknown, its efficacy 
among people with TRD is now widely accepted with response rates of over 50% consistently 
reported (e.g., Prudic et al., 1996). The National Institute for Clinical Excellence suggests it is 
considered as a treatment option for those who have not responded to alternative interventions 
(2020). In the New Zealand context, ECT is also recommended by the Royal Australian and New 
Zealand College of Psychiatrists as a treatment for people with depression who have not responded 
to adequate trials of antidepressant medication and psychotherapy (Weiss et al., 2019).  
Several other somatic treatments have also been investigated among people with TRD. 
Repetitive transcranial magnetic stimulation (rTMS) involves the delivery of magnetic pulses to 
stimulate neurons in the brain cortex (Cusin & Dougherty, 2012). Unlike ECT it does not require a 
general anaesthetic, so is being increasingly explored as an alternative that is less invasive and has 




however, the Royal Australian and New Zealand College of Psychiatrists has recommended that it be 
made more widely available for the treatment of people with depression (2018). Response rates of 
rTMS are reported to be comparable to ECT (approximately 50%) (Fitzgerald & Daskalakis, 2011) 
and a recent systematic review and network meta-analysis described both ECT and rTMS as 
significantly more efficacious than all pharmacological treatments other than ketamine 
(Papadimitropoulou et al., 2017). Somatic treatments that require surgery, such as deep brain 
stimulation (DBS) and vagus nerve stimulation (VNS), have also been investigated as treatment 
options for TRD. These involve implantation of devices that stimulate certain brain areas or nerves 
(Voineskos et al., 2020). Whilst evidence for the effectiveness of these somatic treatments is 
growing, there are uncertainties about response rates, administration, and duration of antidepressant 
effects (National Institute for Health and Care Excellence, 2020).  
 Non-pharmacological somatic interventions show promise for those with depression who 
have not responded to other treatments, such as antidepressant medication. However, due to the high 
costs of administration (~$6,000-$250,000USD)(Cusin & Dougherty, 2012), their relative 
invasiveness, and, in some cases, the stigma associated with them, they are often reserved for when 
all else has failed. Many argue, however, that these approaches should be employed much more 
frequently and swiftly among people with TRD (Mutz et al., 2019). 
Psychological treatments for TRD. Despite a lack of consideration of psychological 
therapies in definitions of TRD, research groups have begun to explore the effectiveness of various 
forms for psychotherapy in the treatment of TRD. Interventions trialled among people who have 
failed to respond to other antidepressant medications include cognitive behavioural therapy (e.g., 
Wiles et al., 2007), dialectical behaviour therapy (e.g., Harley, Sprich, Safren, Jacobo, & Fava, 
2008), and interpersonal therapy (e.g., Souza et al., 2016), among others. Whilst high quality work 
on the area is limited and many of these studies are uncontrolled, the reported findings appear 




findings and report that, overall, psychotherapeutic interventions appear effective among people with 
TRD (Ijaz et al., 2018; McPherson et al., 2005; Trivedi, Nieuwsma, & Williams, 2011). Ijaz et al. 
(2018) note that, due to paucity of high quality studies, comparisons between the different forms of 
psychotherapy cannot currently be made. Of note, is the fact that the majority of existing studies 
explored the effectiveness of psychotherapeutic interventions as an adjunct to antidepressant 
medications, with participants continuing with treatment as usual whilst engaged in 
psychotherapeutic sessions. This means there is limited evidence for the effectiveness of 
psychotherapy as a stand-alone treatment for people with TRD. The STAR*D study is one of the few 
studies to have explored this. The authors reported no significant difference in improvements 
between those who switched to cognitive therapy after not responding to one antidepressant and 
those who switched to another antidepressant (Thase, Friedman, & Biggs, 2007). The effects of 
cognitive therapy were slower to emerge than the effects of antidepressants. However, as research 
suggests that many people with depression have a preference for psychological input over 
medication, it is useful to know that these forms of treatment may result in comparable outcomes 
among people with TRD. Additionally, the effects of psychotherapy among people with TRD have 
been reported to endure long term (Ijaz et al., 2018).  
Summary of treatments for TRD. Over the last few decades the range of available treatments 
for TRD has expanded considerably. Clinicians and people experiencing TRD are now in the 
position to choose from an array of pharmacological, somatic, and psychological interventions. 
Whilst a large number of studies have aimed to explore the effectiveness of these interventions, 
questions remain about their efficacy. The majority of these interventions have not been specifically 
approved for use among people with TRD (Papadimitropoulou et al., 2017) and there is still no 
standardised treatment approach or set of guidelines (Shelton, Osuntokun, Heinloth, & Corya, 2010). 
This is likely a result of a number of factors. Firstly, the previously outlined conceptual issues 




Heterogeneity in TRD definitions leads to some studies including participants who are significantly 
more treatment resistant than in other studies. This makes investigation of comparative efficacy very 
challenging (Ruhé et al., 2012). Secondly, many of the studies have been described as 
methodologically limited in other ways. For example, many do not include follow up beyond 2-4 
weeks, control groups, or comparisons of various treatments (Papadimitropoulou et al., 2017; 
Ruberto et al., 2020). It is likely that these issues have impeded researchers from arriving at more 
robust conclusions and from developing guidelines for the treatment of this group. In the absence of 
treatment guidelines for TRD, some have suggested that health professionals base their treatment 
decisions on the idiosyncrasies of the patient and personal experience (Ruberto et al., 2020; Trivedi, 
Fava, Marangell, Osser, & Shelton, 2006). It is somewhat concerning that, whilst so much research 
has been conducted and there is now an abundance of treatment options, this vulnerable group may 
receive care based on guesswork rather than evidence.     
Long term outcomes of TRD. Despite significant research on the area and the development 
of new and novel treatment approaches, long-term outcomes for people with TRD remain poor. The 
STAR*D study reported that with each successive treatment failure chances of achieving remission 
decreased significantly (Rush et al., 2008). Poor outcomes appear to be the case even among people 
who eventually find a treatment that works. Rush et al. (2008) described a strong association 
between number of previously failed rounds of treatment and relapse rates after 12 months. This is 
supported by findings of a systematic review of studies exploring longer-term outcomes of TRD, 
which reported that 80% of those who had eventually responded to a treatment experienced relapse 
within a year (Fekadu, Wooderson, Markopoulo, et al., 2009). This review also highlighted that TRD 
is associated with poorer quality of life, more functional impairment, and increased mortality when 
compared to depression that does respond to treatment as expected. People with TRD experience 
longer periods of illness, more severe difficulties, and more comorbid physical and mental disorders 




al., 2009). Perhaps understandably then, TRD presents significant economic and humanistic burdens 
to patients, their families, and healthcare systems (Johnston, Powell, Anderson, Szabo, & Cline, 
2019; Mauskopf et al., 2009; Mrazek, Hornberger, Altar, & Degtiar, 2014).   
Rationale for the present research 
Despite the emergence of the construct of TRD over 50 years ago, there remains a lack of 
consensus on how non-response to treatment in depression should be defined and conceptualised. 
These conceptual issues have substantive implications for research on the topic of TRD more 
broadly, preventing researchers from accurately estimating prevalence and from reaching conclusive 
findings on risk factors and the most effective treatments. These issues also likely have flow-on 
effects for those in clinical domains. Faced with a distinct lack of guidance, clinicians may struggle 
to offer care in a systematic or evidence-based manner and patients with TRD may endure a 
potentially random spate of treatments for months or years with little improvement.   
What approaches to defining, conceptualising, and explaining TRD do appear to have in 
common, is the tendency to frame the individual and their depression as the reason for non-response 
to treatment. When people with depression do not experience improvement following the standard 
pharmacological treatments, they are considered ‘treatment resistant’. This is likely fuelled by 
widespread assumptions that existing treatments are effective and will therefore result in cure, and 
the unease that results when this is not experienced or witnessed. Some authors are beginning to 
explore the possibility that it is the service delivery and treatment approach that is the source of 
symptom persistence rather than the idiosyncrasies of the person experiencing depression. For 
example, they have pointed to emerging findings that antidepressant medications are not as effective 
as once thought and, instead, may exert effects that resemble resistance or lead directly to symptom 
continuation. The majority of the literature, however, remains focused on exploring why a person is 
treatment resistant and what new (mostly pharmacological) treatments can be developed and offered 




Combined, these factors create a unique context and shape how people experience and make 
sense of their depression that does not resolve despite treatment. Whilst there is research exploring 
the experiences of people with other forms of persistent depression, there is no known literature 
exploring the experiences or perspectives of this group. This research addresses this gap in the 
literature, by exploring the ways that people make sense of and account for their experiences of 
depression that does not respond to treatment as expected.  
Research aim 
The aim of the research was to explore how people make sense of and account for their 
experiences of TRD. The thesis addresses this research aim using a narrative psychology approach. 
A narrative approach was employed so that the stories of those experiencing TRD could be explored.  
Chapter overview 
This thesis takes the form of a thesis by publication. Specifically, the thesis comprises of two 
findings chapters presented as journal articles, one findings chapter presented in standard chapter 
format, and five background and supporting information chapters provided in standard chapter 
format. In this first chapter, Chapter One, the research context has been explored, and the basis for 
the present study as well as the research aim have been presented. This chapter provides an overview 
of the area of interest without repeating the nuances of the introduction sections of the two journal 
articles. Chapter Two outlines the methodology of the research, including the social constructionist 
epistemology and the narrative approach. Chapter Three outlines the method employed when 
carrying out the research, including the setting, the recruitment process, the participants, the 
interview process, the analytic process, as well as ethical considerations. As the method sections of 
the journal articles were limited in depth due to word count restrictions, Chapters Two and Three 
provide a more in-depth outline of the research methodology and method. 
Chapter Four presents journal article one, which has been published in Qualitative 




TRD. Chapter Five presents journal article two, which outlines two narratives that participants drew 
on to account for their experiences of TRD. This is being considered for publication by Sociology of 
Health and Illness. The journals allow authors to include submitted or published articles in a thesis or 
dissertation. Dr Mary Breheny, Dr Kirsten van Kessel, and Dr Joanne Taylor provided support and 
guidance throughout this process, assisted with the analysis, and provided feedback on writing and 
guidance on conceptual and theoretical issues. They were therefore included as co-authors on the 
journal articles included in this thesis. Chapter Six presents the findings of a single case narrative 
analysis in standard format. It outlines two alternative narratives, which were drawn on to account 
for experiences of TRD. In time, this chapter will be developed for publication.  
Chapter Seven integrates the findings and discussions presented in Chapters Four, Five, and 
Six, in an overall discussion. It also includes the conclusion. Finally, Chapter Eight offers a 
reflection on the research process and an exploration of the role of researcher in shaping the research 
findings. Whilst efforts have been made to limit repetition throughout this thesis, some was 













CHAPTER TWO: METHODOLOGY 
This chapter outlines the social constructionist epistemology and narrative psychology 
theoretical framework that underpin this research. It begins with an outline of mainstream 
approaches, which to date have informed the majority of research on depression and TRD. It then 
provides an overview of social constructionism and narrative psychology as a lens for research on 
the experience of mental distress, as well as a rationale for their use in the present study.  
Mainstream approaches to the study of depression 
Psychological research, including the study of depression and TRD, has predominantly been 
rooted in positivist epistemology. Positivism asserts that it is possible to gain objective knowledge 
about the world (Willig, 2013). Underpinning this paradigm are a number of assumptions. Firstly, it 
is assumed that the object of research exists – that there are true realities and phenomena out there in 
the world to be discovered and understood (Stoppard, 2000). Secondly, it is assumed that objective 
knowledge about these phenomena can be gained through processes such as measurement, 
observation or rational deduction (Stoppard, 2000). From this perspective, knowledge assumes the 
position of ‘truth’ or ‘fact’ and is viewed as entirely detached from the values, judgements, 
subjective experiences, and perceptions of those conducting the research or viewing the world. It is 
also seen as possible, or even preferable, to discover and understand these ‘truths’ or ‘facts’ 
independently of the sociocultural context in which they are produced (Rohleder & Lyons, 2015; 
Stoppard, 2000). 
Within this framework, the study of mental distress is considered comparable to the study of 
natural sciences (Stoppard, 2000). With the premise that there are fundamental laws that underlie 
human experience and behaviour, positivism asserts that objective psychological phenomena can be 
revealed and understood (Murray & Chamberlain, 1999). Depression and TRD are examples of 
psychological phenomena that are believed to exist. Under the umbrella of positivism, there are 




depression results from negative biases in cognitive processes (e.g., Beck, 1976) and biological 
theorists argue that both depression are treatment resistance result from biological abnormalities in 
the brain or body (e.g., Bennabi et al., 2015; Syvälahti, 1994). These theories are united, however, in 
their assertions that depression and TRD – and the associated psychological variables or processes – 
exist.  
As well as framing phenomena such as depression as objective realities, positivism asserts 
that these psychological variables can be unearthed, measured, and understood in an impartial 
manner (Burr, 1995). As human experiences are often not easily observable by researchers, they 
must be defined and operationalised in a way that makes them measurable. Subjective human 
experiences are labelled as ‘mental illness’ or ‘depression’, operationalised using standardised 
criteria, and assessed or measured using surveys (Stoppard, 2000). In the case of treatment 
resistance, the persistence of low mood despite treatment is labelled TRD, and operationalised and 
assessed according to a range of standardised definitions and staging models. Within positivist 
frameworks, phenomena such as depression are viewed as existing within the bounded individual 
independent of their socio-cultural context. As a result of this, the experience of depression is 
individualised and the impact of the surrounding context on the person and their depression is 
minimised (Stoppard, 2000). This is the case with TRD, with the majority of research focused on the 
individual as the reason for non-response to treatment.  
Rooted in positivism, Western psychology and psychiatry favour individualistic and 
decontextualizing paradigms. Consequently, they frame depression as a set of symptoms situated 
within the bounded individual (Newnes, 2014). Signs and symptoms of distress are believed to be 
objectively assessed and understood by health professionals using clinical interviewing, standardised 
measures, or diagnostic criteria such as the DSM. Additionally, knowledge gathering also occurs 
through self-observation and self-measurement on the part of the person experiencing mental 




communicate their findings to health professionals, who then use this information to build an 
‘objective’ picture of the person’s subjective experience (Stoppard, 2000). Lastly, regardless of the 
believed nature of the person’s depression, improvement is deemed to come about through changes 
to the individual in question. Any impact of the broader sociocultural context tends to be minimised. 
These positivism-informed framings have long been criticised by scholars across a wide range of 
disciplines. They reject the possibility of ever achieving objective and value-free knowledge 
(Stoppard, 2000) and suggest that when broader contexts are ignored, responsibility for mental 
distress is placed on the individual experiencing the distress (e.g., McLellan, 1995).  
Social constructionism 
In contrast to positivism, social constructionist ideas argue that it is more appropriate to 
regard reality as constructed through social interaction (Murray & Chamberlain, 1999). Within this 
framework, a critical approach is taken towards taken-for-granted ‘truths’ about the nature of the 
world. The assumption that the world has a true nature that can be unproblematically and objectively 
revealed through observation is fundamentally challenged (Burr, 1995). Rather than knowledge 
reflecting an objective reality, social constructionism argues that knowledge arises through 
interactions with others (Burr, 1995; Willig, 2013). Shared versions of reality and understandings of 
ourselves are said to be conceptualised through daily social interactions between people. As a result 
of this, social exchanges and linguistic processes of all varieties are a predominant focus for social 
constructionists (Burr, 1995; Crossley, 2000). As these social interactions do not occur in a vacuum, 
social constructionism argues that knowledge is dependent on the surrounding sociocultural and 
historical conditions. The understandings that a person or group has are highly influenced by the era 
in which they are alive, the place in which they live, and the economic, social, and political climate 
at the time (Burr, 1995). For Foucault (1973) this is inextricably linked with power – as within any 
socio-cultural context, there are institutions with the power to promote their favoured version of 




fallible, partial, and provisional (Smith & Sparkes, 2006; Stoppard, 2000). According to Burr (1995), 
each of the many knowledges carries with it implications for social action. Different constructions of 
phenomena encourage or discourage certain ways of acting in the world.  
From a social constructionist perspective, the taken-for-granted concepts of mental distress, 
depression, and TRD are not ‘real’ phenomena located within the individual able to be objectively 
unearthed and understood. Just because these concepts have been framed as distinct categories (e.g., 
mentally ill or mentally well; treatment responsive or treatment resistant), does not mean that they 
reflect true divisions. Instead, social constructionism views these understandings as constructs that 
have been created through social interactions (Burr, 1995). This means that concepts such as TRD 
have been defined and categorised through social processes, in accordance with the values, beliefs, 
and powers of those doing the defining (Caplan & Cosgrove, 2004). According to social 
constructionism, understandings of mental distress are products of the social, political, and economic 
context. For example, as medicine and science are privileged in modern day Western society, certain 
constructions – namely, biomedical models – of mental distress are favoured. From this perspective, 
it is argued that biomedical understandings of depression predominate in Western society today due 
to the power of certain institutions, such as the pharmacological industry, in structuring shared 
understandings (Burr, 1995). Constructions of TRD in Western contexts are similarly shaped by the 
powerful institutions of medicine and science. Each particular understanding of mental distress, 
depression, or TRD brings with it certain options for social action (Burr, 1995). For example, 
biochemical constructions of depression and TRD may encourage the social action of widespread 
antidepressant prescription and consumption, and individualising constructions may encourage 
people with depression and TRD to take personal responsibility for their distress.  
Narrative psychology 
Narrative psychology is primarily concerned with exploring the ways in which humans 




Silver, 2013). According to Sarbin (1993), it is human nature to tell stories about the self, others, and 
the world, and this process is a fundamental part of everyday life across cultures. When recounting 
experiences, people arrange the components in a way that can be understood by others, with a 
beginning, middle, and end to add causality to an otherwise disconnected array of events (Murray, 
2003; Polkinghorne, 1988). Narratives structure an account of events in a way that imparts meaning 
and allows people to make sense of their pasts and predict their futures (Murray, 2003).  
Storytelling is particularly evident in situations where people’s expected life courses have 
been disrupted, for example by the experience of significant illness (Stephens, 2011). In these 
circumstances, it is argued that the narrative which has previously formed the cornerstone of the 
person’s identity is disturbed and a discrepancy between ideal self and actuality may result (Silver, 
2013). At these times of significant upheaval, “narrative wreckage” (Frank, 1995, p. 55) or 
“biographical disruption” (Bury, 2001, p. 169) are said to occur. Or, in the specific case of mental 
illness, the person is said to experience “an incoherent story” or “an inadequate account of oneself” 
(Polkinghorne, 1988, p. 179). In these situations, the person becomes ungrounded, ceases to be able 
to make sense of the situation, and loses a sense of who they are and their life direction. Life feels 
chaotic and meaningless and there is a breakdown in coherent life story (Crossley, 2000). When 
disruptions such as these occur, the person is faced with the challenge of making sense of what is 
going on and reconstructing their life narrative and identity in order to maintain a sense of coherency 
(Crossley, 2000). At these times, people often turn to storytelling (Silver, 2013). Narrative 
psychologists argue that through hearing themselves speak of their experiences, observing others’ 
responses, and hearing their stories being retold, people engage in a meaning making process which 
allows them to make sense of the experience and restore a sense of order (Crossley, 2000; Murray, 
2008; Sarbin, 1993).  
As well as allowing people to make sense of their experiences, narratives play a central role 




of self may be lost or challenged, such as the experience of mental illness, people work to reconstruct 
a meaningful self-concept through engaging in storytelling (Crossley, 2000; Hiles & Cermak, 2008). 
Narrative researchers note that through the process of telling stories about the self and the world 
people not only come to understand themselves but also create themselves (Crossley, 2000). Rather 
than revealing an ‘essential’ self, narratives allow people to present favoured versions of the self 
(Riessman, 2003). Through telling stories, people position themselves – as social actors in the world 
– in certain lights. This occurs through people deciding which stories to tell and which to withhold as 
they relay certain events and account for their actions, with differences according to the context and 
the audience (Hiles & Cermak, 2008).  
As people are embedded in certain contexts, the stories they tell and the identities or positions 
they adopt are inextricably linked to the broader social, cultural, and temporal landscape (Crossley, 
2000). As Murray (1999) notes, people are born into contexts that are stocked with an assortment of 
social narratives that they can adopt, resist, and negotiate as they make sense of their everyday 
experiences. When people tell personal stories about their life experiences and position themselves in 
certain ways, they are always doing so with reference to these narratives. However, the narratives 
circulating in society are not value free. Instead, some narratives condition the way people think, 
speak, and position themselves more than others, due to the fact that they reflect certain power 
interests (Murray, 2003). As a result of this, even phenomenological accounts are telling about the 
nature of our world (Silver, 2013; Stephens & Breheny, 2013). In the case of depression, 
examination of personal stories gives insights into the commonly held beliefs, societal rules, and 
systems and forces, that structure understandings of mental distress and inform positioning within a 
given context. For example, examination of depression stories in a Western context may illuminate 
dominant biomedical narratives of mental distress, which inform the way a person understands their 
depression (e.g., as biochemical in nature) and positions themselves (e.g., as a chemically 




Narrative analytic approach 
Within the theoretical framework of narrative psychology there are a variety of approaches to 
analysing narratives. Narrative analysis is a theoretical approach rather than a singular prescribed 
method. This means that guidelines do not provide step-by-step instructions, but rather, offer a way 
of considering, exploring, and understanding the way in which people make sense of themselves and 
their experiences through storytelling (Stephens & Breheny, 2013). Broadly, employing a narrative 
analytic approach means engaging in in-depth investigation of the content and function of the story 
that has been told, and exploration of what is telling about what has been included in this story and 
what has been left out.  
Murray (2000) has proposed four levels of narratives to consider when engaging in narrative 
analysis: personal narratives, interpersonal narratives, positional narratives, and ideological 
narratives. Personal narratives are individuals’ stories about their experiences of certain events or 
phenomena. At this level, analysis is focused on how the individual is using narrative to understand 
and explain their experiences and (re)define their identity (Stephens & Breheny, 2013). This level of 
analysis is similar to other phenomenological approaches within qualitative research and has become 
the dominant focus in narrative analyses (Murray, 2000). However, as humans are social beings who 
interact with others and exist and function within certain sociocultural contexts, many researchers are 
interested in more social levels of analysis, namely, the interpersonal, positional, and ideological 
levels (Murray, 2000). At the interpersonal level, analysis is focused on how narratives have been 
jointly constructed by both the storyteller and the audience (Stephens & Breheny, 2013). The level of 
analysis involves examining the ways in which the interviewer’s questions, silences, and responses 
informed the stories the interviewees chose to tell. It also extends to consideration of the storyteller’s 
imagined audience beyond the interviewer, for example, future readers of disseminated reports or 




Murray’s positional level of analysis is concerned with the moral and social functions that a 
narrative may perform (2000). At this level, narrative researchers explore how storytellers position 
themselves by using narratives to perform certain identities and resist or avoid others (Stephens & 
Breheny, 2013). Additionally, consideration is given to the positioning of interviewers, audience 
members, and other characters, as well as the power relations that exist. At the ideological level, the 
narrative analysis is focused on the publicly available narratives that circulate within the wider 
sociocultural context (Murray, 2000). These include the often taken-for-granted societal and cultural 
ideas and assumptions that inform individuals’ and groups’ thoughts, beliefs, stories, actions, and 
positions. For example, in the domain of mental distress, these may include widely held ideas about 
recovery, medicine, and what it means to have a mental illness. Stephens and Breheny (2013) 
combined Murray’s positional and ideological levels into the so-called public level. Whilst these 
narrative approaches, and the manner in which they have been presented above, give the appearance 
of structured frameworks comprised of distinct levels, the authors highlight that this is not the way 
narratives are structured. Instead, as narrative production occurs, each of these levels are at play in an 
interconnected manner at all times (Murray, 2000; Stephens & Breheny, 2013).  
Locating the present research 
Much of the previous research on TRD has been rooted in a positivist epistemology. This 
frames TRD as a phenomenon that is biochemical in nature, which exists within the bounded 
individual and is largely separate from context. From this perspective, TRD can be objectively 
understood through exploration of causal factors and clinical characteristics, measured using 
standardised definitions and staging models, and (eventually) effectively treated with medication. 
From a social constructionist perspective, this view of TRD may prevail in Western settings due to 
the power of certain institutions (e.g., the pharmaceutical industry) in promoting their favoured 
versions of reality (Burr, 1995; Foucault, 1973). Much of the existing work on health beliefs and 




(Murray, 1999). This is the case with TRD, with the predominant focus of research on the individual 
as both the site of pathology and the reason for non-response to treatment. By ignoring broader 
contexts, it is argued that researchers and clinicians assign blame to individuals for their mental 
distress (e.g., McLellan, 1995). 
Grounded in a social constructionist epistemology, this study will employ a narrative 
approach to research guided by the analytic approaches of Murray (2000) and Stephens and Breheny 
(2013). With this epistemological and theoretical leaning, the present study will provide an 
alternative perspective to taken-for-granted understandings of TRD. In contrast to much of the 
existing literature which is individualising, the research will contextualise understandings of TRD 
and the corresponding options for social action. As storytelling is particularly evident at times of 
significant illness, a narrative approach is well suited to the exploration of these understandings 
(Stephens & Breheny, 2013). Through employing a narrative approach, the research will illuminate 
dominant narratives of mental distress and recovery that powerfully shape the way these people 
make sense of persistent depression and navigate identity. With this methodological approach, it is 
hoped that rich and nuanced insights will be offered into the manner in which the unique construct of 











CHAPTER THREE: METHOD 
To contextualise this research, this chapter begins with an outline of the setting in which the 
present research took place. This includes a description of the private practice that was the site of 
recruitment and data collection, an overview of the private practice’s surrounding suburb, as well as 
some context of mental health service provision in New Zealand. This enables the reader to situate 
the private practice and the participants within a wider social context. This chapter then outlines how 
this research was conducted. This includes an overview of the recruitment process, a description of 
the participants, and details of the interview procedure and analytic process. The chapter concludes 
with a brief discussion of the ethical issues considered in this research. Consistent with the previous 
chapter, as this document is presented as thesis by publication and the articles are included in their 
original forms, some of this chapter’s content is repeated in the Method sections of the two articles 
(presented in Chapters Five and Six). This predominantly relates to the content on the recruitment 
process, the participants, the interview process, and the analysis. As the Method sections of the 
articles were constrained by journal word limits, the opportunity has been taken to include full and 
unabridged versions in this chapter.  
Setting 
The private practice. Recruitment and interviewing for this research occurred at a 
psychiatry and psychology private practice in an inner city suburb of Auckland, New Zealand. The 
private practice offered the services of four psychiatrists, two psychologists, and a psychotherapist to 
adults experiencing a range of mental health difficulties. More specifically, services offered included 
psychiatric and psychological assessment, diagnosis, and treatment of mental illness or distress. The 
private practice website defined mental illness in a manner consistent with Western psychiatric 
conceptualisations of mental distress. Broadly, the website described mental illness as a disorder of 
the mind that impacts emotional, cognitive, perceptual, and behavioural domains and can interfere 




self-referral by an individual or their family/support people or through referral from other health-
professionals such as general practitioners (GPs).  
The practice was neutrally decorated and had a large reception and waiting room, a small 
kitchenette area supplied with refreshments, a bathroom, and four consulting rooms. Two reception 
and administration staff were employed at the practice who frequently greeted clients by name upon 
their arrival. Interviews were conducted in one of the consulting rooms at the private practice. These 
rooms were the clinical spaces typically used by clinicians when interacting with clients. The 
consulting rooms had plain décor and were furnished with armchairs, coffee tables, bookshelves, 
clocks, and desks. Each room had a large window with blinds drawn for privacy. On display in the 
consulting rooms were practicing and registration certificates as well as a range of clinical 
psychology and psychiatry books, including recent and current versions of the DSM.  
The surrounding area. The private practice was located in a central, predominantly 
residential suburb of Auckland, New Zealand. The suburb is significantly less ethnically diverse than 
other areas of Auckland or New Zealand overall, with predominantly Pākehā (New Zealand 
European) residents (81.5%). This is disproportionately high compared to the general Auckland 
region (53.5%) and the total population of New Zealand (70.2%). The number of Māori residents 
(8.2%) is also significantly lower in this suburb than in the broader Auckland region (11.5%) and 
New Zealand as a whole (16.5%). This pattern also holds for Pasifika residents and Asian residents 
(Statistics New Zealand, 2018). Whilst historically a working-class suburb, the suburb has seen 
significant gentrification in recent years and is now predominantly upper-middle class. Residents of 
the suburb have higher levels of educational attainment, with over 50% achieving a Bachelor’s 
degree or higher, compared to 31.1% in the general Auckland region and 24.8% in New Zealand 
overall. Residents are also significantly more likely to be in professional or managerial roles than 
residents in the general Auckland region and in NZ generally. Unemployment is low and residents of 




Auckland region ($34,400) and the total NZ population ($31,800) (Statistics New Zealand, 2018). 
Combined, these recent statistics highlight that residents of the suburb are not comparable to 
residents in Auckland or New Zealand more generally, in that they are predominantly Pākehā (New 
Zealand European), affluent, and tertiary educated.  
The broader New Zealand health system context. New Zealand has a universal publicly 
funded health service, with a vision to provide equal access to high quality treatment to all New 
Zealand residents (McLintock, 1966). This public health service comprises of 20 district health 
boards across New Zealand that provide services free-of-charge to New Zealand residents within 
their assigned geographical regions (Ministry of Health, 2018). Funding covers the majority of health 
services, including hospitalisation, mental health, public health, aged care, and services in the 
community (Ministry of Health, 2016a). Despite the public health service’s strengths, people in New 
Zealand are often faced with long waitlists unless treatment is deemed urgent (Organisation for 
Economic Co-operation and Development, 2013). This is equally the case for mental health services. 
The majority of public mental health funding (~96%) is allocated to specialist services, which serve 
the needs of the 3% of people experiencing the most severe mental health difficulties in any given 
year (Government Inquiry into Mental Health and Addiction, 2018). Approximately 20.7% of New 
Zealanders experience a mental disorder in any given year (Oakley Browne, Wells, & Scott, 2006) 
and this number is steadily on the rise (Ministry of Health, 2019). A small minority of these people 
can access GP or psychologist care through accessing the remaining (~4%) public mental health 
funding. This funding is specifically targeted towards particularly vulnerable groups, such as Māori 
and Pasifika people and those on low incomes (Government Inquiry into Mental Health and 
Addiction, 2018). However, the majority of New Zealanders experiencing mental distress or disorder 
who do not make up the 3% most severe are unable to access publicly funded mental health care.   
These factors have led to an increase in privately funded specialist services. Private services 




prompt access to non-urgent or elective treatments (Ministry of Health, 2016b). Whilst this takes 
some pressure off the public health service, the costs of both the private services themselves and 
private health insurance are high and therefore prohibitive for most New Zealanders. Only 35% of 
New Zealanders are reported to have private health insurance (Ministry of Health, 2016b) and, of 
this group, it is estimated that less than a third have comprehensive plans that cover mental health 
services (Health Funds Association of New Zealand, 2019). Whilst it is common internationally for 
private health insurance to be paid for by employers, the majority (79%) of people with private 
health insurance in New Zealand pay for it themselves (Ministry of Health, 2016b). In New Zealand, 
the groups most likely to have private health insurance are those with high incomes who live in 
larger cities (Ministry of Health, 2016b). 
The private practice that served as the setting for this research was one such privately funded 
specialist service. Clientele of the service – including any research participants – were therefore 
affluent enough to pay for services directly or to afford private health insurance with comprehensive 
plans that covered mental health care. This private service would therefore not be accessible to the 
majority of New Zealanders.   
Recruitment 
Participants in this research project were recruited by a psychiatrist working at the private 
practice. This psychiatrist was highly experienced in the domain of general adult psychiatry, with 
over 20 years of psychiatric experience working with adults in both public and private health 
settings. His general approach included assessment, diagnosis, and treatment of mental illness as 
well as evaluation of relevant physical health domains. Treatments offered were largely 
pharmacological in nature. At the time of recruitment and interviewing, he was also beginning to 
offer transcranial magnetic stimulation (TMS), a somatic treatment offered to people experiencing 
depression that had not responded as expected to antidepressant medications. Additionally, the 




based psychotherapeutic input. He also frequently made referrals to clinical psychologists within the 
private practice or elsewhere for more comprehensive psychological input.   
In order to recruit participants for the research, the recruiting psychiatrist consulted his 
records to identify existing clients on his personal caseload who met criteria for inclusion in the 
research (see Participants section below for these criteria). Following this, during or after the clients’ 
routine appointments, the psychiatrist enquired as to whether they were interested in participating in 
a study on depression. If interested, he provided them with an Information Sheet and Consent Form 
(Appendix A) that detailed the purpose of the study and what participation would involve. He also 
asked permission for their contact details to be shared with me and for them to be contacted via 
telephone. Following this, I contacted those interested via telephone to explain the purpose of the 
study and answer any questions that had arisen from their reading of the Information Sheet. 
Following this brief discussion, if the clients were willing to participate in an interview, a date and 
time was set for the interview to take place. 
Participants 
To take part in the research, participants needed to be adult clients (at least 18 years of age) 
of the recruiting psychiatrist at the private practice. Participants also needed to have a current DSM-5 
diagnosis of major depressive disorder, and be considered ‘treatment resistant’ according to the most 
commonly employed definition of TRD: have failed to respond to two or more rounds of 
antidepressant medication at an adequate dose and duration. This diagnosis of depression needed to 
be the primary disorder. Additionally, the participants must not have a current or lifetime diagnosis 
of bipolar disorder I or II or a psychotic disorder, an unstable, serious, or life threatening medical or 
neurological disorder, or be at serious, high, or imminent risk of suicide. The participants also 
needed to be able to provide informed consent and participate in 60-120 minute interview. Suitability 




Twelve people volunteered to participate in this study. Of these 12, three elected not to 
participate after being contacted by phone by the researcher, citing mental health issues that made it 
difficult to engage in an interview. The remaining nine participants ranged in age from 28 – 65 years, 
with a mean age of 47 years. Three of the participants identified as women and six identified as men, 
and all participants identified as Pākehā (NZ European). Over half of the participants (56%) had 
completed a bachelor’s degree or higher, and all but one of the participants were currently employed 
or self-employed. Six of the participants were married or in de facto relationships and three were 
single or separated. All participants met the criteria for participation in the research outlined above. 
As well as having current diagnoses of depression, five of the participants also indicated that they 
had been diagnosed with generalised anxiety disorder. Whilst not essential for participation and not 
considered in this definition of TRD, the participants had often engaged in a number of other 
treatments, alternative therapies, and lifestyle changes. These included psychological therapy, yoga 
and meditation, and exercise.  
Interview procedure 
To begin each interview, I introduced myself and my background as a clinical psychology 
trainee and doctoral student. Following this, the Information Sheet and Consent Form, which the 
Consultant Psychiatrist had previously provided, were reviewed and any questions were addressed. If 
participants were comfortable proceeding, they were asked to sign the Consent Form. At the time of 
the interview, participants also completed a brief demographic questionnaire (Appendix B).  
Following this, I commenced audio recording and invited the participants to tell the story of 
when their depression first began. Whilst the term ‘treatment resistant depression’ was used in the 
Information Sheet, I used the broader term ‘depression’ throughout the interviews. Following the 
initial prompt, the interviews were predominantly participant-led, with an open structure and no 




experienced, understood, and made sense of their depression through storytelling in mind throughout 
the interviews.  
Whilst the interviews were not structured, I attempted to elicit narrative accounts and rich 
descriptions through broadly employing a style of questioning suggested by Murray (2003). Firstly, I 
specifically asked for narrative accounts, for example, by asking questions such as, “Could you tell 
me the story of your first experience of depression?” or “Could you tell me the story of your first 
encounter with a mental health professional?”. Secondly, I made frequent reference to certain times 
and places in order to encourage these sorts of accounts. For example, I asked questions such as, 
“Could you tell me more about the time the doctor said you have depression?” or “Where were you 
living when you first experienced depression?” I ended each interview by asking “Is there anything 
that we haven’t talked about today that you think is relevant or important?” The interviews were 
conducted in a relatively informal manner and I sought to be encouraging, supportive, and 
empathetic.  
Overall, this general interviewing approach allowed for flexibility within each interview as it 
progressed. The interviews ranged in length from 34-77 minutes. Following the interviews, I offered 
participants a $50 petrol voucher to thank them for their time and willingness to share their story. 
After each interview, I also made brief notes on the interaction, for example, the general demeanour 
or level of engagement of the participant or strong narratives that seemed to have emerged in the 
interviews. 
Data analysis 
Analysis was guided by the narrative approaches of Murray (2000) and Stephens and 
Breheny (2013), with particular focus on analysis of multiple layers of meaning and the intersection 
between these layers. The interviews were transcribed using Inqscribe, a freely available transcribing 
tool. Data analysis began at this stage, as I became more familiar with the general structure and 




transcription was cross-checked for accuracy and then reread multiple times as part of the continued 
familiarisation process. Following this, the transcripts were printed with double lined spacing and 
wide margins and notes were made about the participants’ accounts.  
I repeatedly read through each transcript until personal stories emerged for each participant. 
Whilst identifying personal stories, I looked for subjective accounts of depression that had characters 
engaging in certain actions (e.g., a health professional diagnosing depression) and a recognisable plot 
– a beginning, middle, and end (e.g., an evolving account of a first episode of depression). At times, 
personal stories were presented in seamless and unbroken sequences. However, at other times they 
were difficult to follow, complicated, had deviations from the plot, or were abandoned. The 
structural characteristics of a story were not taken as indicative of its value as narrative data (Wong 
& Breheny, 2018). Transcripts were then compared and contrasted, with commonalities and 
differences identified in the personal stories told by participants. To aid this process, highlighters 
were used to colour code the various personal narratives that emerged.  
During this analytic process, when considering the interpersonal level of narratives, I also 
considered how I had contributed to the construction of the stories that emerged. I considered what I 
had chosen to share about myself, my presentation and demeanour in the room, my reactions and 
responses to participants’ stories, and how these factors had influenced storytelling - in terms of what 
the participants chose to disclose and what not to disclose. I also considered how my thoughts, 
beliefs, assumptions, and prior experiences, which I brought to the interaction, had shaped the 
interaction, the stories told, and the positions and identities negotiated, adopted, and rejected. My 
voice is often included in the extracts presented in this thesis, so that this co-construction is evident. 
A more thorough discussion of reflexivity and the role of the researcher in this research is presented 
in Chapter Eight.  
Throughout the analytic process, I also considered the broader social context in which the 




narrative production. To do this, I considered how this context and the publicly available narratives 
that circulate within it may have influenced the stories that were told, the stories that could be told, 
and the stories that were discouraged or could not be told. In this research, these publicly available 
narratives often included narratives of clinical psychology, medicine, mental distress, and recovery 
that shape how depression and mental distress are storied. The analytic process was not linear. 
Instead, I created multiple visual brainstorms, drafted multiple written pieces outlining various 
narratives, and discussed the emerging stories in supervision meetings. Findings were repeatedly 
reviewed, reconsidered, and rewritten as discussions were had and as the findings section of the 
thesis was drafted.   
Ethical considerations 
Ethical approval to undertake this research was granted by the New Zealand Health and 
Disability Ethics Committee – Northern A (HDEC Ethics Reference: 16/NTA/197/AM05). Details 
of the ethical considerations relevant to this research were outlined in detail in a comprehensive 
online form which was reviewed by the committee. Along with two supervisors, I also attended the 
committee meeting and answered further questions regarding the study. Given that those with TRD 
are considered to be a vulnerable group, care was taken at every stage of the research process to be 
aware of the vulnerabilities of participants and to protect their interests. Specifically, primary ethical 
concerns related to the consent process, maintaining confidentiality when the interviews took place 
in the existing healthcare provider’s place of work, and the potential for distress during or following 
interviews.  
Firstly, the fact that the research took place in the offices of the participants’ existing 
healthcare provider and that the participants were recruited by this healthcare provider presented 
issues relating to the consent process and potential for coercion into participating as well as 
confidentiality. To mitigate these risks, both the recruiting psychiatrist and I told the participants that 




their standard of care at the practice. I also explained that only my research supervisors and I (and 
not the recruiting psychiatrist or other private practice staff) would hear the audio recordings or read 
the transcripts and that all identifying information would be removed prior to publication. To ensure 
anonymity, pseudonyms have been used in this thesis and any published material, and any 
identifying information has been removed.  
Given the sensitive nature of the topics discussed, another concern was the potential for 
participant distress during or following the interviews. I reminded the participants that they were free 
to end the interview at any time without consequence. If participants became distressed or upset I 
was able to use clinical skills to support them through their distress and to ask them if they would 
like to pause, postpone, or end the interview. On several occasions throughout the interviews 
participants became mildly distressed. In these instances, after a brief pause and discussion about 
how to proceed, all participants reported that they were happy to continue. Additionally, the 
interviews only occurred when psychiatrists or psychologists working at the private practice were on 
site, so that I could seek out support from registered professionals in managing a participant’s 
distress if need be. Throughout the interviewing process, outside support was not needed. Following 
the interview, I acknowledged the sensitive nature of the content discussed and enquired as to how 
the participant was feeling about continuing with their day. In all instances, the participants reported 
that, whilst the content was somewhat difficult, they had valued the opportunity to talk about their 
depression and felt able to transition back to their daily lives. I reminded the participants that the 
Information Sheet (of which they had a copy) contained contact details for the private practice as 
well as helplines, crisis teams, and the region’s public mental health services, which could be 
contacted for follow-up support if needed.  
These ethical considerations were also addressed in the Information Sheet and were discussed 




frequent opportunity for participants to ask questions: on the phone at first contact, upon meeting 
























CHAPTER FOUR: ARTICLE ONE – Narrating the experience of TRD 
This chapter has been published as: Kroch, E., Breheny, M., van Kessel, K., and Taylor, J. 
(2021). Order and Disorder: Navigating narrative tensions in the experience of treatment resistant 
depression. Qualitative Psychology. 
Abstract 
A significant proportion of people with depression do not experience expected recovery 
following treatment with antidepressant medication and are considered to have treatment resistant 
depression. Despite this, there is relatively little research exploring the experiences of this group of 
people, who represent a significant minority of those who experience depression. The current study 
addressed this gap in the literature by exploring how people with treatment resistant depression 
understand and make sense of depression that has not resolved following adherence to professional 
advice and treatment. A narrative approach was adopted, with a particular focus on personal stories 
told by participants and interpersonal stories co-constructed between the participants and the 
interviewer. The accounts of nine people with treatment resistant depression recruited from a private 
psychiatry and psychology practice in Auckland, New Zealand were analysed. Two narratives were 
identified: firstly, a narrative of order was used to organise and make sense of their experiences, 
which was informed by wider clinical psychology assumptions and expectations of recovery. 
Secondly, a narrative of disorder was used to describe the persistence of depressive symptoms and 
the difficulty they experienced predicting and responding to these experiences. Across these 
accounts, there was a general pattern of participants drawing on the narrative of order when storying 
early experiences of depression and, after outlining experiences that disrupted these ordered 
constructions, drawing on the narrative of disorder when storying later experiences. However, this 
pattern was not strict. Instead, a narrative tension emerged, with the participants repeatedly switching 
back and forth between the two narratives. Ultimately, the participants used both narratives to make 
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Introduction 
Major depressive disorder (hereafter referred to as depression) is traditionally conceptualised 
as a clinical condition that involves sad, empty, or irritable mood, and physical and cognitive 
changes that adversely impair a person’s functioning. It is defined using symptom-based diagnostic 
classification systems such as the Diagnostic and Statistical Manual of Mental Disorders (DSM) 
(American Psychiatric Association, 2013). Depression is a leading cause of disability in the 
developed world (World Health Organisation, 2019) and affects approximately one in six people in 
New Zealand (Oakley Browne et al., 2006). Consequently, the development of treatments has been a 
priority.  
Pharmacological and psychotherapeutic treatments have advanced significantly over recent 
years and have improved outcomes, however, a considerable proportion of people continue to 
experience significant distress even after receiving interventions (Berlim, 2007). This lack of 
expected treatment response is frequently termed treatment resistant depression (TRD). TRD is most 
commonly defined in academic literature as an episode of depression that has not responded to two 
or more trials of antidepressant medication at an adequate dose and duration (Brown et al., 2019). 
However, systematic reviews highlight that there is considerable heterogeneity among definitions 
adopted in empirical studies, and little overlap between academic and clinical understandings 
(Brown et al., 2019). Some studies employ definitions based on progression through staging models, 
or consider diverse forms of treatment when calculating number of treatment failures (Brown et al., 
2019). This lack of a common definition creates a challenge in estimating prevalence. However, 
STAR*D, the largest study to date evaluating effectiveness of depression treatments, found that only 
50% of the sample had achieved remission from depression following two rounds of treatment (Rush 




The term TRD is often used interchangeably with ‘chronic depression’ and ‘recurrent 
depression’, which leads to confusion in both clinical practice and scientific literature. However, 
TRD appears to be unique, as most people with ‘chronic depression’ have not received adequate 
treatment, and people with ‘recurrent depression’ do respond to treatment and experience periods of 
full recovery. Therefore, neither group can be considered ‘treatment resistant’ (Gelenberg et al., 
2006). People with TRD have sought and received adequate treatment, yet have not experienced 
expected recovery from depressive symptoms. Consequently, they can feel discouraged and 
hopeless, report high levels of self-injurious behaviour, and experience poor quality of life (Dunner 
et al., 2006; Greden, 2001). TRD also significantly influences support people, health services, and 
society (Wiles et al., 2013) and is considered a major challenge for clinicians (Wijeratne & 
Perminder, 2008). 
Health Service Experiences. When individuals experience depression without recovery, 
there can be implications for health service experiences (McPherson & Armstrong, 2009; 
McPherson, Byng, & Oxley, 2014; McPherson, Walker, & Carlyle, 2006). Primary care counsellors’ 
reactions towards these clients have been found to be predominantly negative. They described 
feeling deskilled and powerless in their work, finding the sessions painful and draining, and 
experiencing ‘heartsink’ moments when these clients entered the service (McPherson et al., 2006). 
General practitioners’ (GPs) described patients as burdensome, manipulative, or difficult people with 
generally unpleasant characteristics, and there was a general loss of empathy when patients did not 
improve over time (McPherson & Armstrong, 2009). Whilst these health professionals typically 
draw on medical models of depression, this was not the case for patients with TRD. Instead, they 
used psychosocial explanations, such as previous trauma, problematic attitudes or personalities, 
social deviance, and deficits in coping skills to explain prolonged symptoms (McPherson & 
Armstrong, 2009). This suggests that, when individuals respond to treatment as expected, GPs label 




patients do not respond to antidepressants, responsibility is attributed to the client for not recovering 
due to them being ‘difficult’, ‘manipulative’, ‘unpleasant’ and ‘socially deviant’. These explanations 
for TRD can be understood in terms of publicly available narratives that frame how clinicians and 
patients understand depression to progress and resolve. 
Narratives of Depression and Recovery. Personal narratives of single episodes of 
depression tend to follow a typical sequence, which broadly includes a) an initial realisation that 
something is wrong, b) a struggle to come to terms with and understand the new experience and 
identity, c) a period of help seeking, and d) a transition to recovery (Karp, 1994; Schreiber, 1996). 
Similar patterns are documented in recent studies exploring the experience of depression (Bygstad-
Landro & Giske, 2017; Hajela, 2013; Hänninen & Valkonen, 2019; Ridge & Ziebland, 2012). 
Hänninen and Valkonen (2019) found that depression and recovery were experienced as a gradual 
shift from disengagement and isolation to reengagement with everyday life. Similarly, Bygstad-
Landro and Giske (2017) describe the experience of depression in terms of the grounded theory of 
‘risking existence’, which consists of four phases: a deep sense of isolation, shame, and turmoil, 
beginning to open up to others, learning how to manage their depression, and accepting themselves 
and their depression and re-entering the world. When narrating their depression, people describe 
profound feelings of sadness, hopelessness, apathy, irritability, and fragility (Hajela, 2013). 
Depression has also been described as a painful paradox. As well as experiencing significant 
struggle, withdrawal, and isolation, people simultaneously want to engage, take control, confront 
their issues, form relationships, recover, and make plans for the future (Danielsson & Rosberg, 2015; 
Rapmund & Moore, 2000; Sarkohi, Frykedal, Forsyth, Larsson, & Andersson, 2013). These studies 
highlight a shared public narrative of depression that progresses from onset of difficult experiences, 





These public accounts of depression all include a recovery phase, which tends to follow a 
period of help-seeking. People who have recovered from depression highlight the importance of 
periods of introspection and reflection (Hänninen & Valkonen, 2019). They attribute their recovery 
to the personal insights, such as becoming more aware of the factors contributing to their depression 
and learning to trust their instincts (Ridge, 2018; Steen, 1996). People who have recovered from 
depression also tell of shifts in the way they view themselves, the world, and their futures (Ridge & 
Ziebland, 2006; Steen, 1996). For example, they stop engaging in self-blame, begin to adopt more 
hopeful attitudes about recovery, and begin to see depression as an experience distinct from the self, 
rather than part of the self (Ridge, 2018; Ridge & Ziebland, 2006). Eventually, people tell of being 
able to look back on their depression experience and rewrite it more positively (Hajela, 2013; 
Hänninen & Valkonen, 2019; Karp, 1996; Ridge & Ziebland, 2006; Schreiber, 1996). For example, 
depression is reconstructed as a spiritual journey, an experience leading to increased self-awareness, 
as motivation to find meaning in life, or as means to connect with a more authentic self (Ridge & 
Ziebland, 2006). Throughout this process, people impose a sense of meaning and order to their 
experiences of depression.  
These personal narratives of depression are consistent with broader publicly available and 
favoured narratives of illness. For example, the findings are consistent with Western recovery 
narratives that suggest “yesterday I was healthy; today I am sick; but tomorrow I will be healthy 
again” (Frank, 1995, p. 77). This is the culturally dominant narrative of illness; inherent in this 
narrative is the modernist expectation that behind every suffering there is a remedy, and that health is 
the normal condition that people ought to have restored (Frank, 1995). This aligns with dominant and 
publicly available accounts of depression in which seeking help and following medical advice will 
result in recovery. 
Narratives of Depression Without Recovery. The publicly available illness and depression 




recovery. Those who experience ‘chronic depression’ or ‘recurrent depression’ describe feeling stuck 
or like a failure, dreading future recurring episodes, and contemplating suicide (Ridge & Ziebland, 
2006). Their stories have profound themes of hopelessness and fatalism (Gask, Aseem, Waquas, & 
Waheed, 2011; Stigsdotter-Nyström & Nyström, 2007). In contrast to the accounts of linear 
progression through phases told by people experiencing single episodes of depression, people with 
‘longer-term depression’ tell of cyclical or fluctuating symptoms as well as differences from episode 
to episode. Whilst some people experience symptom-free periods, others tell of continual symptoms 
with constantly fluctuating severity (Chambers et al., 2015). These people struggle to establish, or 
even imagine, a recovery narrative (Ridge & Ziebland, 2006) and, instead, speak of the need to 
accept depression as a chronic condition (Chambers et al., 2015). Those with ‘chronic depression’ or 
‘recurrent depression’ may be unable to situate their experiences within a broader process of 
meaning-making (Stigsdotter-Nyström & Nyström, 2007). This sits in contrast to the sense of hope 
and expectations of recovery evident in dominant publicly available narratives of depression 
(Rapmund & Moore, 2000; Sarkohi et al., 2013).  
These longer-term depression accounts (Gask et al., 2011; Ridge & Ziebland, 2006; 
Stigsdotter-Nyström & Nyström, 2007) have links to chronic illness narratives. Chronic illness has 
been likened to a “biographical disruption" due to the illness’ significant impact on the person’s 
expected life course (Bury, 2001, p. 169).When a biographical disruption occurs, the individual is 
faced with the challenge of reconstructing their identity and life story in order to maintain a coherent 
sense of self (Crossley, 2000). The same has been said for long-term mental distress, with the 
suggestion that these individuals are experiencing “an incoherent story” or “an inadequate account of 
oneself” (Polkinghorne, 1988, p. 179). In these cases, “narrative wreckage” may ensue, where people 
draw on a chaos narrative of uncertainty about the future, lack of order, and life never getting better  
(Frank, 1995, p. 68). Unlike the culturally favoured recovery narrative, there is widespread 




undermines any sense of the controllability of the experience of mental distress. Depression without 
resolution undermines the widespread expectation that help-seeking will result in recovery. 
Drawing on these publicly available narratives about illness, people diagnosed with 
depression are likely to expect recovery, at least initially. However, a person with TRD does not 
experience recovery and, instead, may try many antidepressant medications without significant 
improvement (Berlim, 2007). When expected recovery does not occur, they may be viewed as 
difficult patients by medical professionals (McPherson & Armstrong, 2009). As a result of this, 
people with TRD do not have dominant narratives of recovery from depression to draw on. They 
must search for new ways of making sense of their experiences. There is no known research 
exploring how people with TRD experience, understand, or make sense of depression that does not 
resolve. This study will address this gap in the literature by conducting an in-depth narrative analysis 
of the stories told by nine people experiencing TRD.  
Method 
Narrative Psychology.  This study used a narrative approach to explore how people 
understand and make sense of TRD. Narrative psychology is concerned with the ways in which 
people organise, make sense of, and interpret their lived experiences through storytelling (Murray, 
2008; Silver, 2013). Storytelling is particularly evident in situations where people’s expected life 
courses have been disrupted (Stephens, 2011). It is used to make sense of changes in life 
circumstances and facilitates understanding of why and how an event happened and who the 
individual was before the event occurred. Storytelling also helps a person to renegotiate their identity 
and restore a sense of coherence (Crossley, 2000; Murray, 2008; Sarbin, 1993; Stephens, 2011). 
Narrative psychology is also concerned with the ways people construct and maintain their identities 
through storytelling (Hiles & Cermak, 2008). In this study, a narrative approach provides insight into 
how people make sense of the disruption of TRD, and how they take up and negotiate identities such 




concerned with the surrounding socio-cultural context, insights are gained into the publicly available 
narratives or local moral orders that shape how people describe and account for their experiences of 
TRD.  
Participants, Setting, and Procedure. This study took place at a private psychiatry and 
clinical psychology practice in an upper middleclass suburb in central Auckland, New Zealand. The 
practice receives self-referrals and referrals from GPs and specialists in the Auckland region with 
patients paying for services either directly or through private health insurance. New Zealand has a 
universal healthcare system and comparatively few people have private health insurance (Ministry of 
Health, 2018). As a result of this, it is expected that the clientele of this private practice were 
affluent. 
Participants were recruited by a psychiatrist working at the private practice, who identified 
people on his caseload with TRD and enquired as to whether they were interested in participating in 
a study on depression. The recruiting psychiatrist specialised in psychiatry over 20 years previously 
and had worked in private practice full time for 15 years. His general approach included assessment 
and diagnosis of mental illness and physical illness, as well as provision of medication and/or 
transcranial magnetic stimulation. The psychiatrist was also trained in cognitive behavioural therapy 
and, at times, provided short-term skills based therapy or made referrals for therapy elsewhere. 
Those who expressed interest in the study were given information sheets and asked for permission to 
be contacted. The first author then contacted those interested, provided a brief overview of the study, 
and answered any questions. If they were willing to be interviewed, a date and time was set for the 
interviews.  
Nine people with TRD volunteered to be interviewed for this study. Participants met DSM-5 
criteria for major depressive disorder (American Psychiatric Association, 2013) and their depression 
was assessed to be ‘treatment resistant’ by the recruiting psychiatrist, based on the most commonly 




produced significant clinical improvement (Berlim, 2007). The delivery of these medications needed 
to be considered adequate in terms of dosage, duration, and compliance. Whilst not essential for 
participation, the participants had often also engaged in other treatments, such as psychological 
therapy. Participants ranged in age from 28 - 65 years, with a mean age of 47 years. Six participants 
identified as men and three identified as women, and all participants identified as New Zealand 
European. The study aimed to recruit people who were receiving adequate treatment for their 
depression. As a result of this, the sample was not representative of the population with depression in 
New Zealand in terms of age, gender, socioeconomic status, or ethnicity (Oakley Browne et al., 
2006), which is likely due to the study setting.  
Data were collected through individual semi-structured interviews. Interviews took place at 
the private practice where the participants had been recruited, once participants had given informed 
consent and completed a demographic questionnaire. The interview started with the participant being 
invited to tell the story of when their depression first began. Following this prompt, the interviews 
had an open structure with no fixed interview questions. The aim was to explore how people 
understood and made sense of their TRD through storytelling. As suggested by Murray (2003), the 
interviewer attempted to elicit narrative accounts and rich descriptions, by, firstly, asking  “Could 
you tell me the story of when you first sought help?” and, secondly, by encouraging them through 
reference to times and places, for example, “Could you tell me more about the time the doctor told 
you that you have depression?” This approach allowed for flexibility in response to each interview as 
it progressed. Although the information sheet used the term ‘treatment resistant depression’, the term 
‘depression’ was used in the interviews. The interviews ranged in length from 34 to 77 minutes and 
were audio recorded. Following the interviews, participants were offered a $50 petrol voucher to 
thank them for their time. Ethical approval was provided by the New Zealand Health and Disability 




Analysis. The first author transcribed the interviews and cross-checked the transcriptions for 
accuracy. In the extracts, words are underlined to show emphasis. Analysis was guided by the 
narrative approaches of Murray (2000) and Stephens and Breheny (2013). This involved focusing on 
multiple levels of meaning, including personal stories, interpersonal stories, and publicly available 
narratives, as well as the intersection between these levels. First, personal stories about subjective 
experiences of TRD were identified. Accounts of experiences were categorised as personal stories if 
they had a plot: a beginning, middle, and end, as well as characters. Secondly, the accounts were 
examined for interpersonal stories co-constructed between the participants and the interviewer. 
According to Murray (2000), narratives exist in a social world and are co-constructed between 
multiple people (a narrator and an audience). “Interviewers are not neutral bystanders” Stephens and 
Breheny (2013, p. p. 16); they bring to the interaction a set of characteristics and a particular 
perspective which shape the narratives that emerge. In the present study, interpersonal stories were 
understood as stories of experiencing and managing mental distress co-created in the interview room. 
The exploration of interpersonal stories involved consideration of how the first author’s position as a 
clinical psychology trainee and the setting of a psychiatry private practice may have shaped the 
stories told (see Findings for detailed discussion of this). Lastly, publicly available narratives were 
considered. Publicly available narratives are the beliefs and ideas shared within society that shape the 
personal and interpersonal stories told. In this study, these included broader narratives of clinical 
psychology, medicine, mental distress, and recovery, for example, the expectation of return to 
wellness following help-seeking (Frank, 1995) and the Western psychiatric framing of mental 
distress as a set of observable, measurable, and targetable symptoms located within the individual 
(Newnes, 2014). Narratives such as these circulate widely through popular psychology and the media 
and shape how depression is storied. In the analysis, exploration of publicly available narratives 
involved reflecting on assumptions shared by participants and the interviewer about the nature of and 




“how things should be” (Wong & Breheny, 2018, p. p. 252) shared across stories, questions, 
participants, and encounters. In telling stories about their depression, the participants reflected 
societal ideas about depression in general. Similarly, in asking questions about participants’ 
depression, the interviewer subtly reproduced constructions of depression shared within broader 
social structures. Whilst publicly available narratives were an important part of the analysis, the 
focus of the present study was predominantly on personal and co-constructed stories. Given the 
social nature of narratives and the co-construction that occurs, Murray (2000) suggests that both the 
interpersonal context and the social context be considered during narrative analysis.   
Findings 
 Two narratives that structured the participants’ accounts of TRD were identified: a narrative 
of order, in which depression was storied as predictable and understandable, and a narrative of 
disorder, in which depression was storied as unpredictable and incomprehensible.  
A narrative of order.  
Depression has clear causative factors. Participants told stories of interrogating their 
external worlds and experiences for patterns in order to predict shifts in their symptoms. They linked 
shifts in their depression to changes in their external environments. At times, they linked the onset of 
episodes to these factors. For example, Dean linked the initial onset of his depression to going “to 
university the first time around the 1980s, because I spat the dummy badly [behaved in a petulant 
manner] and sort of intentionally failed exams and shit like that” and Chris linked his first episode to 
a “bit of a binge drinking episode”. Similarly, Darryl attributed his first episode to the fact that “my 
mother died and we’d just had our first baby and my wife’s stepmother at that time was also 
diagnosed with cancer” and his second episode to “the break-up of my marriage”. The participants 
told of carefully examining their external environments and experiences in order to understand past 




depressive episodes as predictable: logically linked to external factors, such as challenging life 
events.  
Participants also told of interrogating their external environments for factors that contributed 
to the more subtle shifts of their depression across the days, weeks, and months. For example, Chris 
described identifying a link between time of day and mood, highlighting a predictable pattern of 
gradual improvement across the day, but “every morning without consideration, I wake up back 
down again”. In a similar vein, both Paul and Dean looked for patterning across time and questioned 
whether “winter” led to the worsening of their depression. Dean also suggested that his depressive 
symptoms returned on a cyclical or “annual basis”. Paul’s pattern seeking attempts also extended to 
observation of others’ experiences. He spoke of other peoples’ seasonal changes in mood, noting that 
“a lot of people, even if you’re not depressed, middle of winter is still bad for you”. Through 
interrogating their external worlds, the participants narrated a degree of patterning and predictability 
to their depression. Telling stories of these patterns offered a sense of order and certainty, and this 
was reflected in the decisive tone of the stories. These stories were also used to demonstrate that the 
participants had developed awareness of the self in relation to the external world.  
Depression is a discernible internal process. Participants also narrated accounts of 
interrogating their internal worlds for patterns to help them make sense of their experiences. They 
told of looking for and becoming “attuned” to internal cues that signalled shifts from periods of 
relative wellness to periods of depression. In storying their experiences in this way, depression was 
framed as an internal condition that could be observed and understood through careful introspection. 
For example, Dean told of how he had learned to become “more attuned” to his current internal state 
and how he could now “recognise” when he was “getting the wobbles”. 
Dean: This year’s been good. But I’m sort of getting the—I don’t think I’m getting 




Int: Yeah. So can you recognise it then because you’ve been through those cycles 
[of depression]? 
Dean: Yeah. Well I suppose I’m just much more attuned to stress, I suppose, and 
avoidance. And I know I’m avoiding shit. 
He described evaluating a set of internal factors, which he viewed as closely linked to his depression, 
such as his perceived level of “stress” and the degree to which he believed he was “avoiding shit”. 
Dean’s assertions that “I can recognise that” and “I’m much more attuned” positioned him as the 
expert in his internal experiences, capable of registering subtle shifts and skilfully discerning 
between “getting the wobbles” and “getting depressed”. Similarly, using a weather watching 
metaphor, Paul highlighted an idiosyncratic set of signs and symptoms that indicated to him that the 
“cloud” of depression was “coming on” again. These signs included his “mood changing”, his “head 
getting heavier”, and shifts in the way “he do[es] things” and “talk[s] to people”. Through his 
detailed and fluent listing of these signs and his assertion that “once you know the symptoms” you 
can recognise them quickly, Paul positioned himself as someone with a high level of self-awareness. 
He also framed depression as set of internal symptoms that, with work, could be observed and 
understood. Paul also noted that his wife had begun to engage in this pattern-seeking and learned to 
“pick” when “the cloud” of his depression was returning. In highlighting that others also engaged in 
this pattern-seeking, he legitimised it as a process and framed depression as something that could be 
objectively understood. These stories framed depression as a set of internal signs and symptoms that, 
through self-awareness and introspection, could be objectively observed. They further framed TRD 
as an ordered experience.  
Depression is measurable. In their attempts to identify patterns in their depressive 
experiences the participants told of using nuanced rating systems. These stories framed depression as 
a measurable construct. Chris, for example, described using a 10-point wellness scale as a tool for 




whilst “the majority of the time, [he’ll] go to bed feeling good, like sort of 9 or 10 out of 10”, he 
wakes up in the morning “back down” the scale again. Similarly, Sarah told of using a percentage 
system, where 100% was wellness and 0% was depression, to monitor shifts in her mental state.  
Sarah:  So, you’re thinking, you’re on edge to think “um, okay, I’m going along 
alright” and you’re constantly judging, also the other thing is you’re judging 
what level you’re at. So you’re trying to figure out “am I 50% of the way 
there, am I 20% of the way there? Am I 70% of the way there? Or am I going 
downwards again, am I going up?” And you’re sort of constantly aware of 
what you’re thinking and how you’re feeling. And where it should be just 
something in the back of your mind that “ok I’m having a bad day” or “things 
are going really well” but when you’re in a depressed state you’re constantly 
having to judge whether “am I well or not? Am I not well?” and that’s 
difficult.   
Through using these percentage and number systems, which are commonly utilised in medicine and 
clinical psychology to quantify subjective emotional states, the participants reduced the complex and 
multifaceted experience of depression to a single number or point on a scale, and so presented their 
experiences as contained. Their depression was narrated as constantly moving up and down this 
scale, however, these fluctuations were limited by the scale endpoints. They presented an ordered 
construction of depression as an experience that, with effort, could be tracked and understood. In 
narrating shifts in this way, the participants attempted to translate their internal experiences into an 
objective system that could be communicated to others. They became dispassionate observers of 
their own subjective experiences. Depression was positioned as a project separate to the self that they 
were tracking and containing. Again, this contributed to the construction of the ordered narrative of 




the assessment of current state became a major life focus. These rating systems were not simple to 
manage.  
Co-constructing the narrative of order. This ordered construction of depression occurred in 
conjunction with the interviewer. Narratives exist in a social world and are co-constructed between 
people. In this study, stories about TRD were shaped by understandings of mental distress and 
recovery shared by participants, as long-term service-users, and the interviewer, a clinical 
psychology trainee. The first author contributed to the ordered construction of depression by eliciting 
accounts of internal processes, such as thoughts and feelings, that she saw as factors contributing to 
the participants’ depression. For example, during Paul’s story of the return of his depression she 
asked, “What was that like?” and during Sarah’s account of her diagnosis she asked, “How were you 
feeling when that happened?” These questions encouraged descriptions of symptoms, interpretations, 
thoughts, and feelings. Depression was reduced to a discrete set of symptoms located within the 
participants. The interviewer also supported the narration of depression as having clear causative 
elements by interrogating the participants’ experiences for factors that explained the onset, 
improvement, or worsening of their depression. For example, she asked Paul, “so at that time where 
you first became depressed, what was going on in your life? You said you had a couple of kids 
then?” and, following mention of when he first became depressed, she asked Dean, “what was 
happening at that time?” Similarly, following the story of Chris’ worsening depression and attempted 
suicide, she asked, “can you tell me more about the time when you took the overdose? Like what 
was going on for you there?” At times this was led by the first author, at times this was led by the 
participants, but always they engaged in this process together.  
This narrative was informed by publicly available narratives of clinical psychology, 
medicine, mental distress, and recovery. As both interviewer and participant were deeply embedded 
in this paradigm (the first author as a clinical psychology trainee and the participants as long-term 




Clinical psychology strives to understand, categorise, and contain experiences of mental distress. It 
seeks predictability and certainty. To do so, it employs diagnostic categories, rating scales, and 
explanatory and causative models. Mental distress is framed as a set of symptoms situated within the 
person that can be objectively assessed, measured, and targeted. Depression is constructed as having 
logical or causative elements (Newnes, 2014). Publicly available narratives place value on building 
self-awareness about these internal processes and potential external contributing factors, by engaging 
in a careful process of introspection (Hänninen & Valkonen, 2019; Ridge, 2018). Alignment with 
these publicly available narratives was supported by the setting. The interviews took place in a 
private practice where the participants usually received clinical services. Upon entering they were 
greeted by a receptionist and seated in the waiting room where other service users were coming and 
going. The interviews were in a consulting room with armchairs, annual practicing certificates 
displayed on the walls, bookshelves of clinical books, a clock on the wall, and plain décor, and the 
interviewer was conservatively dressed and well-spoken. These setting related factors reinforced the 
therapeutic context and supported the familiar narrative of depression as understandable.   
A narrative of disorder. Despite the pervasiveness of the order narrative and the way that it 
was reinforced by the interviewer and setting, it did not completely frame the participants’ 
experiences. In making sense of and accounting for their experiences of TRD, participants also told 
another story; of depression as an experience characterised by disorder.  
Depression is random and unpredictable. Within the overarching narrative of disorder, 
depression was described as an unpredictable ebbing and flowing of experiences. Participants 
narrated their depression as a disorganised and confusing experience. They described their 
experiences as characterised by constant movement, with symptoms storied as constantly “coming 
and going”. This troubled the previously outlined story of depression as having clear and logical 
causative factors. Dean, for example, highlighted how fluctuations in depressive experiences could 




Dean: …the depressive episodes and the no sleep and the sleep problems and shit 
didn’t seem to match any sort of stresses, if you know what I mean. It wasn’t 
as though, “ooh I’m stressed” or, “ooh, I’ve made a mistake,” or whatever. 
They just happened. Maybe it’s winter, I don’t know. But it sort of happened a 
lot. 
The participants’ depression appeared to be storied as less predictable over time. Whilst, as 
outlined previously, early episodes were narrated as strongly linked to external triggering factors, 
this was not the case with current or recent experiences of depression. This is evident in Chris’ story 
summarising his history of depression: 
Chris: It initially started—what, maybe 35—probably 35 years ago. My first instance 
was a bit of a binge drinking episode with my flatmates. I woke up the next 
morning all anxious, depressed, confused. So anyway, that subsided and I’ve 
learnt my lesson from that, obviously. Uh and then when was the next one? It 
also happened in Australia when I was living over there with a group of 
flatmates. So gradually I thought, “gee, these symptoms are coming back 
again”, so I ended up coming home—not the sole reason for that but partially. 
So I went and saw a doctor, they gave me some antidepressants, they never 
really worked. So then at that stage my depression was coming in and going 
out type of thing, and it wasn’t there permanently at that stage. So in the end I 
went and saw [a psychiatrist] and spent a few years with her. She put me on 
fluoxetine and lithium and I had some really good, long spells on that 
medication. And then after a while it started to come back again.  
At the beginning of his story, Chris narrated his early episodes of depression as discrete; with a clear 
beginning and end. He carefully examined them for causative elements by linking them logically to 




Chris’ account shifted to describing depression as a series of undifferentiated amorphous episodes 
with no clear triggers. He described the depression “coming in and going out” over time without 
much detail.  
Similarly, whilst Darryl’s descriptions of early experiences of depression were clearly linked 
to external life stressors, such as births, deaths, relationship breakups, and illness, current and recent 
episodes were described as the opposite. He noted that, with his most recent depressive experiences, 
“there wasn’t any sort of obvious sort of stressors that were starting it” and that, unlike early 
episodes triggered by life events, recent episodes have “been sort of different in that yeah I suppose 
it really was quite a sort of insidious sort of coming on to me”. However, they described being 
unable to do this over time. Ultimately, they narrated the search for a “match” between depressive 
episodes and circumstances as futile. As Chris highlighted, no amount of interrogation of their 
experiences could explain their depression:   
Chris: I don’t know why I get depressed. So many people ask the question, you know, 
“has something gone on in your life?” And yeah, I used to try and find things 
that it could be and then I just gave up because I couldn’t find anything to 
cause it. 
Depression is not observable or measurable. Within the narrative of disorder, the 
participants also told of how constant fluctuations led to difficulty accurately gauging and 
communicating one’s current internal status. Again, this troubled ordered accounts of depression as a 
discernible internal process that could be objectively observed and measured. Sarah, for example, 
repeatedly questioned her ability to accurately assess what was occurring in her internal world. She 
described how fluctuations in her depressive symptoms occurred so regularly and randomly that she 
was constantly questioning “…is this just a bad day? Or is this a bad moment? Or, is the drugs not 
working?” Despite concerted efforts to track, understand, and contain her depressive experiences, 




also questioned whether a shift had even occurred in the first place, separate from her perception of 
it, which she felt she could not necessarily trust. Paul also storied uncertainty regarding his internal 
state as a result of the frequent fluctuations. He told of falsely interpreting bodily sensations 
associated with physical illness or fatigue as depressive symptoms. This meant that he often believed 
that he was experiencing the “onset of another episode” when he was merely experiencing “a flu 
coming on” or was “just tired because I’ve been doing this, this, this”.  
Similarly, Dean described how frequent changes in mood led to a sense that he was no longer 
a reliable interpreter of his own experiences. 
Dean: Well, when I’m in it [depression], I think it’ll never stop. I mean, 
intellectually, you know it will, but sort of emotionally, you think, “this is it for 
life, I better start making plans to jump off a bridge or take an overdose”, 
something like that. And then it passes, whether it’s because of medication or 
because it’s just body chemistry or something. Um and then you just think 
back and think “the past year is just a total stranger”. So I don’t know. I 
mean, a lot of it is self-deception. A lot of it is self-deception. 
Int:  What do you mean by that? 
Dean: Um, I don’t know. Sort of like lying to yourself all the time, that “things will 
get better”. Or that “things won’t get better. I should check out”. Um, I don’t 
know. 
Dean described the confusion he encountered as a result of this constant cycle and his need to 
interpret these shifts. Unlike ordered stories of the self as an objective observer of internal processes, 
Dean positioned himself as “in” his depression; caught up in an emotional vortex of uncertainty. 
Switching back and forth between viewing his depression “emotionally” and “intellectually”, he 
framed depression as an experience that could not be dispassionately observed and measured. 




experiences as characterised by “self-deception” – he felt there was some internal duplicity 
occurring. This stood in stark contrast to ordered accounts of depression as an experience that, 
through introspection and self-awareness, could be understood and contained. As a result of these 
constant fluctuations, Dean no longer saw himself as an honest and reliable interpreter of his inner 
world. In these stories, participants framed depression as something that was so frequently shifting, 
that it was impossible to accurately gauge their current status. They described feeling doubtful about 
their abilities to be experts in their internal worlds and to accurately report what was going on for 
them. The participants’ attempts to determine patterns and understand the triggers of depressive 
symptoms depended on reliable access to their internal worlds. Without this, attempts to seek and 
confirm patterns were described as fraught and leading to the sense of self-deception.  
Depression is unrelenting. Within the narrative of disorder, depression was also storied as an 
experience that would be ongoing. Whilst participants described initial surprise when depressive 
symptoms returned after periods of relative wellness, with time, they came to narrate the return of 
depression as inevitable. Chris, for example, described feeling shocked when his depression returned 
after his initial episode and round of treatment—“gee, these symptoms are coming back again”. 
However, as the fluctuations in depression continued over the months and years, the return of 
depression was presented as an expected outcome. Sarah described how, despite experiencing 
periods of feeling “really positive”, she had now come to expect that her depression would always 
return:  
Sarah: I’ve had a couple of times where I’ve had the drugs last for about 9 months or 
maybe 12 months before I’ve started to go downhill again. So you have these 
times where you think “right, I’m really positive, I’m really good, I’m going 
along” and then you’re going along for a long time and you’re doing different 
things and then you start to gradually go “okay, that could be just a blip” or, 




you know, “these things happen”, you know, “you need to find a different way 
of coping” or things like that and it gradually goes back and back and back 
and back… and then you get very sad and upset that things go backwards, 
because, you know, you expected it to last. And you get to the point where I am 
now where you don’t expect it to last, where you should expect it. 
Sarah told of a recurring pattern of improvements in her mood being disrupted by the re-emergence 
of depressive symptoms. Periods of wellness were narrated as progress - “going along” - towards 
apparent resolution of symptoms. Initially, she described active efforts to stay on this upwards 
trajectory through engaging in positive self-talk. She told of reassuring herself that recovery is not 
linear and that a “blip” or “bad day” was not necessarily indicative of full on relapse. Staying on this 
course appeared precarious, however, with Sarah suggesting that, despite her efforts, she usually 
ended up going “downhill again”. Repeated experiences of progress being derailed lead Sarah to “get 
to the point” where she no longer believed consistently good mood was possible. Paul described a 
similar gradual realisation that his depression would be an ongoing struggle: 
Paul: I had my first bout and I was good for a while then I had another lot then I 
was alright then I had another lot and that’s when I thought “I don’t think this 
will ever pass”. It’s like it’s gonna reoccur and reoccur. 
In these accounts, participants told of letting go of personal expectations of progress and eventual 
resolution of symptoms. Whilst they did describe experiencing periods of relative wellness, the 
return of their depression was narrated as inevitable.  
Order and disorder: a profound narrative tension. Across the participants’ accounts, a 
tension emerged between narrating depression as understandable and ordered and narrating 
depression as chaotic and confusing. Rather than drawing on one of these narratives in isolation, 
each of the participants drew on both. They repeatedly switched back and forth between these two 




narratives to make sense of and account for their experiences of TRD - and both had advantages and 
disadvantages for the participants as social actors in the world. The narrative of order made 
experiences of depression more knowable and predictable. It also allowed participants to remain 
aligned with medical paradigms or publicly available narratives of depression and position 
themselves as good patients doing all they could to recover. This is the narrative made available in 
clinical contexts and there is an expectation by clinicians and patients alike that this will be the 
narrative adopted. To resist this narrative would be to let go of the alliance with psychiatry and 
psychology and disrupt the expectations regarding how people conduct themselves within clinical 
encounters. However, for the participants with TRD, this narrative did not completely frame their 
experiences – they also drew on a narrative of disorder. This narrative allowed them to account for 
the fact that they continued to experience depressive symptoms long term.  
Across the use of these narratives several shifts were evident in the way that depression was 
storied. First, there was a temporal shift in the adoption of these narratives. Stories about early 
depressive experiences included more frequent, confident, and comprehensive accounts of order. 
Participants described ordered constructions of depression matching their experiences – they told 
stories of being able to identify patterns, observe their own internal experiences, track and measure 
changes, and predict shifts. However, this appeared to be less the case with episodes described over 
time, with participants outlining repeated experiences that undermined and troubled this narrative. 
They described a recognition that this narrative did not account for their trajectory of depression as a 
whole. Whilst this general pattern in narrative adoption was evident, it was not strict. Participants 
continued to shift back and forth between these narratives throughout the interviews. 
As this temporal shift in narrative production occurred, so too did participant positioning. In 
aligning themselves early on with publicly available narratives of depression and mental illness – by 
narrating early experiences of distress as contained, understandable, and manageable – the 




However, with recognition that the narrative of order did not completely represent their experience, 
the participants shifted to subtly framing themselves and their depression as different from the norm. 
Sarah, for example, concluded her account above with the assertion that “you should expect it 
[wellness]” to last and, in doing so, pointed towards the dominant Western expectation of recovery 
from illness. She suggested that, whilst it was reasonable for the average person to expect return to 
wellness, she was different and this was not the case for her. Similarly, Chris’ in his comment that 
“so many people ask the question, you know, ‘has something gone on in your life?’” made reference 
to the publicly available narrative of depression being caused by “stressors” and, therefore, a logical 
and predictable phenomenon. He highlighted his difference from the norm, however, in stating that 
whilst “[he] used to try” to apply this thinking to his own depression trajectory, it did not fit so he 
“gave up”. It was with time and repeated experience of their depression journeys deviating from 
expected trajectories that people with TRD began to narrate their experiences and position 
themselves as different from those experiencing depression that does respond to treatment as 
expected.  
Discussion 
A significant minority of people with depression do not experience recovery following 
several rounds of antidepressant medication (Crown et al., 2002). Emerging research now also 
suggests that antidepressant medication is not as effective as once thought (Rush et al., 2006; Rush et 
al., 2009). The current study explored how people understand and make sense of depression that has 
not resolved even with seemingly adequate input from health professionals. The process of narrative 
analysis revealed some of the ways people with TRD make sense of this experience. Two narratives 
that structure participants’ accounts emerged: a narrative of order and a narrative of disorder.  
The narrative of order was informed by powerful publicly available constructions of 
depression within psychiatry and psychology. Within these fields, depression is framed as a discrete 




2014). For example, recent research frames TRD in almost exclusively biological terms; a biological 
flaw situated within the individual to be rectified with pharmacological treatment (Akil et al., 2018; 
Ragguett, Tamura, & McIntyre, 2019). Once targeted through treatment, the assumption is that the 
prior level of mental health will be restored. In this study, both the participants and the first author 
were embedded in this paradigm and imbued with these expectations and, consequently, co-
constructed the ordered account of TRD. These publicly available narratives may align with 
experiences of people who recover from depression as expected, for example, people whose 
experiences follow a linear progression from illness to wellness (e.g., Karp, 1994; Schreiber, 1996). 
However, they may not completely represent the experiences of those who experience depression 
without recovery. Conversely, the narrative of disorder was akin to findings of the limited existing 
research on experiences of longer-term depression, which suggest that the experience is characterised 
by constantly fluctuating symptoms (Chambers et al., 2015).  
As well as not completely representing the experiences of those who do not experience 
recovery as expected, narratives of order may also be unhelpful for this group. McPherson and 
colleagues (2014) suggest that the inherently structured medical paradigm may not create the most 
appropriate health service context for people with TRD. Instead, the focus on models, categorisation 
systems, and standardised questioning restricts the discourses and identities that can be adopted and 
negotiated within clinical encounters. As a result of this, the narratives that emerge do not reflect the 
multifaceted realities of people with TRD; shared understandings between health professionals and 
patients are not reached and effective solutions are not offered. McPherson et al. (2014) suggest that 
rigid adherence to this paradigm may lead to frustration among both GPs, when patients do not ‘fit’, 
and patients, when GPs’ constructions of their difficulties do not reflect their realities.  
The context of this study likely shaped the stories that were told about TRD. Researchers 
have stressed the importance of considering the impact of storytellers’ social positions, for example 




2003). In the present study, the participants were affluent with considerable security in terms of 
employment, housing, and support systems. These factors afforded them a high level of access to 
resources. As described in the interviews, they were able to register at a private psychiatry practice, 
to trial unfunded medications, to take leave from work, and to engage in alternative approaches such 
as yoga and meditation classes. Available resources affect people’s ability to respond to and make 
sense of life disruptions (Bury, 1982; Stephens & Breheny, 2013). With ample time, security, and 
resources, they were able to focus on self-development, making sense of their experiences, and 
revising their identities in the face of illness. In terms of narrative production, their affluence may 
have made them more committed to the medical paradigm and the narrative of order, as they were 
able to mobilise whatever resources necessary to continue to pursue treatment to manage their 
depression. They were also easily able to story virtuous identities as good patients doing all they 
could to recover, even when the odds were against them. Without this level of privilege, people with 
TRD may produce very different kinds of stories. People with TRD struggling to access appropriate 
mental health services or to maintain secure housing and employment may produce narratives less 
aligned with this medical paradigm and have to work harder to produce virtuous identities. Further 
research in alternative settings would strengthen our understanding of the impact of social 
circumstances on shaping how people make sense of TRD. 
It is important to consider how these findings may provide insights that could improve 
healthcare experiences and outcomes for people with TRD. Clinicians enter encounters with clients 
with their own set of often unexamined assumptions. Stories of long-term chaos and distress are 
challenging to hear in clinical encounters (Frank, 1995). Embedded in powerful medical paradigms, 
clinicians search for order to make sense of the ‘dis-order’ they witness. They co-construct or impose 
narratives of order with their clients and, in doing so, attempt to bring about narrative resolution to 
mental distress. Diagnostic categories and explanatory models are fundamental components of 




human existence. There is undoubtedly reason to continue employing these approaches as they 
appear useful for the majority of people who recover as expected. However, these findings suggest 
that a different approach may be beneficial for people with TRD. Specifically, this may include the 
following: 1.) increasing self-awareness about the tendency to impose order in clinical encounters, 
2.) creating space for alternative stories that may frame clients’ experiences, 3.) integrating 
approaches based on chronic illness models, 4.) adopting ‘living well’ models of recovery rather than 
symptom reduction models, 5.) encouraging a move away from constant symptom monitoring and 
6.) utilising third wave therapeutic approaches which focus on acceptance. In turn, these approaches 
may lead to more fulfilling clinical interactions for both client and clinician and allow space for the 
conception of more effective or fitting management strategies. 
Conclusion 
Much of what is known about depression is based on people who respond to treatment as 
expected. This paper sheds new light on the narratives people draw on to structure their accounts and 
to make sense of their experiences of depression that do not respond to treatment as expected. 
Through the process of narrative analysis, two narratives emerged: a narrative of order and a 
narrative of disorder. The order narrative was informed by wider clinical psychology assumptions 
and expectations of recovery. This narrative introduced a sense of containment: TRD was made more 
understandable, predictable, and manageable. Conversely, within the narrative of disorder, TRD was 
storied as a constant yet unpredictable ebbing and flowing of symptoms. Across these accounts, there 
was a general pattern of participants drawing on the narrative of order when storying early 
experiences of depression and, after outlining disruptions to these ordered constructions, drawing on 
the narrative of disorder when storying later experiences. With this came a general shift from 
positioning the self as a ‘typical’ person experiencing depression to a person experiencing depression 
differently. Whilst the narrative of order may be helpful for many people experiencing short-term 




constant striving to tell this ordered story, a comfort in hearing this story, and an expectation in 
healthcare settings that this will be the story co-constructed, however, for this group of people, this 
narrative does not appear to completely encapsulate their experiences. Recognising and addressing 

























CHAPTER FIVE: ARTICLE TWO – Accounting for the experience of TRD 
This chapter is being considered for publication as: Kroch, E., Breheny, M., van Kessel, K., 
and Taylor, J. (2020). “If medication isn’t helping me, maybe it’s just me”: Accounting for treatment 
resistant depression. Sociology of Health and Illness. 
Abstract 
A significant proportion of people experiencing depression do not respond to treatment as 
expected. Whilst there is growing literature exploring the ways in which lay-people, patients, and 
health professionals conceptualise depression that does resolve, there is no known literature 
exploring how people account for persistent distress. The current study aimed to address this gap by 
specifically exploring how people account for the persistence of their depression despite receiving 
treatment. Nine participants were recruited through a private psychiatry and psychology practice in 
Auckland, New Zealand. Participants’ interviews were analysed using a narrative approach and two 
overarching narratives were identified: (i) a treatment resistant brain explanation, in which persistent 
distress was attributed to flaws in personal biochemistry rendering antidepressants ineffective, and 
(ii) a treatment resistant personality explanation, in which persistent distress was attributed to 
fundamental flaws in character that were beyond the reach of medications. Rather than linking their 
depression to external factors, as is seen in accounts of depression that does resolve, people with 
TRD strongly attributed their persistent distress to factors within themselves. Whilst alternative 
narratives were at times drawn on by participants, these explanations also situated depression and 
recovery as the responsibility of the individual. It is now widely recognised that causal beliefs about 
health and mental health influence patients’ approaches to help-seeking and health professionals’ 
approaches to service delivery. Health professionals need to be aware of patients’ tendencies to shift 
to self-blame when antidepressants are ineffective, but they must also be cognisant of the role they – 





Keywords: New Zealand; depression; treatment resistant depression; narrative; qualitative research; 
causal explanations; identity 
Introduction 
A growing number of studies have explored the ways people explain their depression and 
depressive symptoms. Beliefs about the cause of distress or illness are thought to have considerable 
impact on people’s approach to help-seeking and engagement in treatment (Prins, Verhaak, Bensing, 
& van der Meer, 2008). Similarly, the views of health professionals have been explored, as they are 
thought to influence treatment decision-making, interactions with clients, and the views of patients 
themselves (Geraghty et al., 2017). Whilst there is increasing interest in how depression is 
understood and explained, there is little work exploring how the persistence of depression is 
accounted for. This is the case even though persistence of distress following treatment is experienced 
by a significant proportion of people with depressive symptoms. For instance, STAR*D, the largest 
study to date to evaluate the efficacy of a range of depression treatments, found that only 50% of 
people experienced remission following two rounds of treatment (Rush et al., 2008). Those who do 
not experience significant clinical improvement following treatment are frequently referred to as 
having treatment resistant depression (TRD). TRD appears to be unique from so-called chronic 
depression and recurrent depression as most people with chronic depression have not received 
adequate treatment and people with recurrent depression do respond to treatment and experience 
periods of remission (Gelenberg et al., 2006). People with TRD have been found to experience poor 
quality of life, high levels of physical and mental health comorbidity, and significantly impaired 
functioning (Brown et al., 2019; Greden, 2001). 
Explanations of depression. Among people currently experiencing depressive symptoms, 
depression is commonly believed to result from external social factors. In their systematic review of 
qualitative studies, Prins et al. (2008) found that depression was often framed as an understandable 




be especially the case early on in depression experiences. People experiencing their first hospital 
admission were more likely to name recent and distinct stressful life events as triggers of their 
depression compared to people who had been hospitalised multiple times (Buus, Johannessen, & 
Stage, 2012). Similarly, in a previous study exploring experiences of TRD, early episodes of 
depression were presented as isolated incidents clearly linked to external events (Kroch, Breheny, 
van Kessel, & Taylor, 2021). Psychosocial causative explanations frame depression as 
understandable given the circumstances and even predictable. Buus et al. (2012) suggest these 
explanations may be predominant as they espouse the idea that recovery is possible through personal 
action. Additionally, some argue this way of understanding depression carries fewer moral 
implications, as people are seen to be responding to challenging aspects of normal life rather than 
being fundamentally unwell (Kangas, 2001).  
Whilst not the predominant causative explanation, people do at times provide biological 
reasons for their depression. Within this explanatory accounting, depression is framed as the result of 
a chemical imbalance in the brain. In their systematic review, Prins et al. (2008) found this 
explanation for depression was more commonly presented by people who were currently 
experiencing depression compared to lay-people who had not experienced depression. A number of 
studies also suggest that, whilst not central to people’s accountings of depression, biochemical 
explanations continue to be drawn on to some degree, especially when justifying engagement with 
treatment (Buus et al., 2012). This is consistent with findings of recent thematic syntheses of 
qualitative studies exploring patients’ views of antidepressant use (Malpass et al., 2009; Maund et 
al., 2019). These syntheses found that patients endorsed biochemical explanations as well as 
psychosocial explanations to legitimise their continued use of antidepressant medication. 
Biochemical explanations position depression as a treatable condition for which the individual is not 




have strong links to culturally favoured narratives describing progression from illness to treatment to 
cure (Buus et al., 2012; Frank, 1995).  
These studies suggest there is an inconsistency between the explanations people give for the 
occurrence of their depression and the rationalisations they provide regarding treatment. Rather than 
drawing on a single explanation, participants drew on psychosocial explanations whilst remaining 
open to biochemical explanations to explain use of antidepressant medication. Both accounts worked 
to increase perceived control over depression through either changes to life circumstances or 
biochemistry (Buus et al., 2012). People’s views about the causes of their depression are 
multidimensional and complex (Prins et al., 2008). Their explanations appear to shift and evolve 
over time, often in relation to the stage of their depression and their engagement in treatment (Buus 
et al., 2012; Kroch et al., 2021).  
Health professionals’ explanations of depression. Similar findings have emerged in studies 
exploring health professionals’ understandings of depression. Meta-syntheses of qualitative studies 
suggest that, again, two predominant yet contrasting causal explanations are held: a psychosocial 
explanation and a biomedical explanation (Barley, Murray, Walters, & Tylee, 2011; Schumann, 
Schneider, Kantert, Lowe, & Linde, 2012). The psychosocial explanation was primarily adopted by 
clinicians in primary healthcare, with a minority attributing depression to chemical imbalances. But, 
similar to the views of patients, rather than employing either one of these explanatory accounts, 
clinicians negotiated and switched between them. There appeared to be some dissonance in the 
accounts: whilst depression was largely framed in psychosocial terms, it was treated as a medical 
illness (Barley et al., 2011; Schumann et al., 2012). Clinicians highlighted that, after repeated 
exposure to patients with challenging life circumstances, they had come to view depression as 
largely psychosocial in nature. However, embedded in medical contexts, they held medicalised 
models of distress, employed medicalised discourse, and described antidepressants as their most 




As with patients’ accounts, these contrasting causal explanations likely held different 
functions. Psychosocial models contextualise a person’s distress within their life circumstances and 
may be normalising for patients (Geraghty et al., 2017). Conversely, clinicians described employing 
biochemical explanations in a number of circumstances, even when they themselves did not believe 
them. These circumstances included instances where they wanted to instill a more concrete sense of 
hope, when they believed a chemical imbalance explanation would be experienced as less 
stigmatising, or when they wanted to encourage antidepressant use (Johnston et al., 2007; Rogers, 
May, & Oliver, 2009). Biochemical explanations were also endorsed when patients were not 
experiencing challenging life events to attribute the depression to (Schumann et al., 2012). This 
indicates that clinicians provide explanations strategically, not entirely in response to their objective 
assessment of the cause of patients’ depression. These studies highlight that, similar to patients, 
clinicians draw on and negotiate contrasting reasonings when accounting for their patients’ 
depression, engaging in clinical encounters, and delivering treatment.  
Explanations of persistent depression. Despite the research on explanations of depression, 
there is little research exploring how the persistence of depression is accounted for. People in this 
group make up a significant proportion of those experiencing depression. The limited work in the 
area suggests causal explanations among people experiencing longer-term depression may differ 
significantly to beliefs of those experiencing early episodes of depression. For example, in contrast 
to the psychosocial explanations given for depression, Buus et al. (2012) found people who had been 
hospitalised for depression multiple times did not reference specific external index events at all. 
Instead, as their depression persisted, emphasis was placed on enduring factors such as stress, 
fatigue, and personality. As time goes on, people experiencing long-term depression shift to framing 
depressive episodes as unpredictable and unexplainable (Buus et al., 2012; Chambers et al., 2015). 
Similarly, people experiencing TRD describe early depressive episodes as discrete periods of low 




experiences as a series of undifferentiated amorphous episodes unrelated to external life situations. 
In early episodes, efforts are made to resolve depression through rectifying these social 
circumstances, however, this is less the case over time (Kroch et al., 2021).  
The little work in this area also suggests that health professionals’ causative beliefs about 
depression evolve as their patients’ depression persists. When working with people with TRD, 
McPherson and Armstrong (2009) found that general practitioners’ (GPs) explanations shifted from 
being largely biomedical in nature to being focused on people’s enduring traits or the experience of 
trauma. For example, clinicians attributed patients’ lack of improvement following treatment to 
problematic attitudes, social deviance, and deficits in coping skills. This shift in conceptualisation of 
depression likely has significant impacts on health professionals’ approaches to treating this patient 
group, patients’ experiences of receiving services, and patients’ own explanatory accountings. For 
example, counsellors and GPs’ attitudes towards people with TRD were found to be predominantly 
negative (McPherson & Armstrong, 2009; McPherson et al., 2006). Furthermore, recommended 
clinical interventions, such as cognitive behavioural therapy, were not deemed useful for this group 
so few referrals were made (McPherson & Armstrong, 2009).  
In summary, the ways people experiencing TRD explain their depression may differ 
significantly from those with depression that does respond to treatment. However, there is no known 
literature focused on how this group accounts for their persistent distress. This is of particular 
interest as, unlike people with other forms of long-term depression, those with TRD have received 
adequate treatment yet have not experienced significant clinical improvement (Gelenberg et al., 
2006). For many people with TRD, their depressive symptoms last for years and lead to significantly 
reduced quality of life and functioning (Greden, 2001). As this group make up a significant 
proportion of those experiencing depression (Rush et al., 2008), it is important to understand how 
they account for this. This study explored how people experiencing TRD explained the persistence of 





Narrative Psychology. This study employed a narrative approach to explore how people 
experiencing TRD made sense of and accounted for the persistence of their depression through the 
process of storytelling. Storytelling helps people make sense of disruptions to their expected life 
courses, as it facilitates understanding of how and why an event occurred (Stephens, 2011). As a 
process, it also helps people makes sense of and renegotiate identity in the face of such life changes, 
and, over time, facilitates a restored sense of order and coherence (Crossley, 2000; Murray, 2008; 
Sarbin, 1993). Narrative psychology is interested in the ways people make sense of and account for 
lived experiences and negotiate identities through the process of hearing and telling these stories 
(Hiles & Cermak, 2008; Murray, 2008; Silver, 2013). Concerned with the surrounding socio-cultural 
context, narrative psychology also considers broader societal structures and publicly available 
narratives that shape how individuals and groups story their experiences (Murray, 2008). In the 
present study, a narrative approach provided insight into how people with TRD made sense of and 
accounted for the persistence of their depressive symptoms in spite of adequate treatment. It also 
explored how these people took up and negotiated identities such as ‘depressed’, ‘patient’, ‘chemical 
resistant’, or ‘personality disordered’, and how publicly available narratives and local moral orders 
informed their accountings of TRD.   
Participants, Setting, and Procedure. The study took place at a private psychiatry and 
clinical psychology practice situated in an upper middleclass suburb in central Auckland, New 
Zealand. The private practice gains clientele through either self-referral or referrals from other health 
professionals, with services either paid for directly by clients or by private health insurance. 
Participants were recruited by a psychiatrist at the practice, who identified patients with TRD, 
informed them of the study, and enquired as to whether they were interested in participating. This 
psychiatrist had over 20 years of psychiatric experience and had worked full-time in a private 




physical illness and provision of treatment, in the form of medication, transcranial magnetic 
stimulation, and/or short-term skills based cognitive behavioural therapy. Clients who expressed 
interest in participating in the study were provided with information sheets and asked for consent to 
be contacted. The first author then made contact, provided further information on the study, and 
answered questions. If they agreed to participate, a time and date was arranged for an interview.  
Nine people experiencing TRD agreed to participate. The participants ranged in age from 28-
65 years, with a mean age of 47 years. Three participants identified as women and six identified as 
men, and all participants identified as Pākehā/New Zealand European. Participants met DSM-5 
criteria for major depressive disorder (American Psychiatric Association, 2013). They were also 
deemed by the recruiting psychiatrist to have TRD based on the most commonly employed 
definition: two or more antidepressant medications from different classes at adequate doses and 
durations had not produced significant clinical improvement (Brown et al., 2019). The study aimed 
to recruit a specific sample of people who had received adequate treatment for their depression. As a 
result of this, many of the participants had tried many more than two antidepressants and had also 
engaged in other treatments, such as psychological therapy. Based on the practice location, the costs 
associated with accessing the service, and the high level of engagement in other privately funded 
treatments, it is expected that the participants were affluent. When compared to the population 
experiencing depression in New Zealand (Oakley Browne et al., 2006), the sample was not 
representative in terms of age, gender, socioeconomic status, or ethnicity. This was likely due to the 
study setting.  
Data were collected through individual semi-structured interviews conducted by the first 
author. Interviews occurred at the recruitment site, once participants had given informed consent and 
completed a demographic questionnaire. They began with the interviewer inviting participants to 
share the story of the onset of their depression, for example, by asking, “Could you tell me the story 




the general aim of exploring how participants accounted for TRD. Based on the suggestions of 
Murray (2003), the interviewer attempted to encourage rich descriptions and narrative accounts 
through referencing times and places, for example, by asking, “Could you tell me more about the 
time the doctor said you have depression?” Interviews were audio recorded and ranged in length 
from 34 to 77 minutes. Participants were offered a $50 petrol voucher to thank them for their time. 
Ethical approval was gained through the New Zealand Health and Disability Ethics Committee 
(16/NTA/197/AM07). 
Analysis. The first author transcribed the audio recordings and cross-checked the transcripts 
for accuracy. In terms of transcription conventions, words are underlined to show emphasis and 
bracketed ellipses show where transcript sections have been edited for brevity or clarity. The names 
and identifying details of the participants have been changed. Analysis was informed by the narrative 
analytic approaches of Murray (2000) and Stephens and Breheny (2013), which involve exploration 
of multiple levels of meaning: personal stories, interpersonal stories, and publicly available 
narratives, as well as how these levels intersect. Initially, personal stories the participants told about 
their subjective experiences of TRD were identified. Accounts were deemed to be personal stories if 
they included characters engaged in an overarching plot. Secondly, interpersonal stories were 
considered, and were understood to be stories of experiencing mental distress co-constructed 
between the participants and the interviewer. Lastly, publicly available narratives that shaped the 
personal and interpersonal stories were considered. These included broader narratives concerning 
mental distress, recovery, clinical psychology, and medicine that circulate in society through popular 
psychology and the media.  
Findings  
Two narratives that accounted for the persistence of depression were identified: (i) a narrative 
of a treatment resistant brain, in which depression persists due to a flaw in biochemistry which 




depression persists due to fundamental flaws in personality that are beyond the reach of 
antidepressants.  
(i) A treatment resistant brain. Some participants accounted for the persistence of their 
depression by suggesting they had a treatment resistant brain. Their biochemical constitution was 
understood to resist the effects of medication and, consequently, antidepressants did not lead to 
resolution of depressive symptoms. The participants used this understanding as the foundation for 
why their depression had persisted even in the face of adequate treatment, when others treated in 
similar ways had recovered.  
“I’m definitely chemical resistant”. Chris provided a clear articulation of this narrative. In 
spite of persisting with several antidepressants as prescribed, he had experienced, at the most, short 
term relief of symptoms. He accounted for this by suggesting he was “chemical resistant”: 
Chris: Anyway, once again I probably spent 18 months, two years with [the 
psychiatrist] trying out different medications. When I say trying different 
medications, I must have tried at least 20 different antidepressants over that 
period of time, and none of them gave me long-term relief. Very short-term in 
some cases, sometimes none (…) [The psychiatrist] is getting a machine in 
from the States I believe, and it’s for treating people that haven’t had any luck 
with medication. Like medication resistant, which I obviously am because I 
just keep trying and trying and trying all different ones and no relief at all (…) 
I’m sort of, not so much at my wit’s end, but I’m definitely chemical resistant, 
yeah. Definitely, for the amount that I’ve tried (…) I was peeved off because it 
would’ve been nice to find the right medication that would put me on the 
straight and narrow.  
In these accounts, Chris’ body was presented as resisting the psychotropic effects of the medications 




statement that he was “chemical” or “medication” resistant throughout the story. He defined a 
category of people who are treatment resistant - “people that haven’t had any luck with medication” - 
and positioned himself definitively within this group, “convinced” that medication would not work 
for him. Throughout these accounts, Chris made references to a “machine” for treating this group of 
people. This machine’s mechanism of action is not the delivery of chemicals, as is the case with 
antidepressant medication, but, instead, the delivery of magnetic fields. This accounting allowed for 
the possibility of future treatment success, with Chris expressing hope that the machine may be “the 
candidate for me”.  
Similarly, Michael provided an explanatory account of the persistence of his depression 
despite treatment rooted in a biochemical resistance to medications. Michael described in general 
terms the ways some severe illness might not respond to medications: “yeah, just a medical illness 
that was bad and didn’t respond to medications.” He then linked this explicitly to why his depression 
had not resolved because it too was beyond the scope of medication - “but no, I think it was probably 
just treatment resistant illness for some reason.” Michael suggested that the severity of his depression 
had meant that medications were ineffective in resolving his symptoms. He also likened his 
depression to medical illnesses that do not improve with medication, firmly situating his depression 
as biological. Michael situated this resistance within his depression – a “treatment resistant illness” - 
whereas Chris situated it within himself – “I’m medication resistant”. However, both participants 
framed biochemical processes occurring within the body as the explanation for non-response to 
medication.  
These stories of the experience of TRD framed depression as a biological disorder that can be 
resolved through interventions that alter brain biochemistry, such as antidepressant medication or 
transcranial magnetic stimulation. This idea was common throughout the participants’ stories, but 




Dean: [The psychiatrist] said it was just regular old depression and anxiety and that 
could be treated with chemicals. So that’s my story really. I’ve sort of like 
always been a depressive, had problems for a long time. And then I’ve tried 
for treatment over a long time and the treatments have been hit and miss. And 
I’ve got my own sort of episodic load of bullshit, that’s just me, it’s my 
chemistry, I presume. I assume it’s just chemical, I dunno. Is it? 
Drawing on what he has been told by his psychiatrist, Dean accounted for non-response to treatment 
by suggesting that he had a certain type of “chemistry” that leads to “episodic” depression. He 
framed his depression - “my own sort” – as different to other people’s, who may have different 
chemical constitutions. Although “regular old depression” was viewed as a biological disorder that 
could be resolved with antidepressants, in Dean’s case, his chemistry was seen to interfere with this 
process.  
Within this explanatory accounting, symptoms of depression were not viewed as relevant or 
meaningful components of the participants’ identities and, instead, were viewed as resulting from 
and persisting due to the misfiring of a disordered brain that resisted the balancing effects of 
antidepressants. Accounting for TRD in this way located the responsibility for persistent distress on 
biological processes within the body; either the chemical makeup of the person or the nature of their 
depressive illness.  
“I’m just really unlucky”. The “chemical resistant” brain accounting provided an 
explanation of why depression may persist despite antidepressant medication, but it did not explain 
why it was the case for these people. To account for this, participants framed their lack of response 
to antidepressant medication as a simple misfortune. Lily, for example, after questioning aloud in the 
interview, “why am I in that group of people that trial all these different ones and nothing happens?”, 




Lily: Um, I mean there’ll always be a percentage of people, I guess, that don’t 
respond. (…) In the past when I didn’t respond to anything I was kind of like, 
“I’m just really unlucky”, like that kind of became more a focus. Like, for 
example, at university they show a graph of people responding to 
antidepressants, it’s like, you know, two thirds of people respond to the first 
one, but then there’s this percent of people that don’t respond to the first one. 
But then some of those people respond to the second one, but then there’s 
another group… So I was like, “I’m just in that group at the end which didn’t 
respond”.  
Drawing on knowledge of antidepressant response rates acquired through her mental health training, 
Lily accounted for her lack of improvement by situating herself as part of the small group who 
statistically lie at the tail end of a distribution and do not respond to medication. Chris (above) 
similarly referred to himself as one of the “people who haven’t had any luck with medication”. It was 
assumed that antidepressants do work for most people, even if it was not the case for them. Through 
references to luck, lack of improvement in symptoms was attributed to chance and uncontrollable 
biochemical processes rather than participants’ actions or character.  
(ii) A treatment resistant personality. The second narrative attributed persistent distress to 
problematic personality factors that were viewed as beyond the reach of antidepressant medication. 
Participants suggested that these treatment resistant “personality” factors either maintained the 
depression, prevented improvement, or were, in and of themselves, the problem. Throughout this 
narrative, participants used phrases such as “temperament” and “tendency” when speaking about 
their personalities. These words were treated as equivalent terms which described a central stable self 
that had particular enduring characteristics.  
“That sort of contributes a lot to my low mood” - Personality maintains depression. When 




personality factors maintained their depressive symptoms. For example, Amanda attributed her long-
term distress to elements of her “temperament” that meant she continued to experience “low mood”.   
Int:  What’s that been like, trying out different [medications] along the years? 
Amanda: Um, it’s been really frustrating because firstly, I don’t know how much change 
I should expect from medication, because I know my thinking and stuff tends 
to be quite negative and, you know, like that sort of contributes a lot to my low 
mood. (…) Um and I guess it’s sometimes going, yeah it would be great if 
medication fixed it. Like it’s not going to fix everything and I know that but, 
um, to make it easier. And I guess that’s why sometimes I wonder - if 
medication isn’t helping me, maybe it’s just me (…)  
Int: And earlier you mentioned thinking about whether it’s something about you, 
the reason why the medications aren’t working (…)? 
Amanda: Um, I don’t have the best self-esteem and my self-talk’s not very good. And so 
I guess I think maybe it’s just because of that and because of things like I sort 
of feel a bit out-of-control in life and stuff like that, and maybe if I just did life 
better then I wouldn’t feel so down. Um yeah, and maybe no amount of 
medication will change because I can’t change until I change the way I see 
myself (…) I would say it’s a lot to do with temperament. Um, that I am 
someone who is more sensitive and takes things on—everything—even more 
so than my siblings. I’ve always been an internaliser (…) I tend to be a 
perfectionist and everything like that, and I guess for as long as I can 
remember I’ve learnt the way of thinking that I’m not good enough and 
nothing I do is good enough. I remember talking to someone once and they 




myself and everything all day long and constantly berating myself and 
everything. 
Amanda provided a clear causative account, suggesting that her “temperament” explained her 
persistent depression. Amanda told a story of receiving feedback from someone who suggested it 
was “no wonder” she continued to “feel depressed” when she thought this way. Amanda framed 
these personality factors as essential components of her identity, present “for as long as I can 
remember”. Most of Amanda’s accounts centred around concrete and global descriptions of identity 
(“an internaliser”, “a perfectionist”). They were also framed as enduring, with Amanda indicating 
she had “always” been this way. She also described having “learnt” a “way of thinking”, suggesting 
this way of seeing herself had become a stable part of her identity over time. Similarly, Lily (p. 94, 
below) explained that “people have a tendency” and “people are just like that”, suggesting there are 
certain types of people with certain enduring sets of characteristics that can be objectively unearthed.  
 “I’m not doing it right” - Personality prevents improvement. At times, participants also 
storied personal attributes as factors that interfered with resolution of symptoms. Amanda (above) 
noted that her personality led her to feel unable to “[do] life” in a way that was conducive to good 
mood. She suggested that if she could behave differently and do “life better” she may experience 
some improvement. However, when asked directly by the interviewer about whether this was 
possible, Amanda stated that, “I’d like to think I could, but I don’t think I can”, suggesting that 
control over this might be wishful thinking rather than an accurate assessment of a possible 
alternative.  
Darryl also blamed his personal failings for his persistent depression:  
Darryl: I’m not doing it right, because if I was doing it right I’d be alright now (…) 





Darryl attributed persistence of his difficulties to his inability to do “it right”. He positioned 
antidepressant medication as a treatment that “should work”, and his personal failings as the factor 
that interfered with this happening for him. Dean also drew upon this explanation when describing a 
chance interaction with a stranger, which prompted him to consider the role of personal attributes in 
persistent distress:  
Dean: I was just thinking, “well, fuck, if he can get it together when he’s got the 
responsibility of a disabled—severely disabled—child, then why am I 
indulging myself and feeling this way?” [Int: And that stuck in your head?] 
Well, I suppose it’s the thing that, um, I’m taking up valuable space for no 
good reason, you know? I should either get with the programme or fuck off. 
Dean attributed his continued difficulties to his inability to “get with the programme”. He compared 
himself to a stranger he perceived to be functioning well despite significant adversity, suggesting that 
if someone like this could live happily then he should also be able to. Dean suggested that the 
persistence of his distress may have resulted from him “indulging myself” and allowing himself to 
continue “feeling this way”.  
Michael also provided an account of his personal attributes preventing improvement, rooted 
in the idea that he lacked the effort or ability to do what was necessary for his depression to resolve:  
Michael:  You also, like, almost felt a responsibility. Like a disappointment in yourself 
for each step, for each failure. If something wasn’t working it was like, “that’s 
because of me”, like “it’s my personality, I’m pathetic, I’m weak”, all sorts of 
stuff, “and that’s why this isn’t working”. “Everyone’s putting in all this effort 
and I’m still not getting better”. And how that reflects upon you as well (…) 
You can’t even respond. 
Michael viewed himself as responsible “for each [treatment] failure” due to being “pathetic” and 




natural result of medication taking and as something that should not be difficult to achieve. The fact 
that he “can’t even respond” was taken as further proof he was fundamentally flawed. Whilst 
participants clearly described doing something wrong, they were vague about what doing better 
would involve. Instead, they drew attention to global failings in character that prevented them from 
recovering from depression.  
“I don’t actually have depression”- Personality is the problem. At times, rather than 
suggesting that personality flaws maintained their depression or prevented improvement, participants 
framed personality as the problem in and of itself. They suggested they were not actually 
experiencing depression and, instead, their distress lay directly in these personality factors. Lily, for 
example, accounted for her persistent distress in this way:  
Lily: I don’t know if it’s just me being really paranoid, but it kind of feels like 
maybe I’m just trying to get attention or maybe I’m just a really negative 
person who is really pessimistic, and I don’t actually have depression, and I’m 
kind of making it up essentially. And even though it’s like, “no, you have all 
these really strong symptoms that you wouldn’t really be able to make up”, 
it’s still kind of hard to see it rationally. 
  (…) 
Lily: I guess, it’s always kind of been like, “am I actually just quite a cluster B type 
personality, kind of with like emotional distress or maybe slightly 
manipulative?”, I don’t know. But that’s just kind of, I don’t know, the 
tendency to pathologise everything. But in my work as a [mental health 
professional], I’ve seen people who haven’t responded to treatment before, 
and it’s like, “oh well, they don’t actually have depression, they actually have 





Lily: I think it’s hard to deny that the symptoms of depression that I have are there 
(…) But I don’t know if there’s also—like it’s potentially to me a possibility 
that there’s something else at play at the same time. I mean, obviously, people 
have a tendency to be more negative or pessimistic (…) And I think people are 
just like that. And obviously people can change and stuff, but I think I’ve been 
like that since I was a child. And obviously I could still change that and that 
would be ideal, because obviously that means that I’m vulnerable to these 
periods of low mood.  
Lily suggested that her long-term distress was caused, not by depression, but by a pervasive and 
problematic personality – “just a really negative person who is really pessimistic” – that could not be 
rectified with antidepressants. She also suggested she may have an underlying personality disorder: 
an enduring and impairing pattern of thinking, feeling, and behaving. Drawing on her mental health 
training, Lily indicated that, more specifically, she may have a “cluster B” personality disorder 
characterised by emotional, erratic, and dramatic behaviours. Lily framed her mood difficulties as 
the “emotional distress” commonly experienced with such disorders, noting that her “manipulative” 
traits may have led her to “make up” her depression. This accounting was justified through Lily’s 
mental health training and employment, framing this account as reasonable and legitimate. Michael 
similarly described the possibility that his persistent distress was due to the fact that “I’m not 
actually depressed. I’m just being silly”. He described himself as “just being pathetic” or needing to 
“stop being ridiculous”.  
In these stories, the lack of effectiveness of antidepressant medication was presented as 
supporting evidence that the problem lay in personality rather than depression. For example, Amanda 
described wondering, “if medication isn’t helping me, maybe it’s just me. Maybe I can’t do life very 
well or something”. Similarly, Lily questioned, “if it [my depression] was real, wouldn’t it respond 




treating depression. As a result of this, the observed ineffectiveness of antidepressants led 
participants to question their diagnoses of depression.  
“Medication isn’t going to fix everything”. Throughout accounts of personality either 
fuelling depression, preventing improvement, or being the problem in and of itself, participants 
suggested they were not experiencing symptom resolution because antidepressants could not address 
these enduring problematic traits. Amanda, for example, questioned “how much change I should 
expect from medication” when the root of her depression was seen to be pervasive personality traits. 
She expressed doubt that antidepressants could target these habitual and deeply engrained thinking 
patterns, suggesting, “yeah it would be great if medication fixed it, like it’s not going to fix 
everything”. Lily also expressed doubt and drew on her mental health training to assert that 
“obviously for those type of [personality] problems, medications don’t work as well”. With 
medications viewed as futile, improvements were viewed as possible only through direct changes to 
who they were as people. Amanda asserted, “I can’t change, until I change the way I see myself” and 
Michael suggested improvements would occur if he managed to “stop being like this” and “stop 
being ridiculous”. Similarly, Lily suggested it “would be ideal” if she could change her tendencies as 
they made her “vulnerable to these periods of low mood”. 
Counter narratives. Cutting across these attributions of persistent distress to personality 
factors were two counter stories; of personality as malleable, and of flawed personality accounts as a 
symptom of depression.  
“People can change”. Although most descriptions framed personality as stable and unable to 
be targeted with medication, Lily at times grudgingly acknowledged the possibility that people “can 
change”. Following an extended account of personality as set, Lily shifted to stating that “obviously 
people can change and stuff…and obviously I could still change that and that would be ideal”. In 
entertaining the idea that personality is potentially malleable or that problematic tendencies can be 




narrative of personality as changeable, however, was weak. Lily’s recurrent use of the words 
“obviously” and “ideal” suggested she was demonstrating a commitment to this narrative as it was 
the culturally favoured and idealised narrative in Western mental health settings, rather than because 
it usefully framed her experiences.   
“I kind of believe it’s the depression”. Also challenging the attribution of persistent distress 
to personality, participants at times suggested that their negative appraisals of their personalities may 
be a symptom of mental distress. This narrative accords with psychiatric conceptualisations of 
negative thinking and feelings of worthlessness as symptoms of depression. For example, Lily 
questioned whether the belief she had a personality disorder was “just me being really paranoid” or 
had come about due to a “tendency to pathologise everything”. She also noted she had “really strong 
symptoms that you wouldn’t be able to make up” and that “it’s hard to deny” she was experiencing 
depression. In doing so, she switched to grounding her persistent difficulties in mental distress rather 
than personality. Similarly, Michael shifted to framing the belief that “I’m not actually depressed” as 
a potential symptom of depression, rather than an explanation for his persistent distress. He prefaced 
his shift by saying, “there’s that thing in depression”, where “a lot of people” experiencing this 
condition may believe they are “not actually depressed”. When asked directly by the interviewer 
about his assertions that his depression was “something to do with me as a person”, Michael 
elaborated on this counter-story: 
Michael: No, I don’t really believe that anymore. I kind of believe it’s the depression 
and that altered sense of self you get at the time, and like the guilt and stuff. 
But no, I think it was probably just treatment resistant illness for some reason. 
I don’t think it’s me. It couldn’t have been me (laughs), but I don’t know. 
Michael was aware that these interpretations may have been a result of his depression, however, even 
whilst presenting this story, Michael used tentative language suggesting he was uncertain about 





A significant proportion of people experiencing depression do not respond to treatment as 
expected. Participants in this study were among this group and described long periods of distress 
despite significant input from health professionals, use of multiple medications, and engagement in 
psychological therapy, alternative treatments, and lifestyle changes. This study focused on the ways 
people with TRD accounted for the persistence of their depressive symptoms in spite of this high 
level of help-seeking and treatment engagement. Two predominant and overarching narratives 
emerged that structured the participants’ explanatory accounts. TRD was described as resulting from 
either a flawed brain that was resistant to the mood improving effects of antidepressants, or a flawed 
personality that was beyond the reach of medication.  
Interestingly, both narratives attributed persistent distress to factors within the person. This 
contrasts existing literature, which suggests that explanations for depression predominantly centre 
around external psychosocial factors (Prins et al., 2008). For example, both patients and clinicians 
have been found to frame depression as an understandable consequence of challenging life events, 
such as bereavement, illness, or divorce (Barley et al., 2011; Prins et al., 2008; Schumann et al., 
2012). These accounts may differ because they are from people whose depression responds to 
treatment as expected. Whilst previous research found that psychosocial factors were referenced by 
people with TRD when speaking about initial episodes of depression (Kroch et al., 2021), this was 
no longer the case in the present study when participants were specifically accounting for the 
persistence of their depression in spite of treatment.  
These findings are consistent with the limited existing literature exploring patients’ accounts 
of persistent depression. Although Buus et al. (2012) did not specifically recruit people with TRD, 
they found that, at each subsequent interview in their longitudinal study, as depression persisted, the 
significance patients placed on triggering index events reduced. Similarly, accounts of people who 




specific index events (Buus et al., 2012). Several factors may explain why people with TRD do not 
draw on psychosocial explanations. Emerging research suggests TRD is described as a constant yet 
unpredictable ebbing and flowing of symptoms with shifts unrelated to external events (Kroch et al., 
2021). This account of TRD troubles psychosocial explanations, in which depressive experiences are 
storied as discrete episodes neatly linked to biographical events and resolved through personal action 
(Buus et al., 2012). This likely means acute psychosocial narratives do not usefully frame 
experiences of people with TRD and are consequently not drawn on.  
With acute psychosocial explanations absent, participants negotiated and switched between 
the two internal attribution narratives as they made sense of the persistence of their depression in 
spite of treatment. The treatment resistant personality narrative aligns with previous findings that 
both patients’ and clinicians’ causative models become increasingly focused on enduring personality 
attributes when depression persists or is considered treatment resistant (Buus et al., 2012; McPherson 
& Armstrong, 2009). McPherson and colleagues (2009) found that, when patients did not respond to 
antidepressants, they were demedicalised by GPs; their difficulties were no longer labelled as 
‘depression’ or conceptualised biomedically and, instead, were attributed to problematic traits or 
behaviours. This demedicalisation was mirrored in the present study, with participants interpreting 
lack of response to medication as evidence to support a shift from an illness-based model to a 
personality deficit-based model. In McPherson and Armstrong’s (2009) research, personality flaws 
were at times framed as personality disorders (remedicalisation) by GPs. Findings from the present 
study suggest this explanation may also be available to patients, with two participants questioning 
whether they were experiencing a personality disorder rather than depression. This highlights a clear 
narrative that lack of expected symptom reduction following adequate treatment indicates a 
fundamental personal issue.  
Participants also attributed the persistence of their depression to having a treatment resistant 




in terms of their personal biochemistry rather than questioning the effectiveness of the 
pharmaceutical treatments. Throughout their accounts, participants continued to draw on this 
biochemical explanatory framework; framing depression as a chemical imbalance and 
antidepressants as a suitable and effective way of rectifying this, and accounted for their own lack of 
improvement by positioning themselves as unfortunate exceptions to the rule. When medications 
said to rectify depression-causing chemical imbalances do not result in cure, it may be expected that 
biochemical narratives of depression would be fundamentally challenged. However, despite the now 
widely accepted lack of evidence (Lacasse & Leo, 2015), the chemical imbalance story remains a 
pervasive and alluring conceptualisation of depression – even for those it seemingly does not serve. 
The strength of this accounting can be interpreted in several ways. Firstly, it enables those with TRD 
to retain hope of future recovery. As noted in other studies (e.g., Buus et al., 2012), biochemical 
models of depression allow for sustained alignment with Western expectations of treatability. Aware 
of this link between biochemical models of depression and restitution narratives, clinicians have 
described strategically employing such explanations in order to encourage antidepressant use and 
promote prognostic optimism among patients (Lacasse & Leo, 2015; Rogers et al., 2009). Especially 
relevant in the case of TRD, continued alignment with biochemical narratives appeared to legitimise 
participants’ continued time and resource intensive search for an antidepressant cure, which is 
consistent with findings of studies exploring patients views towards antidepressant taking (Malpass 
et al., 2009; Maund et al., 2019). 
Secondly, biochemical explanations may persist because of the power of the medicalisation 
of mental distress. Biochemical explanations reflect powerful processes that shape mental health 
services in important ways. Even when biomedical explanations were troubled by persistent 
depression, GPs in previous research were reluctant to completely demedicalise patients’ distress 
and, instead, responded by assigning personality disorder diagnoses (McPherson & Armstrong, 




professionals in responding to mental distress. At least some of the basis of their expertise and 
capability in responding is dependent on these explanations. Moving away from these explanations 
undermines this and can explain, in part, how biochemical accounts continue to be perpetuated 
despite lack of evidence.  
These two causative explanations had different implications for the participants as social 
actors in the world. The treatment resistant brain narrative allowed for an account of persistent 
distress that was not morally laden. Any perceived flaw was confined to biological mechanisms of 
the brain. Reproducing a mind-body dualism inherent in psychiatry, these biological mechanisms 
were firmly positioned as distinct from the ‘self’, so there were no implications in terms of social or 
moral worth. This is consistent with suggestions that biochemical accounts of depression reduce 
sense of personal responsibility for distress (Buus et al., 2012) and are viewed and experienced as 
less stigmatising (Barley et al., 2011). Conversely, the treatment resistant personality narrative had 
profound implications for character. With flaws situated in personality and, therefore, considered 
stable and enduring features of the ‘self’, participants had to manage presentations of themselves as 
inherently flawed people.  
Several sample and setting specific factors may have influenced narrative production in this 
study. Participants had very specific characteristics: they attended a private clinic in an affluent area 
so likely had the resources to support both favourable social circumstances and unlimited and high-
quality treatment. This may have contributed to the lack of adoption of psychosocial explanations – a 
less privileged group of people with TRD may have attributed persistent distress to ongoing 
psychosocial difficulties such as poverty. This setting also likely bolstered use of biochemical 
explanations. The settings in which stories are told are crucial to how they unfold. This Western 
psychiatric setting provided a powerful structure for explanations the participants provided, both in 




interviewer as aligned with this profession (see Kroch et al. (2021) for a more thorough exploration 
of the influence of this study setting on narrative production).  
 This shift from external to internal explanations has important clinical implications. The way 
mental distress is conceptualised matters deeply as it informs people’s approaches to help-seeking 
and health professionals’ approaches to service delivery. These explanations for persistent distress 
likely influence the level of agency people feel they have and the degree to which they persist with 
treatment. Biochemical explanations, whilst less problematic for those who do respond to 
antidepressants as expected, may encourage an ongoing search for the elusive biochemical ‘cure’. 
Additionally, as seen in this study, biochemical explanations are so pervasive that when 
antidepressants do not result in remission, the assumption is that it is the fault of the individual. 
Whilst psychosocial explanations of TRD suggest improvement will occur when challenging life 
circumstances resolve, internal attributions may culminate in a profound sense of hopelessness for 
people with TRD and lead to representations of the self as inherently and permanently flawed. From 
a psychological perspective, these views are harmful – or at the very least unhelpful – and are likely, 
in and of themselves, to perpetuate depressive symptoms. Counter-narratives espousing the potential 
for recovery through transformation of the self are available and encouraged by health professionals, 
but they too place ultimate responsibility on the individual. Clinicians need to be aware of patients’ 
tendencies to shift to self-blame when antidepressants are ineffective, but they must also be 
cognisant of the role they – as social actors embedded in powerful medical contexts – play in 
constructing and perpetuating these narratives. 
Conclusion 
Like anyone experiencing a health or mental health issue, people with TRD want to make 
sense of their experiences. They draw on narratives available to them in the spaces they inhabit to 
understand and explain the fact that they remain depressed despite adequate treatment. When their 




recovery, their options for sense-making are limited. This study has shown that, when the 
biochemical ‘cure’ that is seen to work for everybody else does not work for people with TRD, they 
look inwards. Reinforced by the notions of personal responsibility for one’s state or behaviour 
inherent to Western mental health settings, people with TRD come to attribute their continued 
difficulties to personal flaws and believe that the only way to achieve recovery is to fundamentally 






















CHAPTER SIX: SINGLE CASE ANALYSIS – Accounting for the experience of TRD 
Findings  
This chapter includes the findings of a single case narrative analysis. It explores the 
narratives of one participant, a woman in her forties, experiencing TRD. This participant, Sarah, was 
selected from the wider participant group for this analysis due to the fact that she demonstrated the 
most significant commitment to pursuing treatment and to a narrative of depression resolution. 
Throughout her accounts, she clearly narrated two explanations of persistent distress that differed to 
those outlined in Chapter Five. In contrast to other explanations, these narratives framed distress as 
temporary rather than an issue of fundamental treatment resistance. As a result of this, they allowed 
Sarah to remain more definitely aligned with expectations of return to wellness. Whilst these two 
narratives were evident to some degree in the wider participant group’s accounts, they were storied 
much more tentatively by others. They were also only illuminated through the identification of 
Sarah’s narratives. The striking nature of Sarah’s accounts meant that they epitomised these 
narratives. They were therefore analysed separately and chosen as the focus of this chapter. 
Sarah is a single 48-year-old woman of Pākehā (New Zealand European) descent. At the time 
of the research, she was living in Auckland, New Zealand and was employed in a full-time sales role. 
Sarah had been experiencing depression for approximately nine years. Over this period, she 
estimated that she had been treated with up to 20 medications prescribed by either GPs or 
psychiatrists. Each of these medications had provided only short-term or minimal relief from 
symptoms. As well as receiving pharmacological treatment, Sarah had been attending psychological 
therapy sessions with a clinical psychologist for seven years. 
A narrative of help-seeking and resolution. Sarah described the initial onset of her 
depression in terms of changes she had noticed in her mood and energy. She described having 
worked hard in her sales role for several years without breaks, and beginning to experience a lack of 




this, decided to take a break from work and go on holiday. On her return, however, Sarah described 
realising that she felt no better and, as the weeks passed, she deteriorated further. She sought help 
from her GP, was referred to a psychiatrist in private practice, and was prescribed an antidepressant 
medication.  
Sarah’s account of the onset of her distress followed the standard story of depression, in 
which she realised she was struggling and attempted to address this by seeking professional help. 
This standard story also includes the expectation of return to wellness following help seeking, and 
this was evident in Sarah’s accounts. Sarah recounted the explanation she had given to her 
colleagues after a period of time off due to poor mental health. She described acknowledging to her 
colleagues that she had been having difficulties with her health which had affected her performance, 
and informing them that she was now on the path to recovery: 
Sarah:  …there was a point at the first couple of years where I was very depressed and 
then I had something that was making me better. And I went to a sales 
conference that we had for our staff and said, “oh look, I know that I haven’t 
been very well and helping you guys very much and that’s because I’ve been 
sick and I just want to tell you that I am now getting better”. 
Everything about this story fit the expected and dominant account of depression; a trajectory from 
illness to help-seeking to wellness. In this story, depression was narrated in the past tense. Sarah 
firmly said, “I was very depressed” and “I am now getting better”, describing the depression as over 
and the present and future as characterised by wellness. This story was archetypal; familiar to both 
the interviewee and interviewer as an account of the onset and resolution of an episode of depression. 
It was rehearsed, a story of telling a story about depression, and delivered confidently and fluently. 
In the context of an interview nine years later, after which her depression has ultimately not resolved, 
Sarah still recounted this story. It was her preferred story of depression and the story she hoped yet to 




for the rest of the encounter and the narrative arc of depression resolution was evident throughout the 
interview. 
 However, as well as providing accounts characterised by this expectation of return to 
wellness, Sarah also more tentatively told of depression as an ongoing struggle. In these accounts, 
she explained that, within the nine year period since the initial onset of her depression, “nine 
months” was “probably one of the longest periods” she had experienced of relative wellness. In 
making sense of this persistent distress despite significant input from health-professionals, Sarah 
provided two narrative explanations. At times, she attributed her ongoing depression to an 
unresolved search for medication. At other points, she attributed her persistent distress to her 
engagement in bad patient behaviours.  
It can take time to find a suitable medication. At times, Sarah accounted for the 
persistence of her depression by suggesting that she was experiencing the temporary inability to find 
the right drug to resolve her depression:  
Sarah: … because I know that sometimes it can take time to find something that works 
for you. Like we make skincare…so it doesn’t work for everybody, or some 
people have reactions to certain things and some people cannot drink dairy or 
gluten so, you know, it’s a matter of your body adjusting to it. 
In providing this explanation for her persistent distress, Sarah noted that, just like “skincare”, a 
person may need to try several medications before finding one that suits them, or, just like “dairy or 
gluten”, a person may react badly to one antidepressant and need to try alternatives. Although not all 
medications work for everyone, inherent in this account is the assumption that a suitable 
pharmaceutical treatment exists for each person and is waiting to be discovered. Through storying 
persistent distress in this way, Sarah framed TRD as a temporary difficulty rather than an issue of 




 Sarah continued with this way of accounting for persistent distress even when narrating 
several turning point moments. These moments involved her learning from her psychiatrist that she 
was somewhat different from other patients with depression, and her reading the online blog of a 
woman who had been experiencing TRD for over 15 years. But even as Sarah narrated these turning 
point accounts, which deviated significantly from her preferred narrative of depression resolved and 
– arguably, troubled her explanation of distress being a temporary issue – she continued to account 
for her continued depression in this way.  
Int:  Was there a time that you sort of realised that, you know, you were expecting 
that you would get better and then you realised that it wasn't quite going to 
plan? You know early on? 
Sarah:  No, I probably didn't realise. I thought it was just me. I thought, “oh well, 
maybe it's just me”. And so it wasn't until a couple of years in that [the 
psychiatrist] said, “oh well, um, those people with major depression like 
yourself”, and I'm going, “okay, I didn't know there was different types of 
depression”. So that's when it sort of clicked that there’s more than just 
trialling a couple of different things, that these are people who have the 
inability to find something. And then I read online in a couple of forums and 
there’s this one lady who started up a group called blue something or other 
and she's had major depression and a lack of finding a drug for about 15 or 
20 years. So that's a really long time.  
For Sarah, TRD was about not yet having found the right medication – “the inability to find 
something”. Her focus on “finding” the drug suggested that a suitable pharmaceutical treatment for 
depression for each person does exist, just has not yet been found. Sarah characterised the experience 
of the woman in the blog as a “lack of finding a drug for about 15 or 20 years”. TRD was not 




medication. Through accounting for TRD in this way, Sarah was able to make sense of her longer-
term depression and continue drawing on an overarching resolution narrative despite her stories of 
ongoing depression. This allowed her to keep alive the idealised story of depression offered to her 
colleagues: that after considerable searching she would find something that works and her depression 
would resolve.  
Bad patient behaviour. Within Sarah’s accounts, a second narrative attributed her persistent 
distress to engagement in patient behaviours that were not viewed as conducive to resolution of 
symptoms.  
Sarah:  Um, but I find that when I get quite depressed I tend to withdraw into myself 
and I will cancel [psychology] appointments, and I’ll do the same thing with 
[the psychiatrist] as well. So I tend to withdraw into myself (…) Or—which I 
tend to do a lot—stick my head in the sand and it will go away (…) 
Int: Okay. Yeah, I think those are quite natural responses, hide your head in the 
sand.  
Sarah:  Oh, I do that as a general rule (laughs). Like I was meant to go to the doctor 
because I have some other health things I need to sort, but if I don’t go it’ll go 
away.  
Int:   Yeah. Or it feels like it’s not real for a little bit. 
Sarah:  Yeah (laughs). Try a year! 
Bad patient behaviour was characterised by withdrawal. It involved disengagement from help-
seeking and health professionals’ advice and from the search for “an answer”. Accordingly, Sarah 
presented an account of struggling to adhere to her treatment regime at times. Whilst she had been 
engaged in mental health services for many years, she highlighted her tendency to “stick my head in 
the sand” and avoid appointments with healthcare professionals. By drawing attention to this, Sarah 




at times, not been unwaveringly committed to the search for the right medication, it was unsurprising 
to her that her depression had persisted. Rather than entertaining the possibility that she may never 
recover, Sarah’s enduring symptoms were attributed to this withdrawal and disengagement.  
Whilst the bad patient positioning allowed Sarah to make sense of her lack of improvement 
despite significant input from health professionals, she was aware of the disadvantages of being 
associated with this group:  
Sarah: Um, I think I was surprised that I had ended up in that area (…) And, I mean, 
he [the psychiatrist] made a comment the other day actually where I went, 
“um, am I one of those difficult people am I?” (laughs). 
Int:   You asked that? 
Sarah:  No, he said something along the lines of, “well, um, you’re one of those 
patients that have been around for a long time” and I went, “um, ok, I’m one 
of those people” (laughs). 
Sarah had an impression of the type of people who have “ended up in that area” and was aware of 
the possibility of being viewed as one of these “difficult people”. She consequently stated that she 
was surprised by the psychiatrist’s comments and, in doing so, distanced herself from “those 
patients”. Sarah navigated a fine line between using this positioning to make sense of her lack of 
lasting improvement and resisting alignment with this “difficult” group.  
This bad patient behaviour accounting allowed Sarah to make sense of her persistent distress 
and, similar to the “it can take some time” explanation, it also allowed her to continue drawing on 
the overarching narrative of depression resolution. Again, TRD was framed as temporary rather than 
an issue of fundamental treatment resistance. Inherent in this bad patient behaviour explanation was 
the assumption that, if or when Sarah did choose to fully engage with treatment, her symptoms 
would resolve. This meant that, as well as providing accounts of bad patient behaviour, Sarah 




Int:  What was that like for you when [the psychiatrist] said that [you have been 
around for a long time]? 
Sarah: Um, no that didn’t worry me. Um, because I know it’s said in a safe place, so 
it’s never ever anything that’s said in a negative fashion or something to put 
you down. Where other people can do that, but with [the psychiatrist], you 
know he’s been through it so he knows what it’s like. And I know that I’m a bit 
of a… um, because three or four months ago when we went onto a trial drug 
from America and I’m the first one to try it of his patients. It didn’t work, but I 
was the first one of his patients to try it! (laughs) 
Int:  Oh that’s exciting. Sounds like he’s doing everything he possibly can. He’s got 
the trial drug and you were the first person.  
Sarah:  Well, it’s trialling in New Zealand. They’ve never had anyone trial it in New 
Zealand. Um, and it was $600 a month, so we tried it for six weeks to see if it 
did anything, so yep.  
In this account, Sarah highlighted her motivation and willingness to continue attending appointments 
with her psychiatrist. She also spoke enthusiastically about trialling new, infrequently used, and 
often very expensive medications. Sarah alluded to a positive relationship with her psychiatrist, in 
which he disclosed his personal experience of depression and chose her to be the first patient to trial 
a new American medication for depression. Her use of the personal pronoun, “we”, positioned her 
and the psychiatrist as working alongside each other to find a medication that worked. In drawing 
attention to these experiences, Sarah resisted the absolute positioning as that of a bad patient. 
Additionally, she was able to remain aligned with the narrative of depression resolution. If she 
engaged in good patient behaviour and remained tirelessly committed to finding the “answer” to 
TRD, her distress would one day end. She would be able to story her depression as an overcome 




This narrative analysis revealed how one participant, Sarah, made sense of her experiences 
and navigated positioning in light of a 9-year depression trajectory that had involved taking over 20 
medications with no significant or sustained improvement. In contrast to the accountings outlined in 
Chapter Five, these explanations did not frame the self as fundamentally treatment resistant. Instead, 
both accounts framed distress as a temporary issue that would be resolved once a suitable medication 
was found or bad patient behaviour ceased. Throughout her accounts, Sarah negotiated and switched 
between these narratives. These explanations of persistent distress allowed Sarah to remain aligned 
with Western expectations of return to wellness. They allowed her to hold onto hope that she would 
one day be able to narrate her depression as a thing of the past, as she did to her colleagues at the 


















CHAPTER SEVEN: DISCUSSION AND CONCLUSION 
This chapter provides a summary of the findings presented across the three findings chapters. 
This research explored how people experience and make sense of depression that has not improved 
as expected following treatment. Using narrative analysis, this research identified a number of 
narratives that people drew on when describing their experiences of TRD. These narratives shaped 
the positions or identities adopted, resisted, or negotiated by people experiencing TRD. These 
findings provide insight into how people make sense of the experience of depression that does not 
improve following treatment as well what it means to be a person with TRD. This chapter 
contextualises these findings within the existing literature, discusses clinical implications for health 
professionals working with people experiencing TRD, explores the limitations of the research, and 
outlines potential directions for future work. 
Overview of findings 
When storying experiences of depression that had not improved despite treatment, 
participants drew on two narratives: one of order and one of disorder. Drawing on the narrative of 
order, participants framed their depression as predictable, measurable, and understandable. They 
used the narrative to organise and contain their experiences of depression and draw attention to 
patterns in these experiences. Drawing on the narrative of disorder, participants narrated their 
depression as a random ebbing and flowing of experiences that could not be measured or made 
coherent. This narrative was used to make sense of experiences of unrelenting depression. Across the 
participants’ accounts, a tension emerged between narrating depression as understandable and 
ordered and narrating depression as chaotic and confusing. Rather than drawing on one of these 
narratives in isolation, both were used throughout the participants’ meaning making processes.  
The participants also told stories to account for why they had remained depressed long-term 
despite receiving treatment. At times, participants attributed their persistent distress to having a 




there were two alternative accountings - a narrative of bad patient behaviour and a narrative of taking 
some time to find a suitable medication. Three of these accountings linked persistent distress to 
factors relating to the individual that prevented antidepressants from working effectively. The 
treatment resistant brain accounting attributed ongoing depressive symptoms to brain biochemistry 
that could not be rectified with antidepressant medication, and the treatment resistant personality 
accounting linked persistent distress to character traits that were beyond the reach of medication. 
Similarly, the bad patient narrative attributed TRD to certain patient behaviours, such as withdrawal 
from treatment, that prevented the expected trajectory of symptom resolution from occurring. Whilst 
these three accountings located the treatment resistance in different facets of the self – biology, 
personality, and action – they were all built on a foundational assumption that antidepressants are 
effective for most people. Antidepressants were assumed to result in resolution of symptoms for 
those without flawed brains or personalities, or those who do not engage in problematic behaviours. 
Two of the accountings – the bad patient behaviour account and the explanation that it can take time 
to find a medication that works for you – differed in that they did not construct the self as 
fundamentally treatment resistant. Throughout their stories, participants consistently negotiated these 
narratives as they worked to make sense of their experiences of TRD and explain why they had 
remained depressed long-term.  
The influence of neoliberal narratives 
Several broad ideological narratives served as powerful structuring devices which influenced 
the way people narrated and accounted for TRD and navigated identity. These included publicly 
available narratives of depression, mental distress, and recovery that circulate in clinical psychology 
and medical settings in the Western world. These narratives frame depression in predominantly 
biomedical terms and espouse the idea that resolution of symptoms will occur after a person engages 
in a period of help-seeking, which usually involves medication (Buus et al., 2012; Karp, 1994). 




powerfully shaped by Western frameworks of neoliberalism. Neoliberalism has shaped political, 
economic, and social life in Western countries since the 1970s (Carr & Batlle, 2015). Neoliberalism 
refers to both a political approach that favours free-market capitalism and an ideology that frames 
people as individuals, as autonomous actors responsible for their own lives (Brown, 2009). As an 
ideology, neoliberalism frames good fortune as the outcome of hard work. As a result of this, people 
are encouraged to take charge of their lives, act out of self-interest, and create their own fates 
(LaMarre, Smoliak, Cool, Kinavey, & Hardt, 2018). It follows then, that neoliberal principles assign 
responsibility for misfortune, such as illness or poverty, to the individual or family in question 
(Lemke, 2001).  
Neoliberalism in mental health contexts. When applied to the domain of mental health, 
neoliberal narratives frame the pursuit of mental wellbeing as an individual task. Failure to achieve 
this is seen as reflective of lack of individual drive or merit, rather than failure of the social system 
within which the person is embedded (Carr & Batlle, 2015). Distress is conceptualised as a 
phenomenon that exists within the bounded individual, which abates when the person engages in a 
process of self-mastery, self-control, and self-growth (LaMarre et al., 2018). Rose (1998) argues that 
this framing of mental distress truly came to pass in the 1990s with the closing of state psychiatric 
institutions and the transition to community psychiatry. Mental health services began to be delivered 
predominantly in the community, families were required to take on the majority of care work, and 
governments took a step back and began to govern at a distance (Rose & Miller, 1992).  It was at this 
stage, according to Rose (1998), that the culture of individual blame and accountability in mental 
health domains arose. In the present research, these neoliberal narratives of mental distress and 
recovery strongly shaped the way participants storied their experiences of TRD and navigated 
positioning within these narratives. Embedded in a strongly neoliberal context, the participants 




Becoming self-managing subjects with TRD. When the pursuit of contentment is framed as 
an individual task, the neoliberal directive in times of discontent is to learn to manage and master the 
self. Self-management is predicated on the idea that the person is a stable rational ‘self’ who can 
preside over and manage the separate entity of their ‘disease’ (Weiner, 2011). The participants’ 
narratives contained strong themes of self-management. Whilst, as a concept, self-management 
initially originated in the domain of chronic illness, the allure of empowered and self-managing 
patients has led to the adoption of self-management approaches more broadly (Brijnath & 
Antoniades, 2016). Currently, self-management practices, such as active involvement in health care, 
self-monitoring, and shared decision making are encouraged among people of all health statuses in a 
diverse range of health settings. In the present research, self-management was promoted in the 
narrative of order, with participants presenting their depression as a phenomenon separate from the 
self that they, as self-aware and empowered subjects, were capable of managing and controlling.  
A core component of self-management is surveillance of the self. As a rational manager, the 
self must learn to observe and understand the inner workings of the disease as part of the work of 
mastering and controlling it (Weiner, 2011). In the present research, with a great level of detail, 
participants told of predicting changes in their symptoms in response to environmental triggers, 
observing subtle internal shifts in mood, and using rating systems to measure and communicate their 
current status. At times, they took this a step further and included their partners or family members in 
these self-surveillance practices. Similarly, in an ethnographic exploration of self-management 
discourses among members of a bipolar disorder support group, Weiner (2011) described the “self-
surveilling accountable subject” (p. 463) who engages in the practices of mood charting, record 
keeping, and becoming attuned to environmental triggers. When the self is a project to be honed, 
improved, and mastered, having a nuanced and in-depth understanding of one’s inner workings is of 
paramount importance. These neoliberal themes of self-surveillance are also evident in accounts of 




depression attributed their recovery to their engagement in reflection, introspection, becoming aware 
of contributing factors, and becoming attuned to their instincts (Hänninen & Valkonen, 2019; Ridge, 
2018; Steen, 1996). Consistent with the present research, the message inherent in these accounts was 
that wellbeing is earned through self-surveillance and self-mastery.  
As evident in these studies, within neoliberal mental health contexts, there is a degree of 
moral value ascribed to existing in the world as an introspective and self-aware person. In the present 
research, this was evident in the participants’ positioning. Throughout their accounts, the participants 
continually worked to position themselves as detached, rational, and self-aware experts on their 
internal worlds. However, whilst self-surveillance was storied as common and important, it was also 
storied as problematic in some ways. The problematic side of self-surveillance was seen in the 
narrative of disorder, with participants questioning their abilities to be objective and reliable 
interpreters and reporters of their own internal workings. Similarly, Weiner (2011) noted that, whilst 
engaging in self-monitoring, people with bipolar disorder began to distrust themselves, their 
thinking, and their behaviour and have difficulty distinguishing between themselves and their 
disease.   
As well as engaging in continual self-surveillance, neoliberal subjects experiencing mental 
distress are encouraged to engage in more general self-labour (Brijnath & Antoniades, 2016). This 
self-labour, aimed at maintaining or restoring a content or productive state, involves engagement in a 
toolkit of practices. For example, in Brijnath’s (2016) study, people in Australia experiencing 
depression described engaging in a range of “transformative lifestyle practices” (p. 6) aimed at 
controlling their depressive symptoms. They spoke of taking up meditation and yoga, beginning 
healthy eating regimes, engaging in frequent exercise, and starting practices of reflection and 
journaling. These practices were direct attempts to manage and control fluctuations in mood. In the 
present research, participants also described engaging in a range of self-labour practices. Their 




of having an unwavering commitment to trying new and often expensive medications, of frequent 
engagement in alternative practices such as meditation and yoga, and of lifestyle changes such as 
healthy eating and exercise. Again, such frameworks create the ideal identity of the good patient who 
assumes responsibility for making good choices in order to improve their wellbeing and engages in a 
high level of self-labour (Lorig & Holman, 2003; Teghtsoonian, 2009). In the present research, 
through drawing attention to these activities and their unwavering dedication to them over months 
and years, the participants aligned themselves with the virtuous position of self-labouring, self-
responsible patients who take responsibility for decision making, problem solving, and accessing 
services and resources. This was epitomised by the narrative positioning of the good patient. 
Becoming biomedical self-managing subjects with TRD – the intersection of 
neoliberalism and biomedicine. Several authors have highlighted the compatibility between 
neoliberalism and biomedicine and have argued that, as a result of this, the two ideologies support 
each other (Moncrieff, 2008; Rose, 2007). The neoliberal agenda to create self-managing subjects 
relies on a distinction between rational self and disease, and this is a dichotomy perfectly upheld by 
biomedicine (Weiner, 2011). In modern day psychiatry, distress, which is said to result from 
biological abnormalities, most commonly chemical imbalances, manifests as a contained set of 
symptoms within the individual. The individual - a stable, separate, and rational self - can learn to 
manage and control these symptoms, frequently by choosing to consume medications (Moncrieff, 
2008). Hamilton highlights that “a permanent state of unfulfilled desire” is “the essential state for 
consumers in modern capitalism” (2004, p. 87). The notion of chemical imbalances fuels the idea 
that there is an ideal level of chemical balance that we should all strive for in order to rectify this 
unfulfilled desire (Moncrieff, 2008). Essentially, this notion has allowed for discontent, 
dissatisfaction, or difficulty to be medicalised and consumption of chemistry-altering medications to 
be sold as the answer. As many authors have pointed out, this alliance between biomedicine and 




As a result of this “marriage of convenience” between neoliberalism and biomedicine 
(Moncrieff, 2009, p. 235), many modern-day accounts of self-management relate to the alteration of 
biochemistry. Accordingly, a significant component of the self-management that participants in this 
research engaged in was related to biomedicine. Embedded in a psychiatric private practice, mastery 
of the self was predominantly framed as a biomedical endeavour and narratives of self-improvement 
were strongly linked to altering brain chemistry through antidepressant medication. The participants’ 
self-surveillance not only involved tracking shifts in depression symptoms, but also playing close 
attention to the effectiveness of antidepressants and the degree to which they produced side effects. 
Their self-labour involved attending frequent appointments with their psychiatrist where the 
expectation was that they would accurately communicate the findings of this self-surveillance and 
engage as an active participant in finding a medication that was effective. Additionally, the 
participants’ stories of continued commitment to finding a biochemical cure can be interpreted as 
demonstration of their positions of self-managing and self-responsible patients. The tweaking of 
biochemistry is not the only means of mastering the self within neoliberal contexts, however. For 
example, psychotherapeutic approaches, such as cognitive behavioural therapy, emphasise self-
mastery through the alteration of cognitions (Rasmussen, 2017). In another setting, therefore, such as 
a private psychology clinic, narratives of self-improvement may have been more strongly located in 
the alteration of thinking or behaviour patterns. 
 Recovery within a neoliberal biomedical context. For participants in this research, 
accounts of recovery were strongly influenced by narratives of biomedicine and neoliberalism. 
Under neoliberalism, recovery is equated with a return to existing as a productive member of the 
market society (Esposito & Perez, 2014). To be a normal person means to be capable and willing to 
act as a productive and consuming neoliberal subject (Rose, 1998). Accordingly, there is significant 




a person does not live in this way, they are likely positioned as deviant, abnormal, or pathological 
(LaMarre et al., 2018).  
This framing of recovery was evident in the participants’ accounts. Each of the participants 
emphasised the fact that, despite their often severe and long-term difficulties, they had largely 
remained in employment or tertiary study. Often this work involved running their own business, 
managing teams, or high levels of responsibility. Through these stories, the participants positioned 
themselves as worthwhile, productive, and ‘normal’ members of society, despite significant health 
difficulties. The equating of recovery with productivity was epitomised by the accounts of the 
participant in the single case study. Stories of return to wellness centred around a return to 
functioning as a responsible, productive, and contributing member of her sales team. Returning to 
work was highly significant. This, above all else, was framed as indicative of the return to good 
health. It was fitting that, in her account of informing her colleagues about her return to work and 
normalcy, she was at a sales conference. This conflating of good mental health with desire and 
capability to engage in work also plays out in mental health settings (U'Ren, 1997). Focus in 
therapeutic settings is often on reducing a person’s distress so that they are able to return to work or 
equipping them with the skills to manage the stress associated with work (Esposito and Perez, 2014). 
For example, a person may be taught relaxation techniques, communication skills, or strategies for 
managing ‘unhelpful’ thinking in order to help them perform better or cope in their role.  
With neoliberalism and biomedicine strongly entwined, the return to existing as a normal, 
content, and productive person is frequently articulated as coming about through antidepressant 
treatment. Esposito and Perez (2014) argue that prescription medications are adopted in neoliberal 
societies as a tool to modify behaviours and emotions in order to meld the ideal neoliberal subject. 
For example, they are used to improve concentration or reduce feelings of apathy or stress, 
ultimately creating people who are higher performing and more competitive people across the 




was the case in the present research, with the participants’ accounts of help-seeking, self-
management, and recovery predominantly centred around biomedicine. Under a neoliberal 
framework, people are encouraged to demonstrate mastery, recovery, and improvement regardless of 
level of impairment. This was evident in the participants’ narratives. Despite months and years of 
depressive symptoms, they were committed to narrating their experiences as having some resolution 
that would come about through altering biochemistry. 
Lack of recovery in a neoliberal biomedical context. Whilst framing people as autonomous 
subjects capable of managing their own health may, to some, appear helpful or positive, this 
framework has more advantages for some people than others. These narratives of personal 
responsibility may be comparatively easy to navigate for some people with depression, for example, 
those whose depression follows the expected trajectory from illness to wellness. However, these 
narratives appear more complicated for people with persistent forms of distress. In instances where 
the assumptions inherent in these narratives do not hold, such as among people with TRD, there are 
significant implications for the individual experiencing distress.  
The individual is assigned responsibility. Under neoliberalism, wellness is earned through 
self-mastery. As a result of this, responsibility for not achieving all that is promised within this 
framework – health, success, normality, happiness – is ascribed to the individual (Carr & Batlle, 
2015). This played out in the present research, with participants assuming full accountability for their 
persistent distress, through referring to personal characteristics or behaviours. In some instances, 
such as accounts of “if I just did life better…” or inability to “get with the programme”, they framed 
themselves as people unable to manage the neoliberal imperative to be rational managers controlling 
and containing their distress. In the bad patient narrative, lack of improvement was attributed to not 
acting as the ideal neoliberal patient – disengaging from perpetual self-labour and attempts to self-




Taking responsibility for outcomes and attributing lack of improvement to individual factors 
have been mirrored elsewhere. Literature suggests that, among both people experiencing illness or 
distress and the health professionals who work with them, outcomes are linked to self-control and 
personal effort. People experiencing depression in Australia attributed their depression to a lack of 
self-control and, subsequently, their failure to experience improvement as due to an inability to 
reinstate or learn self-control (Brijnath & Antoniades, 2016). Working-class women in the United 
Kingdom took full responsibility for all areas of life, from health to parenting to finances, and spoke 
disparagingly of anyone who did otherwise (Peacock, Bissell, & Owen, 2014). In terms of health 
professionals, general practitioners in the UK shifted to focusing on the personality traits of people 
experiencing depression when they did not experience improvement following antidepressant 
treatment. For example, they began to attribute their clients’ difficulties to social deviance or poor 
coping skills (McPherson & Armstrong, 2009).  
Additionally, in healthcare more broadly, doctors have been found to construct patients as 
bad, difficult, or challenging when they do not meet the core assumptions of medicine – that 
treatment results in prompt cure (Dubbin, Chang, & Shim, 2013; Shim, 2010; Sointu, 2017). Shaw 
(2004) suggests that in Western contexts patient worth is based on the degree to which a person 
meets the core tenets of medicine. The ideal patient is active, courteous, clearly fits a diagnosis, is 
motivated and compliant, and promptly recovers (Sointu, 2017) When this is not the case, patients 
have been regarded as non-compliant, inactive, non-communicative, and not entirely deserving of 
recovery (Shaw, 2004; Sointu, 2017). In these descriptions, recovery is closely tied to the status of 
actively involved patient. When a person does not engage in self-management, their right to the 
experience of recovery is questioned. This is because, under neoliberalism, work is seen to be the 
defining factor in the circumstances of one’s life.  
The system is absolved of responsibility. As well as assigning personal responsibility, this 




self-manager – obscures the broader sociocultural factors that contribute to distress (LaMarre et al., 
2018). In the present research, this individual focus shaped the participants’ narratives. When 
explaining their persistent distress, the participants made very few, if any, references to social 
circumstances that could be contributing factors, and when they did, they were used solely to account 
for the onset of initial episodes of depression. This focus was mirrored in Brijnath and Antoniades’ 
(2016) study, which found that people with depression in Australia did not talk about social factors 
or reforms as the cause or solution to their depression, despite sometimes experiencing significant 
social disadvantage. Similarly, Peacock et al. (2014) found that healthy women in the United 
Kingdom did not draw on social explanations when making sense of their challenging life 
circumstances, such as parenting, health, or finances, despite experiencing struggle and financial 
constraint.  
Neoliberal conceptualisations of depression and distress appear to disqualify important 
aspects of a person’s depression experience and erase the potential for socially oriented explanations 
of distress. This likely contributed to the lack of socially situated explanations for the participants’ 
persistent distress in the present research. Within a neoliberal framework, social explanations may be 
accepted as the catalyst or ‘trigger’ of distress, but not offered as explanations for long-term distress. 
As depression persists, social accounts are no longer deemed legitimate and, imbued with narratives 
of personal responsibility, a person must assume responsibility for both the persistence of distress 
and the discovery of a solution. This shift in causative accounting is mirrored in the broader 
literature. For example, psychosocial factors appear to be favoured when accounting for acute and 
early episodes of distress (Buus et al., 2012; Prins et al., 2008), however, when distress persists, 
explanations shift to be rooted in personality (Buus et al., 2012; McPherson & Armstrong, 2009). 
This is the case among both those experiencing distress as well as health professionals.  
These findings demonstrate the pervasiveness of the neoliberal framing and the manner in 




mental distress. Even when people are experiencing significant hardship, they appear not to refer to 
this when explaining their distress. Within mental health settings, this framework culminates in 
socio-structural factors such as poverty, unemployment, sexism, and racism being largely ignored. 
When the baton of responsibility is handed to the individual and their family, institutions of power 
are released from their responsibilities of tackling systemic contributors of distress (Brijnath & 
Antoniades, 2016).  
Positioning and moral implications. Each of the narratives outlined in the present research 
made available different options for relational positioning. Narratives of disorder, problematic 
personalities, and bad patient behaviour were characterised by accounts of unsuccessful attempts to 
live up to the neoliberal ideal. In drawing on and negotiating these narratives, participants adopted 
the position of flawed neoliberal self-manager – a person unable to self-monitor and self-master in 
order to recover from depression. Whilst the participants used these narratives to make sense of their 
experiences of long-term distress, there were significant moral implications associated with them. 
Esposito and Perez (2014) note that failing to live up to the neoliberal imperative is at best associated 
with irrational idealism, but more commonly with individual pathology or deviance. Additionally, 
Sointu (2017) has highlighted that failure to inhabit the virtuous position of actively involved patient 
leads to a person’s right to recovery being questioned.  
Aware of the potential problematic identities of flawed, incapable, or difficult patients not 
worthy of recovery, the participants in this research worked to manage their social positioning by, at 
times, distancing themselves from these perceived groups. This is seen in the narrative of order, with 
the participants framing themselves as effective self-managers and ‘typical’ people with depression, 
and in the good patient accounts, with participants framing themselves as people who were engaging 
in significant self-labour. Another way this was managed was through counter-narratives of potential 
for eventual self-mastery. Through drawing on these narratives, which were aligned with neoliberal 




engaging in self-surveillance and self-labour, and who is worthy of recovery. This position was 
associated with a high degree of moral value.  
As well as managing the moral implications associated with the position of failed neoliberal 
subject, the participants in this research had to navigate the potential moral implications of evading 
personal responsibility for this failure. Esposito and Perez (2014) highlight that under neoliberalism, 
assigning blame for one’s situation to factors outside the self is generally regarded as further proof of 
a fundamental issue or pathology. In keeping with this, Peacock et al. (2014) found that participants 
in their study viewed the use of socially contextualised perspectives as a way of actively evading 
responsibilities. The women in their study solely drew on individual explanations and interpreted 
social explanations as a way of justifying failure to achieve what was expected of them. They also 
expressed guilt about using these explanations and fear about others viewing them negatively for 
making excuses. Participants in both the present research and the study by Peacock et al. (2014) at 
times actively resisted the potential identity as that of a shirker.  The women in Peacock et al.’s 
(2014) study engaged in othering – they pushed this stigmatised identity away from the self by 
highlighting differences between themselves and people who they perceived to make up this group. 
In this research, the lack of social explanations could be interpreted as the participants resisting the 
potential positioning as that of a person who avoids or neglects responsibilities.  
Throughout their accounts, participants adopted, resisted, and negotiated multiple positions as 
they made sense of their experiences of persistent distress. Whilst narrating accounts of unsuccessful 
attempts to self-manage and self-master, participants resisted absolute positioning of that of a failed 
neoliberal subject. This occurred though them working to remain aligned with the virtuous neoliberal 
identities of good patient or typical person with depression who is worthy of recovery and worthy of 
re-emerging in the world as a productive and normal person. The participants in this research 
continually navigated this challenging landscape as they storied their experiences of persistent 




with being unable to live up to the neoliberal imperative to self-manage (e.g., as seen in the 
narratives of treatment resistant personality) and with being unwilling to take self-responsibility 
(e.g., as seen in the bad patient accounts and in the lack of social explanations). Either way, failure to 
exist as a self-managing self-responsible neoliberal subject is viewed as evidence of a fundamental 
personal issue (Peacock et al., 2014).  
Arguably, the experience of depression may also fuel these narratives and positionings, 
impacting the manner in which people make sense of their experiences and navigate identity. 
Disturbances in corporeality have long been considered central to the experience of depression. 
Across time, cultures, and contexts, depression has been described as an experience that involves 
altered bodily sensations and functions (Doerr-Zegers, Irarrázaval, Mundt, & Palette, 2017). For 
example, it has been described as an experience of “hyperembodiment”, in which the body feels 
heavy and rigid and serves as a barrier between the self and the world (Fuchs & Schlimme, 2009, p. 
572), and as an experience where basic bodily functions, such as sleep, energy, sex, and appetite, 
shift dramatically (Pfeiffer, 1968). These embodied experiences of distress or discomfort may 
influence the way people make sense of depression or TRD. They may have an impact on the 
narratives adopted, drawn on, and reproduced, and the identities or positions taken on, negotiated, or 
rejected. Unfortunately, however, narrative approaches that privilege linguistic accounts inevitably 
neglect these embodied or physiological experiences. A critical realist approach would allow for a 
more nuanced exploration of the interplay between embodied experience, sense-making, and 
positioning in the domain of TRD.   
Implications 
In Western societies, such as New Zealand, it is likely that these powerful and pervasive 
narratives play out in clinical encounters. Disciplines such as clinical psychology, with their 
emphasis on the individual as both the site of pathology and the source of change, play a key role in 




To the health professional, the process of empowering people to take charge of their own wellbeing 
may seem like a positive approach. Indeed, for many people experiencing mental distress, the ideas 
and expectations inherent in these frameworks may be unproblematic, or even helpful. However, for 
some – perhaps those who do not fit the expected trajectory, especially - the neoliberal imperative 
appears to carry with it several significant burdens.  
As described by participants in this research as well as participants in other studies (e.g., 
Weiner, 2011), engagement in endless self-surveillance results in people questioning their abilities to 
accurately gauge and communicate their internal workings and struggling to differentiate between 
themselves and their disease. Wiener (2011) argues that this is because the experience of mental 
distress undermines the neoliberal and biomedical distinction between self and disease. Instead, the 
experience of mental distress highlights the inextricability of sense of self and manifestations of 
distress. This means that whilst enacting highly encouraged, valued, and expected self-surveillance 
practices, people experiencing mental distress simultaneously come to recognise that they are 
unreliable and uncertain interpreters of their internal workings and increasingly view themselves as 
never fully knowable (Weiner, 2011). This played out in the present research – with a profound 
tension emerging between narrating depression as understandable and ordered (the narrative of 
order) and narrating depression as chaotic and confusing (the narrative of disorder). This tension, 
which is likely fuelled by messages circulating in mental health settings, appears extremely 
challenging to navigate. This is particularly the case for people experiencing persistent distress, such 
as TRD, who must endure this long-term. From a psychological perspective, a mismatch between 
lived experience and expectations in health settings may lead to further distress.  
Findings from both this research and studies exploring the uptake of neoliberal ideology in 
mental health settings suggest that there may be negative implications associated with the imperative 
to self-manage. Across several studies, participants experiencing mental distress described the 




unmanageable (Brijnath & Antoniades, 2016; Peacock et al., 2014). They spoke of the difficulties 
associated with managing endless appointments and medications, engaging in healthy eating and 
exercise regimens, and constantly monitoring symptoms. In some cases, participants described 
having to opt out of some of these responsibilities in order to cope. In the present research, the 
withdrawal described in the bad patient behaviour narrative could be interpreted as a temporary 
opting out of the unrelenting neoliberal imperative to be a rational self-manager.  
As well as leading to disengagement from treatment, the pressure to self-manage also appears 
to encourage engagement in dangerous behaviours. In desperate attempts to reduce depressive 
symptoms and be seen as effective self-managers, participants experiencing depression described 
self-medicating with alcohol and drugs, altering their prescription medication doses without health 
professional consultation, and consuming unregulated alternative remedies alongside or instead of 
prescribed drugs (Brijnath & Antoniades, 2016). These findings illuminate the negative 
consequences of the neoliberal imperative to master, contain, and control symptoms. They suggest 
that the burden associated with these narratives is high and the value placed on being an effective 
and rational self-manager may lead to people engaging in unhelpful behaviours when they cannot 
live up to what is expected of them. This suggests that vulnerable groups of people, such as those 
with TRD, may be left isolated, putting themselves at risk, and without the support of appropriate 
services. 
In addition to the potential burdens of perpetual self-management, the individual focus in 
explanations of persistent distress within neoliberal contexts also appears highly problematic. From a 
psychological perspective, blaming the self for lack of recovery is unhelpful, or even harmful, and is 
likely to maintain feelings of low mood or distress. Additionally, this framing appears to have 
significant implications in terms of the services made available to people. As McPherson and 
Armstrong (2009) have pointed out, health professionals who endorsed narratives of individual self-




psychological therapy not useful. This meant that, for individuals whose difficulties were linked to 
personality, referrals to psychological services were not made.  
In assigning responsibility for lack of improvement to the individual, little focus is paid to 
social factors that may contribute to persistent distress. In the case of TRD, this may manifest as 
health professionals paying insufficient attention to the social or economic conditions of the patient 
or client that could be hindering recovery. In the New Zealand context, deflected attention from 
social contributors of prolonged distress has particular implications for Māori, the indigenous people 
of New Zealand. Colonisation has had profound and enduring negative impacts on Māori. Acts of 
colonisation have resulted in dispossession of Māori culture, language, and land and have manifested 
in significant intergenerational trauma (Russell, 2018). This, combined with modern-day racism, 
socio-economic stressors, and cultural disconnection, has culminated in Māori being 
disproportionately affected by mental health difficulties (Russell, 2018). It is argued that, through 
reproducing neoliberal framings of mental health, health professionals play a role in obscuring and 
perpetuating the social inequalities born out of neoliberalism. In doing so, they release the 
government of its responsibilities (Brijnath & Antoniades, 2016; Pavón‐Cuéllar & Orozco Guzmán, 
2017).  
This neoliberal framing is also mirrored in the way that TRD is defined and conceptualised. 
The majority of approaches to defining, conceptualising, and explaining TRD frame the individual as 
the reason for lack of improvement and non-response to treatment. As Dyck (1994) highlights, the 
ineffectiveness of antidepressant medication in the case of depression is interpreted as indicative of a 
treatment resistant person. This leads to the majority of research on TRD being focused on 
discovering why a person is treatment resistant and developing new treatments to remedy this. As is 
argued with neoliberal ideology more broadly (e.g., LaMarre et al., 2018), the focus on the individual 
as the site of the problem in TRD obscures focus from broader systemic issues. In the case of TRD, 




ineffectiveness of many of the offered treatments, or the socio-cultural factors that could contribute 
to continued distress. For example, despite the category of TRD existing for over 50 years, there 
remains a concerning lack of consensus on several basic issues, such as the way it is defined and 
conceptualised (Wijeratne & Perminder, 2008). Additionally, in both clinical and academic domains, 
there is little evidence to support chemical imbalance hypotheses of depression and it appears that 
antidepressants are significantly less effective than previously thought (Moncrieff, 2008; Rush et al., 
2008). However, in the case of TRD, antidepressants continue to form the basis of treatment (Jenkins 
& Goldner, 2012). Relatively little attention is paid to the social factors that may contribute to lack of 
recovery in TRD. Some studies have suggested that experiences of difficult life events, trauma, 
financial stress, and relationship issues are common among people with TRD (e.g., Amital et al., 
2008; Tunnard et al., 2014). However, as the authors of the Power Threat Meaning Framework 
highlight, these studies are limited in the way that they predominantly conceptualise social or 
economic factors as discrete ‘triggers’ or ‘maintaining factors’, rather than as pervasive systems of 
power and oppression that negatively impact individuals on a daily basis and directly contribute to 
lack of recovery (Johnstone & Boyle, 2018).  
In the domain of mental health, neoliberal narratives have been described as “highly toxic” 
(Peacock et al., 2014, p. 179) and the practices they encourage have been described as “highly 
problematic” (Brijnath & Antoniades, 2016, p. 2). The findings of the present research, as well as 
other studies, suggest that neoliberal narratives of self-management and self-responsibility place high 
burden on the person experiencing distress. This potentially manifests as confusion, disengagement, 
dangerous behaviours, and self-blame on the part of the individual, and patient-blame, reduced 
provision of services, and little attention paid to social factors on the part of service providers. This is 
particularly relevant in the case of TRD, where depressive symptoms persist long-term. For those 
who recover as expected, navigating healthcare under neoliberalism may be a challenging but 




this likely spans months or years. Combined, these findings suggest troubling clinical encounters 
may be experienced by an already vulnerable client group.  
The more these neoliberal narratives of distress and recovery are privileged in clinical 
settings, the less likely it is that alternative narratives will flourish (Peacock et al., 2014). In turn, it 
may become more challenging for people to narrate their distress in ways that reflect the complexity 
of their experiences and the rich contexts in which they are embedded. Concerningly, these 
narratives are reinforced by health professionals in Western contexts in an unintentional and 
unconscious manner in their interactions with clients (LaMarre et al., 2018). Based on these findings, 
it may be beneficial for health professionals to consider the degree to which they reproduce these 
narratives of self-responsibility, self-management, and self-blame. Health professionals could 
consider how they can make space within clinical interactions for the creation of alternative 
narratives that more fully or usefully represent the multifaceted complex existences of those 
experiencing TRD. 
Considerations for future research 
The findings of this research represent the narratives of a small group of people experiencing 
TRD in the context of a private psychiatry practice in Auckland, New Zealand. Whilst a small and 
homogenous group of participants is not deemed a limitation within social constructionist research 
(Burr, 1995) discussion of the impact of participant characteristics and setting on the research 
findings is useful in guiding future scholarship. The participants in this group were all Pākehā (New 
Zealand European), affluent, and had high levels of educational attainment and employment. Six of 
the nine participants in this research identified as male. The participants had been all been diagnosed 
with major depressive disorder and assessed to have TRD and were receiving pharmacological 
treatment delivered by a psychiatrist in a private practice in a wealthy inner-city suburb of Auckland, 
New Zealand. This setting may have contributed to the reproduction of narratives of TRD which 




enterprise where wealthy consumers purchased pharmacological services from highly trained 
professionals in order to manage their own health. Embedded in this particular study context, it is 
perhaps unsurprising that the participants in this research drew so heavily on neoliberal and 
biomedical narratives when storying their experiences. With a wealth of resources available to them, 
they were also well equipped – perhaps more so than any other potential participant group with TRD 
– to embark on the neoliberal pursuit of self-mastery. 
The participant and setting characteristics will have significantly influenced narrative 
production and the findings of this research. Other than this research, there is no known literature 
exploring the experiences of people with TRD, so comparisons to narratives used by other groups 
cannot be made. Further research, therefore, could explore how other groups in varying contexts 
make sense of and account for the experience of the persistence of distress following treatment. 
Research exploring narratives of TRD among people of other genders, socio-economic statuses, and 
ethnicities embedded in different contexts would elucidate the pervasiveness of these narratives and 
the manner in which other groups take up and enact these narratives. This could include research on 
TRD in other settings. For example, research on narratives of TRD among people engaged with the 
public health system may be instructive. Those receiving publicly funded services may have less 
control over the amount and types of services they have access to and may experience considerable 
barriers to engaging in pervasive self-management behaviours such as healthy diets or meditation 
classes. Similarly, people who live rurally may struggle to access psychological and psychiatric 
services, and these gaps in service provision may shape the narratives used to account for their 
persistent distress. Research in settings like these would demonstrate how narrative production 
differs in contexts that may be less archetypically neoliberal or biomedical.  
Although this requires further exploration in the context of experiences of TRD, the limited 
existing literature on adoption of neoliberal discourses in health domains suggests that there may not 




Antoniades (2016) found no differences in way that Indian-Australian and Anglo-Australian 
participants with depression understood and engaged with the neoliberal imperative to self-manage. 
Additionally, neoliberal narratives of personal responsibility were also found to consistently shape 
accounts of healthy working-class women and unemployed men of all ages in the United Kingdom 
(Crawshaw, 2012; Peacock et al., 2014) and members of a bipolar support group in the United States 
(Weiner, 2011). Whilst this research is limited, the little work in the area suggests that narratives of 
personal responsibility are drawn on regardless of age, gender, ethnicity, wellbeing status, or 
location. These findings again highlight the power and pervasiveness of the neoliberal directive. 
They suggest that these narratives may shape accounts of TRD among different groups in different 
contexts. However, further research is needed to explore this.  
 Within the New Zealand context, exploration of the experience of TRD among Māori would 
be valuable. Māori, the indigenous people of New Zealand, have been heavily impacted by 
colonisation. With the well-recognised link between Māori mental illness and colonial trauma 
(Russell, 2018), structural contributors may feature more heavily in accounts of persistent distress or 
lack of recovery. Māori views of mental wellbeing differ significantly from Western biomedical 
models in that they are holistic – framing mental, physical, social, and spiritual health as 
interconnected and interdependent (Mark & Lyons, 2010). Given this, narratives of TRD may vary 
among Māori in New Zealand. Perhaps the availability of alternative conceptualisations of mental 
health would lead to reduced commitment to biomedical narratives, when compared to Pākehā (New 
Zealand European) participants. Neoliberal narratives are pervasive, however, even shaping 
processes of indigeneity among Māori (McCormack, 2012). It may be the case, therefore, that these 
powerful narratives structure the accounts of Māori, or other indigenous groups, experiencing TRD. 





A significant proportion of people experiencing depression do not experience the expected 
improvement following antidepressant treatment. The present research sought to explore how these 
people – who are deemed to have TRD – make sense of and account for these experiences. Set in the 
milieu of a private psychiatry practice in a wealthy inner-city suburb of Auckland, New Zealand, this 
research employed a narrative approach to explore the stories of people experiencing TRD.  
In this research, participants consistently conceptualised their depression as biochemical in 
nature and narrated accounts of becoming self-surveilling, self-managing subjects embarked on a 
mission to understand and contain their depression through engagement with the system of 
biomedicine. When failure to contain and control occurred, and antidepressants did not bring about 
improvement, the participants often assumed responsibility for this. They told of treatment resistant 
brains, personalities, or counter-productive patient behaviours that prevented antidepressants, which 
were assumed to be effective, from working and their depression from abating. These accounts were 
strongly shaped by narratives of mental distress and recovery that circulate in clinical psychology 
and psychiatry settings which are underpinned by discourses of neoliberalism that prioritise personal 
responsibility and self-management. 
In emphasising personal accountability and self-management, and self-blame when they did 
not achieve the desired and expected outcomes, the participants in this research were shaped as failed 
neoliberal subjects. It might have been expected, given their experiences, that people with TRD 
would resist these narratives. Following lack of the promised improvement following months or 
years of biomedical self-management, it might have been expected that participants would question 
biomedical and neoliberal ideologies. Instead, the participants drew on and reinforced the neoliberal 
narratives that provided problematic positions for them. This demonstrates the pervasiveness and 




eventuate, people continue to make sense of, account for, and position themselves with reference to 
these ideas.  
This research has illuminated several broader unexamined assumptions about mental distress 
and recovery that circulate in Western mental health settings. Whilst this work is specifically focused 
on TRD, these findings are relevant for all people experiencing mental distress as well as health 
professionals working in mental health domains. The findings of this research point to the 
importance of health professionals reflecting on their roles in perpetuating cultures of individual 
blame and accountability within mental health settings. This research has also revealed a distinct lack 
of literature exploring the experiences of persistent distress. This highlights the need to explore the 
experiences of people who do not fit the expected trajectory of illness to wellness within neoliberal 
contexts. As rates of mental distress continue to rise, especially within Western contexts, it is vitally 
important to explore how people navigate experiences of mental distress amid these powerful and 














CHAPTER EIGHT: FINAL REFLECTIONS 
This research was powerfully shaped by the fact that, alongside conducting this study, I was 
also training to become a clinical psychologist. This training meant that I commenced the research 
process imbued with the narratives that circulate in Western mental health settings that have been 
written about in this thesis. As a trainee psychologist, I viewed mental illness as a discrete set of 
symptoms located within individual that, with the right skills, could be objectively unearthed, 
understood, and treated. I had full confidence in the discipline and in my ability to help people 
increase their awareness of the internal processes that I saw as the root of their distress. Whilst these 
beliefs shifted and evolved over time, they strongly informed my initial framing of the research 
topic, the manner in which I engaged with participants, the way I interpreted and analysed the data, 
and the writing of this thesis.  
Embedded in this paradigm, I initially applied these framings of mental distress to the 
concept of TRD. The early study documentation, such as the participant information sheet (Appendix 
A), frequently used the term “treatment resistant depression”. It described TRD as a “form of 
depression” the participants “have” that involved “several antidepressants having not worked for you 
as well as might be hoped”. In many of the interviews, especially those that occurred early in the 
research process, I continued this framing. For example, I opened one participant’s interview with, 
“I'm interested in your experience of having depression that hasn't responded to antidepressant 
treatments as doctors and psychiatrists and psychologists might expect and what that's been like for 
you”. This framing meant that, before the interviews began, the participants had been socialised to 
certain narratives of mental distress. TRD had been positioned as a phenomenon they had rather than 
experienced – as something internal to them, and antidepressants were positioned as generally 
effective. These framings, which I originally viewed as objective assessments, may have influenced 




term depression’ or ‘persistent depression’, may have created space for or encouraged other 
narratives.  
My background as a trainee psychologist also deeply informed the manner in which I 
engaged with participants as the interviews progressed. At the time the interviews took place, I was 
working full-time as a psychologist at a private psychology clinic. Inhabiting the world as a 
psychologist, I found it challenging to shift roles when it came to conducting the research interviews. 
Sitting opposite the participants in the private practice consulting rooms that were being used for the 
interviews, I often found myself feeling, acting, and appearing like I was at work as a psychologist. 
As discussed in Chapter Four, at times, I also engaged and spoke like a psychologist. I frequently 
enquired about internal processes such as thoughts and emotions and through my questioning, which 
was at times not dissimilar to a clinical assessment, attempted to understand what had caused the 
participants’ depression and what was maintaining it. In doing so, I contributed to ordered 
constructions of depression and, in placing value on the ability to be self-aware, encouraged 
narratives of self-surveillance and self-mastery.  
In the interviews, I also contributed to the construction of narratives of self-labour through 
frequently enquiring about the participants’ engagement and success with various health 
professionals, treatments, and lifestyle changes. These were approaches to managing mental health 
that I, as a psychologist, perceived to be important and helpful. I asked one participant, “So have you 
found the medications that [the psychiatrist] has given you and other psychiatrists have given you, 
have you found them helpful?” I asked another, “Have you been to many psychologists along the 
way?”, another (after he referred to a self-help book he had read), “And are there other books that 
you found helpful too?”, and another, “And do you think that DBT [dialectical behaviour therapy] 
helped with the depression?” Through this questioning I encouraged accounts of self-labour, 
discouraged potential stories of giving up trying, and reinforced the virtuous position of self-




was likely driven by my curiosity as a psychologist as to whether the participants really were doing 
all they could to get better.  
Lastly, and perhaps most concerningly for me personally, I subtly reinforced narratives of 
personal responsibility throughout the interviews. I directly asked participants to account for their 
persistent distress and, often, my framing in this questioning placed emphasis on the individual. For 
example, I asked one participant “So do you have ideas about why it’s you that has had to go through 
this [treatment resistant] depression?” Here, I positioned the participant as different from people who 
recover as expected and asked them to explain what it was about them that rendered them treatment 
resistant. Additionally, when participants gave explanations for persistent distress that were rooted in 
personal characteristics, I frequently asked them to elaborate or, if time had passed, redirected them 
back to stories relating to this. For example, I directed one participant back to a previously told story 
about negative thinking potentially contributing to persistent distress - “And um earlier you 
mentioned that like thinking about whether it’s something about you, the reason why the medications 
aren’t working. Can you tell me more about that?”. Similarly, after one participant suggested that 
their personality may contribute to long-term depression, I promptly asked them to elaborate – 
“What sort of personality do you think you’d have to have, to feel like this?” I did not do this for all 
explanations of persistent distress storied by participants. Whilst I asked about the participants’ life 
circumstances, it was always in relation to ‘triggers’ occurring at specific time points, rather than 
about ongoing social or economic difficulties. For example, I asked one participant “so at that time 
where you first became depressed, what was going on in your life?” and another, “And what was 
going on at the beginning of the year when you started feeling low again?” Whilst these questions 
encouraged stories of specific precipitating events, they did not create space for stories of broader 
socio-structural contributors to persistent distress. This encouragement of certain narratives and 
discouragement of others likely reflected my professional beliefs (at the time) that personal factors 




This pattern of meaning-making continued to play out as I engaged with the data, began the 
analysis process, and wrote this thesis. In the early stages of analysis, I engaged with the transcripts 
as I had been taught to engage with clinical case studies as a psychologist. Rather than attending to 
the stories of the participants, I looked – through a psychologist’s lens – for factors that could 
explain why these people were not experiencing resolution of symptoms. As a psychologist trained 
predominantly in cognitive behaviour therapy (a type of psychotherapy focused on the link between 
thoughts and mood), the factors I looked for and found often related to the participants’ thinking. 
Again, this likely meant that I attended to certain narratives (such as internal attribution narratives) 
more than others. Throughout the research, I contributed to the construction of depression as a 
process playing out within the bounded individual separate from context, that could be controlled 
and resolved through engaging in a process of self-mastery and self-management. With another 
interviewer and researcher – someone who was not a psychologist or health professional – the 
narratives that emerged may not have been so strongly aligned with narratives of neoliberalism. 
More space may have been created for the creation of alternative narratives.  
Although I have outlined my influence on the data collection and analysis, I was likely just 
one element in a constellation of factors that encouraged these particular narratives. The participants 
were existing clients of the psychiatry private practice, were long term antidepressant users, and the 
interviews took place at the site of treatment and recruitment. My position as a trainee psychologist – 
and the experiences and beliefs that came with that – corresponded seamlessly with this psychiatry 
practice setting and the framings of mental distress that were likely circulating within it. Combined, 
these factors created a very particular research landscape – one that closely resembled a clinical 
setting. With both researcher and participant enacting the positions that they usually adopted in these 
contexts, the research illuminated narratives of mental distress that may not have emerged so 




research to demonstrate how the narratives circulating in these settings shape the participant accounts 
of mental distress.  
This research, spanning several years, shaped me – as a person, a researcher, and a 
psychologist – just as much as I shaped it. I began the research firmly embedded in a mainstream 
scientific clinical training programme. As the research progressed, I began to question the concepts I 
had taken for granted in my study and work as a psychologist. I noticed the discipline’s intent focus 
on the individual as the site of pathology and the source of change and felt ill-equipped when 
working with people experiencing significant social or economic adversity. I noticed my own 
tendencies to assign blame to the client when they were not improving or engaging with therapy as I 
had hoped, as well as negative constructions of these clients circulating in the clinical settings that I 
inhabited.  
Just as the participants in this research navigated narrative tensions in making sense of mental 
distress, so too did I. For much of this research process, I inhabited these two worlds: one as a 
psychologist working at a private practice, teaching breathing exercises, strategies for challenging 
‘unhelpful thinking’, and tools for managing difficult emotions, and one as a researcher critiquing 
these very practices. Spending one day shaping the perfect neoliberal subject and the next day 
reading and writing about the harms of doing so was uncomfortable. At times, this tension 
culminated in me struggling to imagine pursuing a career as a clinical psychologist and, at times, 
lead to me feeling unable to persist with my research.  
With time, discussion, and a break from clinical work, I feel closer to being able to bridge 
these two worlds. This research project has illuminated unexamined assumptions inherent in my 
discipline and forced me to reflect on the type of clinician I wish to be. It has prompted a 
commitment to working, as much as possible, in a way that does not perpetuate a culture of 
individual responsibility and blame. It has also cemented my social justice leaning and commitment 




in me a desire to create space within clinical encounters for the creation of alternative narratives that 
are affirming of the individual, their complex experiences of mental distress, and their unique 
contexts. Whilst the tension of inhabiting these two worlds has been a challenge, I am grateful for the 
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Participant Information Sheet 
 
Experiences and Understandings of Treatment Resistant Depression 
 
Location:    [Redacted location] Auckland 
Ethics Committee Reference:  16/NTA/197  
Lead Investigator:   Ella Kroch, Doctor of Clinical Psychology student 
Contact:    ella.kroch1@uni.massey.ac.nz 
 
 
You are invited to take part in a study exploring clients’ experiences and understandings of treatment 
resistant depression. This study is a doctoral research project lead by a Doctor of Clinical 
Psychology student from Massey University. Whether or not you take part is your choice. If you 
don’t want to take part, you don’t have to give a reason, and it won’t affect the care you receive. If 
you do want to take part now, but change your mind later, you can withdraw from the study at any 
time.   
 
This Participant Information Sheet will help you decide if you’d like to take part.  It sets out why we 
are doing the study, what your participation would involve, what the benefits and risks to you might 
be, and what would happen after the study ends. Before you decide you may want to talk about the 
study with other people, such as family, whānau, friends, or healthcare providers. Feel free to do this. 
 
If you agree to take part in this study, you will be asked to sign the Consent Form on the last page of 
this document. You will be given a copy of this Participant Information Sheet and the Consent Form 
to keep. Please make sure that you have read and understood all the pages.  
 
WHAT IS THE PURPOSE OF THIS STUDY? 
 
• In this study, we are exploring experiences and understandings of treatment resistant 
depression.  
• Whilst there is some research looking at health care providers’ views on and experiences of 
working with people with treatment resistant depression, there is limited research exploring 
clients’ experiences and understandings of this form of depression. The goal of our research 




• The findings are likely to contribute to the development of more effective treatment 
approaches for treatment resistant depression.  
• Our group is made up of one Doctor of Clinical Psychology student as well as clinicians and 
academics who are interested in improving outcomes for people with treatment resistant 
depression. We are based at Massey University, Auckland University of Technology, and 
[Redacted location].  
• This study has been approved by the Health and Disabilities Ethics Committee (HDEC). 
Contact details for this ethics committee are at the end of this form. 
 
WHAT WILL MY PARTICIPATION IN THIS STUDY INVOLVE? 
 
• You have been invited to participate in this study due to your diagnosis of Major Depressive 
Disorder and the fact that several antidepressants have not worked for you as well as might 
be hoped. 
• If you agree to participate, this study will take approximately 1-2 hours of your time and 
involve one trip to [Redacted location] for an interview.  
• The interview will be informal and focus on your experiences and understandings of 
treatment resistant depression. 
• The interview will take place at [Redacted location] and will be within normal working 
hours, so you will need to be available between the hours of 8.30am and 5pm.  
• The interview will be audio recorded so that it can be transcribed and analysed. Your name or 
other identifying information will be removed from the transcripts and any written work, so 
you will not be identifiable.  
• You will receive a petrol voucher to cover your transport costs for this interview and to 
acknowledge your contribution to the research. 
 
WHAT ARE THE POSSIBLE BENEFITS AND RISKS OF THIS STUDY? 
 
• There are no guaranteed benefits, however, you may value having the opportunity to share 
your experiences of depression with a supportive researcher in an informal setting. You will 
also be helping us to understand what it is like to experience depression that is resistant to 
treatment so that we can work to develop more effective treatments.  
• In terms of risks, it is possible that talking about your experiences or understandings of 
treatment resistant depression makes you feel uncomfortable, upset, or distressed. Should this 
happen during the interview, we will stop and consider whether it is best to postpone or 
cancel the session. There is a list of services at the end of this information sheet should you 
feel you need support following the interview. 
 
WHAT ARE MY RIGHTS? 
 
• Your participation in this study is voluntary. It is up to you whether you take part or not. If 
you do decide to take part, you will be given this information sheet to keep and will be asked 
to sign a consent form. If you do not want to take part you do not need to give a reason. If 
you decide to take part but then change your mind, you are free to withdraw at any time 
without giving a reason. The decision to not take part or the decision to withdraw will not 
affect the standard of care you receive from [Redacted location].  
• You have the right to access the information collected about you as part of the study. You 
have the right to request a copy of your interview transcript to read and alter before it is 




• You will be told of any new information related to the study that becomes available during 
the course of the study that may have an impact on your health. 
 
WHAT HAPPENS AFTER THE STUDY? 
 
• Your treatment at [Redacted location] may continue as normal. 
• At the end of the study, your audio recordings will be kept in a locked cabinet in a secure 
room at the School of Psychology, Massey University. Data relevant to our research will be 
entered into a password protected file on the lead investigator’s password protected 
computer. This data will be identified by an identification code, not your name. Your name or 
other identifying information will never be used in any research reports or publications. Only 
members of the study team will be able to access your data. Your data will be stored for a 
period of 10 years and will be destroyed after this time. 
• If you wish, we can send you a summary of the results after the completion of the study. The 
study findings may also be published in academic journals and presented at conferences.  
 
WHO DO I CONTACT FOR MORE INFORMATION OR IF I HAVE CONCERNS? 
 





Doctor of Clinical Psychology student 
School of Psychology 
Massey University  
Email: ella.kroch.1@uni.massey.ac.nz  
 
Research and Clinical Supervisors 
 
Dr Mary Breheny 
Senior Lecturer  




Phone: (06) 356 9099 ext. 83523 
 
Dr Kirsten van Kessel 
Senior Lecturer and Registered Clinical 
Psychologist 
Department of Psychology 
AUT University 
Email: kvankess@aut.ac.nz 
Phone: (09) 921 9999 ext. 769
If you want to talk to someone who is not involved with the study, you can contact an independent 
health and disability advocate on: 
 
Phone:  0800 555 050 
Email:  advocacy@hdc.org.nz 
 
You can also contact the Health and Disability Ethics Committee (HDEC) that approved this study 
on: 
 
Phone:  0800 4 ETHICS 





WHO DO I CONTACT IF I NEED SUPPORT? 
 
If you are having difficult thoughts or feelings following the interview, there is support available to 
you.  
 




Free Phone (anytime): 0800 543 354  
 
Suicide Crisis Helpline 
Free Phone (anytime): 0508 828 865  
 
Depression Helpline 
Free Phone (anytime): 0800 111 757  
Free Text (anytime): 4202 
 
Mental Health Crisis Teams: 
 Waitemata DHB 
 Phone (working hours): (09) 4871414 
Phone (after hours): (09) 4878900 
 
Counties Manukau DHB 
Phone (anytime): (09) 2613700 
 
Auckland DHB 
Free Phone (anytime): 0800 800 717 
 
Maori Mental Health support: 
Waitemata DHB Whitiki Maurea  
Maori Mental Health Services 
Phone:  (09) 822 8555 
 
Counties Manukau DHB Te Puna Waiora  
Maori Mental Health Services 
Phone:  (09) 259 5099 
 
Auckland DHB Manawanui Oranga Hinengaro  
Maori Mental Health Services 















Experiences and Understandings of Treatment Resistant Depression 
 
Location:    [Redacted location] Auckland 
Ethics Committee Reference:   16/NTA/197  
Lead Investigator:   Ella Kroch, Doctor of Clinical Psychology student 
Contact:    ella.kroch1@uni.massey.ac.nz 
 
Please tick to indicate you consent to the following:  
I have read, or have had read to me in my first language, and I 
understand the Participant Information Sheet.   
  
I have been given sufficient time to consider whether or not to 
participate in this study. 
  
I have had the opportunity to use a legal representative, whanau/ family 
support or a friend to help me ask questions and understand the study. 
  
I am satisfied with the answers I have been given regarding the study 
and I have a copy of this Consent Form and Participant Information 
Sheet. 
  
I understand that taking part in this study is voluntary (my choice) and 
that I may withdraw from the study at any time without this affecting 
my care at [Redacted location]. 
  
I consent to the research staff collecting and processing my information, 
including information about my health. 
  
If I decide to withdraw from the study, I agree that the information 





I consent to my GP or current provider being informed about my 
participation in the study and of any significant abnormal results 




I understand that there may be risks associated with participation in this 
study.  
  
I agree to an approved auditor appointed by the New Zealand Health 
and Disability Ethic Committees, or any regulatory authority or their 
approved representative reviewing my relevant medical records for the 
sole purpose of checking the accuracy of the information recorded for 
the study. 
  
I understand that my participation in this study is confidential and that 
no material, which could identify me personally, will be used in any 
reports on this study. 
  
I know who to contact if I have any questions about the study.   




I agree to a researcher contacting my health provider at [Redacted 
location] for diagnostic clarification. 
  






Declaration by participant: 
I hereby consent to take part in this study. 




Declaration by member of research team: 
I have given a verbal explanation of the study to the participant, and have answered the participant’s 
questions about it.  I believe that the participant understands the study and has given informed consent to 
participate. 







































Experiences and Understandings of Treatment Resistant Depression 
 
Please complete the following questionnaire honestly and return to the researcher. Your information will be 
confidential and will remain anonymous. If there are questions you do not wish to answer, you may leave 
them blank. Thank you.  
 
1. What is your age? ________ 
 





3. What is your ethnicity? 
□ NZ European/Pakeha  
□ Maori  
□ Pacific Nations 
□ European (non NZ) 
□ Asian 
□ Other (please specify) ________ 
 
4. What is your relationship status? 
□ Single 
□ Married  




□ Other (please specify) ________ 
 
5. What is your highest level of education? 
□ No schooling 
□ Primary school 
□ Some high school  
□ High school 
□ Trade/vocational training 
□ Some university 
□ Bachelor’s degree 
□ Master’s degree 
□ Doctoral degree 
□ Other (please specify) ________
 
6. What is your employment status? 
□ Unemployed and not currently 
looking for work 
□ Unemployed and looking for work 
□ Self Employed 
□ Employed for wages/salary 
□ A homemaker  
□ A student 
□ Retired 



























































CASE STUDY 6 
 
 
“Am I one of those difficult people, am I?” 




Candidate: Ella Kroch 
Clinical Psychology Programme Massey University 
Student ID:  
Setting: Centre for Psychology, Albany 




This case was completed during internship at the Centre for Psychology in 2018 and 






A significant proportion of people with depression, approximately 20%, do not experience 
recovery even after several rounds of antidepressant medication. Such individuals are said to 
have a form of depression called treatment resistant depression. Health care providers have 
been found to frame these individuals as difficult and manipulative, and to attribute their 
pervasive low mood to social deviancy or personality disorders. In this single case study, I 
explored the ways that one woman, Pauline, made sense of her treatment resistant depression. 
By examining her account from a narrative analytic perspective, I found three overarching 
narrative tensions: ‘Am I getting better or am I stuck?’ ‘Am I good patient or a bad patient?’ 
‘Did my difficult life or my negative thinking cause my depression?’ More specifically, I found 
that Pauline drew on a number of competing narratives and cycled through telling numerous, 
context specific, and often conflicting stories in an attempt to make sense of her lived 
experiences. This analysis suggested that, faced with an experience that does not fit the 
mainstream public account of diagnosis with and recovery from depression, individuals with 
treatment resistant depression struggle to renegotiate their identities and restore any sense of 
coherence.  
Keywords: treatment resistant depression; depression; narrative; identity; illness 
Introduction 
Depression is traditionally conceptualised as a condition that involves sad, empty, or 
irritable mood, and physical and cognitive changes that adversely impair an individual’s 
functioning (American Psychiatric Association, 2013). Major depressive disorder (hereafter 
referred to as depression) is a clinical condition situated within the individual and objectively 
defined by symptom-based diagnostic classification systems, such as the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) (American Psychiatric Association, 2013; 





and a major public health concern (World Health Organisation, 2008). According to Te Rau 
Hinengaro, The New Zealand Mental Health Survey, depression is also highly prevalent in New 
Zealand, affecting approximately one in six New Zealanders (Oakley Browne, Wells, & Scott, 
2006). 
Pharmacological and psychotherapeutic treatments have advanced significantly over 
recent years improving outcomes for individuals with depression, however, a considerable 
proportion of people continue to struggle even after intervention (Berlim, 2007). This lack of 
expected treatment response, which is said to affect approximately 20% of patients with 
depression (Crown et al., 2002), is frequently termed treatment resistant depression. Whilst 
there is a lack of consensus on definitions, treatment resistant depression is most commonly 
defined as an episode of depression that has not responded to two or more trials of 
antidepressant medication at an adequate dose and duration (Berlim, 2007). The term treatment 
resistant depression is often used interchangeably with ‘chronic depression’ and ‘recurrent 
depression’, which leads to some confusion in both clinical practice and scientific literature. 
However, a growing body of research suggests that treatment resistant depression may be 
unique in its own right. In chronic depression, the vast majority of individuals have not received 
adequate treatment so cannot be considered treatment resistant (Gelenberg, Kocsis, 
McCullough, Ninan, & Thase, 2006) and in recurrent depression, individuals do experience 
recovery in between episodes and respond to treatment (Gelenberg et al., 2006). These factors 
suggest that people with treatment resistant depression differ from those with chronic and 
recurrent depression. People with treatment resistant depression often seek help from healthcare 
professionals and receive adequate treatment, yet do not experience recovery from depressive 
symptoms.  
The experience of treatment resistant depression is thought to present additional 





with treatment resistant depression can feel discouraged and hopeless after trialling multiple 
antidepressant medications without significant improvement and report high levels of self-
injurious behaviour (Dunner et al., 2006). In addition to having considerable impact on the 
individual, treatment resistant depression is also thought to present a significant burden for 
support people, health services, and society at large (Thomas et al., 2012; Wiles et al., 2013), 
and to be a major challenge for clinicians (Wijeratne & Perminder, 2008).  
Publicly availably narratives of depression  
Personal narratives and accounts of single episodes of depression tend to fit a 
recognisable pattern. The typical sequence is of a) an initial realisation that something is wrong, 
b) a struggle to come to terms with and understand the new experience and identity, c) a period 
of help seeking, and d) a transition to recovery (Karp, 1994; Schreiber, 1996). During the phase 
of coming to terms with and understanding the depression, stories are told of painful paradoxes. 
People speak of the desire to engage, take control, confront their issues, form relationships, 
recover, and make plans for the future, but simultaneously, feelings of powerlessness, the desire 
to withdraw, and the desire for things to stay the same (Danielsson & Rosberg, 2015; Rapmund 
& Moore, 2000; Sarkohi, Frykedal, Forsyth, Larsson, & Andersson, 2013).  
These accounts and narratives of depression include a recovery phase, which tends to 
come after a period of help seeking and introspection. Once feeling better, individuals attribute 
their recovery to becoming more aware of the factors contributing to their depression, learning 
to trust their instincts, and becoming more active participants alongside their health providers 
(Steen, 1996). Individuals also speak of experiencing shifts in the way they view themselves, 
the world, and the future (Ridge & Ziebland, 2006; Steen, 1996). For example, they cease to 
see depression as part of themselves and, instead, view it as an experience that is distinct from 
the self (Ridge & Ziebland, 2006). After recovering, many individuals appear to rewrite 





journey, as an experience that led to increased self-awareness, as motivation to find meaning in 
life or a more authentic self, or as a chance to stop and rethink their lives and what is important 
(Ridge & Ziebland, 2006). These stories place value on gaining insight and taking responsibility 
as key parts of the process of recovering (Ridge & Ziebland, 2006; Steen, 1996). 
As the media both constructs and reflects socio-cultural realities, analyses of media 
portrayals of depression can also provide insight into public understandings of depression. 
Since the 1990s there has been a shift in the media to portray depression as a largely biomedical 
phenomenon (Clarke & Gawley, 2009). Despite the lack of consensus on causes of depression, 
depression is presented almost exclusively as a malfunctioning of the biological body. It is 
defined in these media portrayals using biological, biochemical, and genetic terms and 
explanations, and is closely associated with the domains of medicine and biology. This 
representation of depression leads to a focus on medication as the appropriate treatment (Clarke 
and Gawley, 2009). There is also an emphasis on the importance of consulting with mental 
health professionals and seeking expert opinion. Today, the dominant metaphor portrayed in 
the media is that depression is the “common cold of mental health” and that the appropriate 
response is antidepressant medication, the “aspirin for the psyche” (Clarke & Gawley, 2009).  
These personal narratives and media portrayals of depression appear to be in keeping 
with narratives of illness more generally. For example, they are consistent with Frank’s (1995) 
restitution narrative of “yesterday I was healthy; today I am sick; tomorrow I will be healthy 
again”. This is the culturally dominant narrative of illness and the story that is told by the 
majority of people who have recently become ill (Frank, 1995). Behind this narrative is the 
modernist expectation that behind every suffering there is a remedy, and that health is the 







Counter-narratives of depression 
Some people with depression, however, do not experience recovery in the expected 
timeframe or manner. For these individuals, the publicly available illness and depression 
narratives may not accurately frame their experiences. Instead, accounts of those who have 
‘chronic depression’ or ‘recurrent depression’ describe feeling stuck, feeling like a failure, 
dreading future recurring episodes, and contemplating suicide (Ridge & Ziebland, 2006). 
Unlike those whose experiences fit with the dominant narratives, these people struggle to 
establish, or even imagine, a recovery narrative (Ridge & Ziebland, 2006). Understandably, 
these stories have profound themes of hopelessness (Stigsdotter Nyström & Nyström, 2007) 
and fatalism (Gask, Aseem, Waquas, & Waheed, 2011). This sits in stark contrast to the 
cautious sense of hope evident in dominant narratives of depression (Rapmund & Moore, 2000; 
Sarkohi et al., 2013). In contrast to those who experienced single episodes of depression, those 
with ‘chronic depression’ or ‘recurrent depression’ were unable to situate their experiences 
within a broader process of meaning-making (Stigsdotter Nyström & Nyström, 2007). 
Instead of drawing on dominant narratives of illness, these accounts have links to 
chronic illness literature. Chronic illness has been likened to a “biographical disruption" due to 
the illness’ significant impact on the individual’s expected life course (Bury, 2001, p. 169). 
When a biographical disruption occurs, the individual is faced with the challenge of 
reconstructing their identity and life story in order to maintain a coherent sense of self 
(Crossley, 2000). In keeping with this, Frank (1995) argues that when people experience 
significant changes in life circumstances, such as chronic illness, “narrative chaos” may ensue. 
The same has been said for chronic mental illness, with the suggestion that these individuals 
are suffering from “an incoherent story” or “an inadequate account of oneself” (Polkinghorne, 
1988, p. 179). In these cases, Frank argues that ‘narrative wreckage’ may ensue where 





getting better (1995). Unlike the culturally favoured restitution narrative, there is a widespread 
discomfort in hearing and telling the chaos narrative, perhaps due to the fact that it reminds us 
of the fragility of the human body or mind (Frank, 1995).  
When individuals experience depression that does not align with dominant narratives of 
illness and recovery, there are implications for health service experiences (McPherson & 
Armstrong, 2009; McPherson, Byng, & Oxley, 2014; McPherson, Walker, & Caryle, 2006). 
Counsellors’ reactions towards these clients have been found to be predominantly negative, 
with counsellors describing feeling powerless, a failure, deskilled, drained, finding the work 
painful, and experiencing ‘heartsink’ moments when these clients entered the service 
(McPherson et al., 2006). Among GPs, there was a general loss of empathy when patients did 
not demonstrate improvement over time. Patients were described as burdensome, manipulative, 
or difficult people with generally unpleasant characteristics (McPherson & Armstrong, 2009). 
When patients did not respond to antidepressants, GPs attributed their problems to social 
deviance rather than depression (McPherson & Armstrong, 2009). Whilst these medical 
professionals typically draw on medical explanatory models of depression, this was not the case 
for patients with treatment resistant depression. Instead, GPs used psychosocial explanations, 
such as previous trauma or abuse, problematic attitudes or personalities, and deficits in social 
skills and coping skills (McPherson & Armstrong, 2009; McPherson et al., 2006). This suggests 
that when individuals respond to treatment as expected, GPs label them as depressed and situate 
their experiences within a medical framework. However, when patients do not respond to 
antidepressants, the medical model is no longer used to explain their symptoms and instead 
responsibility is attributed to the client for not recovering due to the fact they are ‘difficult’, 







Rationale for the current study  
There is evidence to suggest that the experience of treatment resistant depression may 
be significantly different from other forms of depression, in that affected individuals are 
receiving adequate intervention, but are not experiencing recovery. Drawing on publicly 
available narratives, people diagnosed with depression are likely to expect recovery and make 
sense of their situation in terms of  a restitution narrative (Frank, 1995). However, a person with 
treatment resistant depression does not recover. Instead, they trial many medications without 
significant improvement. When recovery does not occur, they may be constructed as “difficult” 
or “socially deviant” patients by medical professionals (McPherson & Armstrong, 2009). As a 
result of this, people with treatment resistant depression cannot successfully draw on dominant 
or publicly available narratives of depression to make sense of their experiences. These people 
must search for new ways of making sense of their experiences. There is no known research 
exploring how these individuals experience, understand, or make sense of depression that is 
treatment resistant. This study will address this gap in the literature by conducting an in-depth 
narrative analysis of the experiences of one woman with a decade long history of treatment 
resistant depression.  
Method 
Narrative Psychology  
This single case study used a narrative research approach to explore how one woman 
has experienced, understood, and made sense of her treatment resistant depression. Narrative 
psychology is concerned with the ways in which humans organise, make sense of, and interpret 
their lived experiences through storytelling (Murray, 2008; Silver, 2013). Narratives also play 
a central role in the way humans construct and maintain their identities (Hiles & Cermak, 2008). 
Through the process of telling stories, individuals not only come to understand themselves, but 





stories present certain versions of the self (Riessman, 2003). Narrative approaches, therefore, 
are well suited to the study of how people present themselves in certain ways, for example, 
often in a favourable light (Stephens & Breheny, 2013). Narrative approaches are also 
concerned with the surrounding socio-cultural context, which informs the stories people tell 
(Murray & Sools, 2015). 
Storytelling is particularly evident in situations where people’s expected life courses 
have been disrupted, for example by illness (Stephens, 2011). Storytelling is used to make sense 
of changes in life circumstances, as it facilitates understanding of why and how an event 
happened and who the individual was before this event occurred, as well as helping the 
individual to renegotiate their identity and restore a sense of coherence (Crossley, 2000; 
Murray, 2008; Sarbin, 1993; Stephens, 2011). Examining such narratives provides insights into 
the effects of an illness on the person’s life, including their day-to-day activities, their 
relationships, and their experiences within medical settings. Narrative approaches also provide 
insight into how people take up and negotiate identities, such as ‘mentally ill’, ‘patient’, or 
‘treatment resistant’.  
Study Context and Location  
The study took place at a private psychology and psychiatry practice in Ponsonby, 
Auckland. Ponsonby is a predominantly upper middle class suburb in central Auckland that has 
undergone significant gentrification over the last 20 years. The private practice is located in a 
renovated villa on a residential street off Ponsonby Road. It offers the services of four 
psychiatrists and two psychologists and, according to its website, combines these two 
disciplines in order to best support clients. The private practice receives self-referrals and 
referrals from general practitioners and other specialists in the Auckland region.  
 The current study was part of a larger qualitative study exploring experiences of people 





12 participants and, at the time of writing, I had interviewed nine individuals. During the 
recruitment phase, the psychiatrist identified individuals on his caseload  treatment resistant 
depression and asked them if they were interested in participating in a “study on depression”. 
If the individuals were interested, they were given information sheets outlining details of the 
study and asked for permission to be contacted. I then contacted these individuals, gave a brief 
overview of the study, answered any questions, and, if they were willing, set a date and time 
for the interviews. Ethical approval for the study was gained through the New Zealand Health 
and Disability Ethics Committee.  
Participant 
From the larger qualitative study, I selected one participant for this single case study 
due to the rich and detailed accounts of depression that she gave. Pauline (name and identifying 
details changed) was a single 48-year-old woman of New Zealand European descent. At the 
time of the research she was living in Auckland, New Zealand and was employed in a sales role 
at a retail company. Pauline had been experiencing depression for approximately nine years in 
total and had been diagnosed with major depressive disorder and generalised anxiety disorder. 
Over the course of her depression, Pauline estimated that she had been treated with up to 20 
medications, each only providing short-term or minimal relief from symptoms. She had 
returned to the psychiatrist for medication reviews as required. Pauline had also received 
psychological treatment from a registered clinical psychologist for seven years.  
Interview Procedure 
Data was collected through a semi-structured interview. Prior to the interview Pauline 
gave informed consent and completed a demographic questionnaire. The interview took place 
in an office at the private practice in Ponsonby where she had been recruited. Upon meeting, I 
introduced myself and shared some information about my background and my roles as a clinical 





of the study was to explore people’s experiences and understandings of depression that had not 
responded to medication or treatment as expected. In contrast to the Participant Information 
Sheet, I avoided use of the term treatment resistant depression, and instead referenced 
‘depression’ more generally. This was aimed at keeping the interview broad rather than 
narrowing the focus to a specific type of story. I told Pauline that there was no right or wrong 
account and that I would be interested in anything that she would like to share about her 
experiences of depression. I then asked whether Pauline would like to start with the story of 
when her depression first began.  
Following this, the interview had an open structure with no fixed interview schedule 
and was largely led by Pauline. I did, however, keep the general aim of exploring how people 
experience, understand, and make sense of their treatment resistant depression in mind 
throughout the interview. As suggested by Murray (2003), I attempted to elicit narrative 
accounts and rich descriptions by, firstly, simply asking for them, for example, by saying “could 
you tell me the story of when you first sought help?” and, secondly, by encouraging them 
through reference to times and places, for example, “could you tell me more about the time the 
doctor told you that you have depression?” This approach allowed for both flexibility of 
conversation and the covering of points relevant to the research questions. The interview with 
Pauline lasted approximately 80 minutes and was audio recorded. Following the interview, I 
offered Pauline a $50 petrol voucher to thank her for her time and willingness to share her story.  
Analysis 
Following the interview with Pauline, I transcribed the interview and cross-checked the 
transcription for accuracy. In terms of transcription conventions, words are underlined to show 
emphasis and ellipses are used to indicate pauses.  Analysis was guided by the narrative 
approaches of Murray (2000) and Stephens and Breheny (2013). This involved focusing on 





narratives, as well as the intersection between these levels. First, I analysed the transcript for 
personal stories told by Pauline about her experience of depression. These were identified by 
searching for mini-accounts that Pauline told with a beginning, middle, and end. Secondly, I 
paid attention to the ways these stories reflect  co-construction between Pauline and myself. I 
considered how my position as a clinical psychology trainee and the setting of a private 
psychiatry practice may have influenced how Pauline told her stories. Lastly, I considered 
publicly available narratives of depression, mental illness, and illness more generally that 
Pauline and I drew on during the interview in our co-construction of stories.  
Findings 
Am I getting better or am I stuck? 
“I, you know, am now getting better”. Pauline described being able to “pinpoint” the 
onset of her depression to 2009, approximately nine years before the interview. She described 
having worked hard in her sales role for several years without breaks, and beginning to 
experience a lack of enthusiasm and enjoyment. She thought she might be “worn out” and, as 
a result of this, decided to go on holiday. On return, however, Pauline realised that she felt no 
better and, as the weeks passed, she deteriorated. She described seeking help from her GP then 
being referred to a psychiatrist in private practice and beginning pharmacological treatment.  
At this stage Pauline’s story of depression did not differ significantly from publicly 
available narratives of depression and a certain hopefulness was evident in her accounts. 
Publicly available narratives of depression include some key elements: realising that something 
is wrong, seeking help from qualified mental health professionals, being diagnosed with 
depression and provided with treatment, diligently following the health professional’s advice 
and treatment protocol and, lastly, experiencing symptom reduction and return to previous level 
of wellbeing. This narrative clearly encourages certain expectations around recovery and, in 





characterised by expectation of return to wellness. This restitution narrative (Frank, 1995) was 
evident in Pauline’s account of explaining her situation to her colleagues at work, as means of 
understanding her situation as ‘yesterday I was a high functioning and healthy working woman, 
today I am depressed, tomorrow I will be a high functioning and healthy working woman 
again’.  
Pauline:  …there was a point at the first couple of years where I was very 
depressed and then I had something that was making me better and I 
went to, ah, a sales conference that we had for our staff and said “oh 
look, I know that I haven’t been very well and helping you guys very 
much and that, that’s because I’ve been sick and I just want to tell you 
that I, you know, am now getting better”. 
Even when Pauline did not have immediate success with medications, she continued to 
draw on the restitution narrative, and told a story characterised by the possibility of return to 
wellness, even if it this takes a while: 
Pauline: ‘cos I know that sometimes it can take time to find something that works 
for you… Like we make skincare, so it doesn’t work for everybody, and, 
or some people have reactions to certain things and so, you know, some 
people cannot drink dairy or gluten so, you know, it’s a matter of your 
body adjusting to it. 
Pauline suggested that, just like “skincare”, an individual may need to try several 
antidepressants before finding one that suits them, or, just like “dairy or gluten”, an individual 
may react badly to one antidepressant and need to try other options. In making this analogy, 
Pauline drew on the publicly available narrative that depression is a biological dysfunction 
that needs to be rectified through medication. As medical explanatory models are less 





allowed Pauline to attribute her difficulties to biology, and provided her with a comfortable 
way of storying her experiences to her colleagues. Pauline found a way to hold on to the 
restitution narrative and, resultantly, hope. Her explanation of the fact that “it can take time to 
find something that works” and her motivation and willingness to continue attending 
appointments and trialling new medications were likely grounded in expectations of finding a 
cure, which were informed by the restitution narrative. 
“No end to the tunnel”. Pauline described an event that functioned as a major turning 
point in the way she made sense of her experiences. She described a discussion with her 
psychiatrist during a routine appointment, during which she received some new information:  
Pauline:  And so it wasn’t until a couple of years in that [the psychiatrist] said “oh 
well, um those people with major depression like yourself”, and I’m 
going “okay, I didn’t know there was different types of depression”. So, 
so that’s when it sort of clicked, okay, that there’s more than just trialling 
a couple of different things, that these, um, are people who have, um, the 
inability to find something.  
Pauline spoke of being told by the psychiatrist that she had a different type of 
depression. Pauline called it “major depression” but the way she described it as “people who 
have, um, the inability to find something” suggests that she was describing treatment resistant 
depression. Pauline continued this account by describing going home and doing some research 
to try to make sense of this information.  
Pauline:  And then I read online in a couple of forums and there’s this one lady 
who started up a group called blue something or other and she's had 
major depression and a lack of finding a drug for about 15 or 20 years. 
So that's a really long time. And she is worse than me that she has some 





had times where I can’t get out of the house. Um, but to recognise that, 
you know, it could go on for that long is, um, frustrating and upsetting 
because you sometimes get to the end of your tether and you think how 
do I go on? (laughs). 
Ella:   Yeah. Yeah. That's completely understandable. 
Pauline:  Yeah. And where at the moment I'm probably a lot more positive because 
what I'm on at the moment has lifted me a little bit to where it's, um, 
where I'm able to cope with everything a lot better… 
In the first section of this excerpt, Pauline described the time she first became aware of 
a counter-narrative of depression: that there are some people who do not recover despite 
treatment. She then began to present an account of her depression as a long-term struggle. 
However, following this, Pauline very swiftly abandoned the “no end to the tunnel” story 
(drawing on counter-narrative of depression) and resumed the previously outlined “I am now 
getting better” story (drawing on the restitution narrative), where she began to talk about a 
medication that has “lifted [her] up a bit”. Pauline had a tendency to (re)focus on the restitution 
narrative by highlighting stories of new and alternative treatments, possible outcomes, and 
opinions of medical professionals. As restitution narratives are the favoured and dominant 
accounts of illness in Western culture and offer concrete hope, it is unsurprising that Pauline 
was drawn to this. I did not, however, subscribe to this and, informed by my personal agenda, 
repeatedly directed Pauline to the “no end to the tunnel” story. 
Ella:  Oh gosh. What about the time you mentioned earlier when you did the 
research and you found, uh, was it the blog of the lady? Can you tell 
me about that time and when you…it sounded like you sort of realised 






Pauline:  It made me sad and upset me mainly because, ah, I don’t want to be. It 
depends on what frame I’m in too. So if I’m quite low it can make me, 
um, seem that there’s no end to the tunnel. Um, but if I’m a little bit more 
positive it can also make me feel down and there’s no end to the tunnel 
(laughs). Um, but also the fact that she does live with it so that, you know, 
even though it is hard, um, ah, and it’s a struggle that she can… she’s 
spent that long a time so she can live with it. But the other end is that 
when I am very depressed, it is, I don’t know how to, how I would cope 
for that length of time to deal with it. ‘Cos it is a very long time, and I 
hate… I mean, going from being positive to having depressive state, it’s 
such hard work. Yeah (in pained voice, sighs). 
Ella:  So do you think when you read that things changed in terms of the way 
you understood what was going on for you?  
Pauline:  I think it did a little bit. When I read it I was quite depressed and it did 
upset me. A lot. Um, so that, um, at that point it was… how the… I don’t 
know if I can cope for that long without… without, with finding, um, 
something that was helpful, um, but, when I’m up a little bit, it’s like well 
I’m not the only one who is going through that and she has coped. So 
there’s two sides of it. So when I’m depressed it’s like oh my god, how 
do I cope, I can’t see the end of… I can’t see any light, and you know to 
think that all those years and you still can’t find something that’s helpful, 
and knowing that, you’re in a such an up and down state all the time. 
Like even just this last year I think I’m on my third or fourth set of drugs.  
After I made several attempts to direct Pauline back to the “no end to the tunnel” story, 





sight. Whilst telling this story, Pauline began to draw on narratives of chronic illness and to 
frame her depression as something that would affect her for the rest of her life. This occurred 
to the extent that feeling “more positive” was no longer viewed by Pauline as being suggestive 
of movement towards recovery (as it was in her “I am now getting better” story), but rather as 
a transient phase of the illness. When individuals with chronic conditions experience a 
reduction in symptoms, they do not assume that they have recovered. Instead, they 
conceptualise this improvement as a short term reprieve from long term illness. Likewise, in 
this account, Pauline no longer attempted to draw on restitution narratives, and instead 
despaired that hope was lost and that there was “no end to the tunnel”. Many people with 
chronic illness accept their circumstances, carry on with life, and make the most of 
asymptomatic moments. However, Pauline told of feeling “down” and like there is “end to the 
tunnel” even when she is feeling “more positive”. For Pauline, feeling better some of the time 
was not enough. Instead, she alluded to living life only being possible when she found a cure.  
Bad patient or good patient? 
When recovery begins to feel unlikely or impossible, Frank (1995) argues that the cause 
of the illness becomes of interest. When publicly available narratives no longer accurately 
frame people’s experiences, they are encouraged to find new ways of making sense of these 
experiences. Accordingly, later in the interview, Pauline began to recount stories of 
hypothesised causes with the narrative purpose of explaining and accounting for her long-term 
depression. Pauline provided an account of her psychiatrist saying to her that she was “…one 
of those patients that have been around for a long time”. At this point in time, lack of response 
to medication troubled explanations of  depression as a malfunctioning biological body. Instead, 
in this story, Pauline began to explore the idea that something about her personality or character 





Ella: I’m wondering, I’m interested in the, the time that you mentioned earlier 
when [the psychiatrist] said “people like you with major depression”. 
Can you tell me more about that situation and what happened and how 
you were feeling when that happened? 
Pauline: Um, I think I was surprised that I had ended up in that area, and then I 
like to do research so I went and had a look and see what major 
depression was or what it was. Um, and the different types of depression, 
so it was, um, it wasn’t, um, I think it was just a general talk, so it didn’t 
make me feel negative. It was just a surprise that, um, there was different 
types of depression and I ended up there sort of thing. And, I mean he 
made a comment the other day actually where I went “um, am I one of 
those difficult people am I?” (laughs). 
Ella:   You asked that? 
Pauline:  No, he said something along the lines “well um, you’re one of those 
patients that have been around for a long time” and I went “um, ok, I’m 
one of those people” (laughs). 
Pauline had an impression of the type of people who “end up in that area” and she 
resisted being positioned in this group. As McPherson and colleagues note, individuals with 
treatment resistant depression have been viewed as “manipulative”, “difficult” people with 
“generally unpleasant characteristics” by primary care clinicians such as GPs (McPherson & 
Armstrong, 2009, p.1139). Pauline was aware of the possibility of being viewed as a difficult 
patient. Pauline repeatedly stated that she was surprised by the psychiatrist’s comments and, in 
doing so, attempted to position herself as not one of “those patients”. Pauline used humour to 
diffuse the tension of me prompting, in a somewhat surprised manner, “you asked that?” Her 





whether this could be the reason for her long-term depression, whilst also distancing herself 
from “those patients”.  
Pauline provided an account of herself as a good patient willing to try a range of 
prescribed medications. Cutting across this narrative was an alternative account of struggling 
to adhere to her treatment regime at times. Pauline suggested that her depression may have 
persisted due to her withdrawing from treatment: 
Pauline:  Um, but I find that when I get quite depressed I tend to withdraw into 
myself and I will miss, not miss [psychology] appointments, cancel 
appointments, and the same as I’ll do the same thing with [the 
psychiatrist] as well that I’ll cancel appointments as well. So I tend to 
withdraw into myself. Yeah.  
Ella: And is that because you just don’t feel like going out and talking to 
people and having to…? 
Pauline:  No, it’s more probably that, um, I feel… ashamed. Well, I was going to 
say ashamed that things haven’t worked (begins to cry). 
Ella:   (offers tissues) 
Pauline:  It’s alright I’ve got some. And upset that (sighs) I have to go through it 
again (blows nose).  
Ella:  Yeah. That makes sense. 
Pauline:  But yeah, or… which I tend to do a lot, stick my head in the sand and it 
will go away. Yeah.  
Ella:   Yeah.  
Pauline:  Yeah. 
Ella:  Do you feel comfortable talking more about what you mean when you 





Pauline:  That my mind or my body have, um, failed me, that, um, that, ah… I don’t 
know (cries). 
Rather than accepting the interviewer’s suggestion that this withdrawal from treatment 
reflected symptoms of her depression (not wanting to go out and talk to people), Pauline 
provided an alternative explanation based in shame. In this excerpt, Pauline stated that she 
withdraws from treatment as she feels ashamed that she must engage with treatment again.  Her 
lack of recovery was shameful for her. . At the same time, her lack of recovery was attributed 
to her avoiding treatment and cancelling appointments. Whilst providing another way to make 
sense of her lack of recovery, this account positioned Pauline in the subject position that she 
had been tirelessly trying to avoid – one of “those difficult people” who clinicians dread.  
To counter ideas about her potentially being “one of those difficult people” or “one of 
those patients that have been around for a long time”, Pauline often returned to a story that, in 
contrast, positioned her as a good patient. In these moments, she spoke enthusiastically about 
attending appointments with her psychiatrist and clinical psychologist and trialling new, 
infrequently used, and often very expensive medications. She also alluded to a positive 
relationship with her psychiatrist, in which he disclosed his own personal experiences of 
depression and chose her to be the first patient to trial a new American drug.  
Ella:   What was that like for you that time when he said that? 
Pauline: Um, nothing, it didn’t worry me. Um, no that didn’t worry me. Um, 
because I know it’s said in a safe place, so it’s never ever anything that’s 
said, um, in a negative fashion or something to put you down. Where 
other people can do that, but with [the psychiatrist], you know that it’s... 
you know he’s been through it so he knows what it’s like, so yeah, and I 
know that I’m a bit of a… um, because 3 or 4 months ago when we went 





patients (laughs). It didn’t work, but I was the first one of his patients to 
try it! (laughs) 
Ella:  Oh that’s exciting. Sounds like he’s doing everything he possibly can. 
He’s got the trial drug and you were the first person.  
Pauline:  Well it’s not, it’s not, it’s trialling in New Zealand. They’ve never had 
anyone trial it, have it, use it in New Zealand. Um, and it was $600 a 
month, so we tried it for six weeks to see if it did anything, so yep.  
Ella:   And so that one wasn’t effective? 
Pauline:  No. 
In drawing attention to these experiences, Pauline presented herself as a person doing 
everything possible to recover. In telling this story, Pauline was able to distance herself from 
“those difficult people” as well as the idea that her long-term depression may have been 
occurring as a result of her character or personal choices. This story also countered the 
previously told “there’s no end to the tunnel” story. Instead, it drew on the publicly available 
narrative of depression and illness that suggests that good patient behaviour will lead to 
recovery. As a result of this, Pauline asserted that there was still hope of recovery.  
In presenting herself as someone who continued to persist in pursuing recovery, 
Pauline’s story aligned more closely to accounts of terminal illnesses such as cancer. Cancer 
sufferers often tell stories of tirelessly battling, drawing on inner strength and bravery to fight 
on and on, and trying any type of treatment at any cost (Ellingson, 2017). In telling a story 
that likened her experience to that of cancer sufferers, Pauline positioned herself as a tireless 
battler against a persistent illness, demonstrating her strength and bravery. Narrating her 
experience of depression in this way suggests that recovery is the only resolution for 





Throughout the interview, a narrative tension emerged with Pauline switching between 
the two competing stories of bad patient versus good patient. She appeared to need both stories 
to make sense of her experiences.  
Did my difficult life or my negative thinking cause my depression? 
“You deserve that pain”. Pauline provided another account of her reluctance to 
engage with treatment, that she felt that deserved the pain of depression. This story was told 
to account for her withdrawal from treatment, that she was not good enough to be well and 
not well enough to go to the doctor:.  
Pauline:  I suppose part of that is, why I haven’t gone to the doctor, is that, is part 
of that is the depression, is that I feel that… it feels difficult to say… I 
deserve the pain (cries). That not that I’m a bad person, but I’m, that’s 
the negative thoughts that I’m a, not a good, not a good person, not good 
enough or well enough that I can go to the doctor. Yeah, that that pain 
is part of just living with everything and that it’s, I live with pain a lot of 
the time, and I just ignore it, and that, is both physical, and then when I 
get a depression, that’s also emotional. So you get used to the pain and 
you get used to thinking that you deserve that pain. Yeah.  
Ella:   I wonder where that comes from? Like the feeling that you deserve it? 
Pauline:  Um… (cries) from… younger and negative things that have happened 
in my life. Um, and they get reinforced and that’s the spiral that leads 
down to the depression as well, is that you think that you’re not good 
enough and so that’s part of the spiral down into the depression and 
then when you’re there you think all those thoughts all the time so it’s 





Ella:  Yeah, yeah. So those negative thoughts get you there and then when 
you’re there it’s happening so much and you sort of start thinking, 
‘well, I don’t deserve to be getting any better’? 
Pauline:  Yeah.  
In this account, Pauline appeared to be suggesting that it her long-term depression may 
be warranted due to her previous experiences or qualities. In telling this story, Pauline 
reconstructed her depression, not as an illness with a biological basis, but as punishment. This 
story likened the depression to a punishment for “negative things that have happened in [her] 
life” and positioned Pauline not as someone with malfunctioning brain biology, but as someone 
deserving the pain of depression. Essentially, the story went: I am a bad person, which is why 
bad things happened to me when I was younger and why bad things are happening to me now. 
In this account, Pauline was employing the same meaning making process that she used in her 
earlier life to make sense of and explain why she was not recovering from depression in the 
present day. 
 This type of account was not unfamiliar to me as a clinical psychology trainee and not 
unfamiliar to Pauline, who had likely told this story many times to psychiatrists and 
psychologists in the months and years prior. This section of the interview took on a strong 
therapy flavour, with me inadvertently positioning myself as therapist and using phrases such 
as “I wonder where that came from” and “it makes me feel happy to hear that…”, and Pauline 
assuming the position of client/patient. As a result of this dynamic, the adopted roles, and the 
shared familiarity, Pauline and I co-constructed a rich and detailed narrative of depression as 
the culmination of a series of difficult or traumatic life events.  
“Negative thoughts”. As well as storying depression as an inevitable consequence of 
difficult life events, Pauline also presented an alternative story. This account suggested that 





rather than the life events themselves. This cognitive conceptualisation is a dominant 
narrative of depression and mental illness more generally within the world of clinical 
psychology. It is likely, therefore, that Pauline learned to account for her depression in this 
way through her seven years of psychological therapy. Within this excerpt, Pauline frequently 
switches between the “you deserve that pain” story and the “negative thoughts” account. The 
psychologised language that Pauline employed to narrate the “negative thoughts” story almost 
made it seem that her psychologist was present in the room, reframing Pauline’s statements 
and helping her “have another way of looking at it”.  
Pauline:  Yes, but since [the negative thoughts] happened when I was younger, 
I’ve had them for such a long time and what I’ve learnt over… is that it 
is hard to let them go and it’s only in the last two or three years that 
I’ve managed to say “well, that was then, that is, um, quite often that 
person reflecting or doing something that’s negative to me but I didn’t 
do anything, ah, that I knew of and I can’t change that”. But that’s 
been really hard to, um, get past… Yeah. And to not, when I’m 
depressed, not to grab onto those thoughts that, you know, “I’m such a 
bad person, that’s why people don’t like me or that’s why they did that 
to me” when it’s quite often themselves doing it because they are angry 
or upset or something or other and then that’s deflecting onto you. But 
that, at the very beginning, those thoughts would be there, and it’s only 
the last couple of years that I’ve managed to try and turn that around 
and have another way of looking at it. Yeah, yeah. 
Conclusion 
This single case study used a narrative research approach to explore how one woman 





three main narrative tensions emerged: ‘Am I getting better or am I stuck?’ ‘Am I good patient 
or a bad patient?’ Did my difficult life or my negative thinking cause my depression?’ Each of 
the stories told by Pauline, whilst often conflicting, had advantages and disadvantages in the 
way that they positioned her and accounted for her experiences.  
The “I, you know, am now getting better” story, which drew strongly on Frank’s (1995) 
restitution narrative and other publicly available narratives of depression and illness, provided 
Pauline with a socially acceptable way of storying her experience of depression to others. It 
also allowed her to conceptualise her depression as a temporary biological malfunction, to hold 
onto hope, and to maintain her position in society as a worthwhile human being. Over time, it 
became increasingly difficult for Pauline to narrate her experiences using this account as her 
depression did not resolve. Instead, Pauline narrated her ongoing struggles with depression 
through the “no end to the tunnel” story, which linked depression to chronic illness. This 
narrative was difficult for Pauline, however, as it required her to accept that her depression may 
not be resolved. 
The conflicting good versus bad patient stories also each had advantages and 
disadvantages for Pauline. The bad patient account provided Pauline with a way of making 
sense of her long-term depression, as it made intuitive sense to her and others that someone 
who does not follow treatment advice would remain unwell. However, her lack of recovery 
contributed to her being positioned as one of the “manipulative”, “difficult” people with 
“generally unpleasant characteristics” who health professionals dread (McPherson & 
Armstrong, 2009), and attributed her depression to flaws within her character. The conflicting 
good patient story allowed Pauline to counter the bad patient story and present herself in a 
positive and virtuous light to me, the interviewer. It also allowed her to hold onto the publicly 
available narrative that good patient behaviour leads to recovery and, resultantly, hope. 





confronting question: what does it mean that I am being a good patient and still not getting 
better?  
Lastly, the stories situated within ‘did my difficult life or my negative thinking cause my 
depression?’  tension, also both had advantages and disadvantages. Pauline’s account of 
depression as inevitable punishment for a life of trauma fulfilled the narrative function of 
accounting for her long-term depression. It was narrated and received as a rehearsed and 
familiar story. Conversely, however, this particular story framed depression and suffering as 
her inescapable fate. The conflicting and more recently adopted “negative thoughts” account 
also provided Pauline with a way of accounting for her experiences of depression. To some 
extent, this account also drew on the restitution narrative so offered some degree of hope to 
Pauline that, if she fixed her negative thinking, she would recover.  
Pauline drew on a number of competing illness and mental health narratives and cycled 
through telling numerous, context specific, and often conflicting stories in an attempt to make 
sense of her lived experiences. This analysis suggests that, faced with a lack of public narratives 
that accurately frame their experiences, individuals with treatment resistant depression struggle 
to renegotiate their identities and restore any sense of coherence.  
Clinical Reflection 
Pauline was the first person I met with treatment resistant depression. As treatment 
resistant depression is the topic of my doctoral research, I had spent many hours reading 
scientific literature and thinking about this form of depression as a theoretical concept. It was 
an entirely different experience, however, to meet Pauline and to hear about the experience of 
treatment resistant depression from her perspective. It was both fascinating and heart-breaking 
to hear Pauline’s story. I could not believe that she had been depressed for nine years, had 
trialled upwards of 20 antidepressant medications, and had attended endless appointments with 





would take to carry on with life. The 80 minute unstructured interview with Pauline produced 
vastly different information to an initial clinical assessment and gave me new insights into the 
nuances of the pain that our clients feel. Following the interview, Pauline remarked that she had 
enjoyed being able to share her story of depression and had found it therapeutic. This made me 
realise the importance of achieving a balance between information gathering, “box ticking” and 
agenda following, AND allowing clients to tell their stories in a way that makes sense to them.  
 Faced with her experiences not fitting the ‘standard story’ of depression, Pauline had 
significant difficulty making sense of what was going on for her. In clinical terms, she explored 
many possible predisposing, precipitating, and perpetuating factors of her depression. For 
example, she spoke about difficult and traumatic life events, being a bad patient, deserving the 
pain, and having negative thoughts. None of these explanations were sufficient alone so Pauline 
cycled through them all, often abandoning one story/explanation in favour of another. 
Following this analysis, I began to reflect on how a large part of our role as clinical 
psychologists is helping people understand what is happening to them. Humans are constantly 
storying their experiences in an attempt to make sense of their lives and this is particularly 
evident after “biographical disruptions”, such as mental illness (Frank, 1995). It has been 
interesting to see how this plays out in clinical practice. On the one hand, some clients have 
rehearsed explanations for why they are mentally unwell, for example, “my mother died” or 
“there is a chemical imbalance in my brain”. On the other hand, many clients tearfully despair 
“I don’t know why this is happening to me!” and are very unsettled by this lack of understanding 
of causation. As clinical psychologists, we have a useful and powerful tool for assisting clients 
in making sense of and understanding their experiences: formulation. In many cases, after 
discussion of a formulation in session, clients have stated that it is a relief to know what is going 





 It was very interesting to read the literature on healthcare professionals’ reactions to 
people with treatment resistant depression (McPherson et al., 2006; McPherson et al., 2009). 
Since reading these articles, I have become more aware of my own reactions to clients and the 
way that certain clients are spoken about and constructed in the workplace. At times I have 
noticed my own “heart sink” feelings when I am seeing a client who is not improving despite 
my efforts. I have also occasionally noticed clinicians attributing clients’ long term difficulties 
to ‘personality disorders’ or the fact that they are ‘interpersonally challenging’. Learning that 
Pauline was privy to the way she was positioned by healthcare professionals has prompted me 
to explore my own feelings of frustration or dread associated with some clients, and to consider 
what I can do about these feelings to prevent them from interfering with treatment. For me, as 
a novice therapist, I have found that my clients’ lack of improvement tends to trigger thoughts 
such as “I’m not good at this job”, “this client would have benefited more in seeing someone 
else”, and “I must be doing something wrong”. This exploration has been useful – it has helped 
me understand where these feelings originate and has prompted me to be mindful and challenge 
this thinking when appropriate. I have also found discussions in supervision to be very helpful 
when I notice these feelings. 
 Whilst grounded in a different epistemology to mainstream clinical psychology, the 
process of meeting Pauline and analysing her data has deeply informed my clinical practice. It 
has expanded my understanding of depression, treatment resistant depression, and mental 
illness, provided me with insight into the lived experience of the pain of treatment resistant 
depression, and has prompted me to consider my own reactions to “difficult” clients. This 
process has been an invaluable experience and I now feel much better equipped to work with 
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